Amino Acids, Peptides, and Proteins

Amino acids and chains of amino acids connected by peptide linkages.
DrugDrug NameDrug Description
DB00001LepirudinA protein-based direct thrombin inhibitor used to reverse and prevent thrombus formation in heparin-induced thrombocytopenia.
DB00002CetuximabAn endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck.
DB00003Dornase alfaA synthetic form of human deoxyribonuclease I used to break down extracellular DNA in the lungs, a major source of mucous viscosity in cystic fibrosis.
DB00004Denileukin diftitoxA recombinant cytotoxic protein based on a combination of diphtheria toxin fragments and interleukin-2 used to treat cutaneous T-cell lymphoma by targeting the interleukin-2 receptor.
DB00005EtanerceptA protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.
DB00006BivalirudinA direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to prevent thrombosis during percutaneous coronary intervention.
DB00007LeuprolideA protein-based luteinizing hormone antagonist used to treat prostate cancer, endometriosis, and precocious puberty.
DB00008Peginterferon alfa-2aA modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.
DB00009AlteplaseA recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.
DB00010SermorelinFor the treatment of dwarfism, prevention of HIV-induced weight loss
DB00011Interferon alfa-n1A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus.
DB00012Darbepoetin alfaA recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia.
DB00013UrokinaseA low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.
DB00014GoserelinA synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.
DB00015ReteplaseA purified form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.
DB00016ErythropoietinA recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia.
DB00017Salmon CalcitoninA synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease.
DB00018Interferon alfa-n3A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus.
DB00019PegfilgrastimA recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy.
DB00020SargramostimA modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.
DB00022Peginterferon alfa-2bA purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers.
DB00024Thyrotropin alfaA recombinant form of thyroid stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue.
DB00025Antihemophilic factor, human recombinantA form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency.
DB00026AnakinraA recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis and neonatal-onset multisystem inflammatory disease.
DB00027Gramicidin DA bactericidal antibiotic used in the treatment of dermatological and ophthalmic infections.
DB00028Immune globulin humanA purified form of human immunoglobulin G and other proteins used to treat immunodeficiency and a wide variety of autoimmune disorders.
DB00029AnistreplaseA form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli.
DB00030Insulin humanA recombinant form of human insulin used to control hyperglycemia in diabetes mellitus.
DB00031TenecteplaseA modified form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli.
DB00032MenotropinsA purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility.
DB00033Interferon gamma-1bA form of recombinant human interferon used to treat infections associated with chronic granulomatous disease and to slow the progression of severe malignant osteopetrosis.
DB00035DesmopressinA synthetic analog of vasopressin used to reduce renal excretion of water in central diabetes insipidus and nocturia.
DB00036Coagulation factor VIIa Recombinant HumanA form of recombinant human coagulation Factor VII used to treat hemophilia A and B.
DB00038OprelvekinA form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy.
DB00039PaliferminA form of recombinant human keratinocyte growth factor used to prevent and treat oral mucositis following radiation or chemotherapy.
DB00040GlucagonA form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures.
DB00041AldesleukinA recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma.
DB00042Botulinum Toxin Type BA purified form of botulinum toxin type B used to block acetylcholine release in the treatment of cervical dystonia and sialorrhea.
DB00043OmalizumabA monoclonal anti-immunoglobulin E antibody used in the treatment of severe asthma and chronic idiopathic urticaria.
DB00046Insulin lisproA modified form of fast-acting insulin used to control hyperglycemia in diabetes mellitus.
DB00047Insulin glargineA modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus.
DB00050CetrorelixA synthetic peptide antagonist of gonadotropin releasing hormone used to prevent luteinizing hormone surges in women undergoing assisted reproduction therapy.
DB00051AdalimumabA monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DB00052SomatotropinA form of recombinant human growth hormone used to treat dwarfism, growth hormone deficiency, and acromegaly as well as to prevent weight loss in HIV patients.
DB00054AbciximabA monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention.
DB00055Drotrecogin alfaA form of recombinant activated human protein C used to reduce mortality in patients with severe sepsis by inhibiting coagulation Factors V and VIII.
DB00056Gemtuzumab ozogamicinA monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia.
DB00057Indium In-111 satumomab pendetideFor diagnosis of extrahepatic malignant cancers
DB00058Alpha-1-proteinase inhibitorA purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency.
DB00060Interferon beta-1aA form of recombinant human interferon used to slow disease progression and reduce the frequency of clinical symptoms in patients who have relapsing multiple sclerosis.
DB00062Human Serum AlbuminA purified form of human serum albumin used to replace lost albumin in patients with hypoalbuminemia, to treat hypovolemia and ascites, and as a part of some diagnostic imaging kits.
DB00063EptifibatideA peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention.
DB00065InfliximabA monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DB00066FollitropinA form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism.
DB00067VasopressinA peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy.
DB00068Interferon beta-1bA form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms.
DB00069Interferon alfacon-1A recombinant interferon similar the interferon alfa subtype which is used to treat hepatitis C infections.
DB00071Insulin PorkA purified form of porcine insulin used to control hyperglycemia in diabetes mellitus.
DB00072TrastuzumabA monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.
DB00073RituximabA monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.
DB00074BasiliximabA monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients.
DB00075MuromonabA monoclonal anti-CD3 antibody used as immunosuppressive therapy in kidney, heart, and liver transplant patients.
DB00078Ibritumomab tiuxetanA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
DB00080DaptomycinA cyclic lipopeptide antibiotic used to treat complicated skin infections and bacteremia due to Staphylococcus aureus.
DB00081TositumomabA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
DB00082PegvisomantA growth hormone receptor antagonist used to treat acromegaly.
DB00083Botulinum toxin type AA purified form of botulinum toxin type A used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications.
DB00086StreptokinaseA purified fibrinolytic bacterial protein used to breakdown thrombosis in myocardial infarction, pulmonary embolism, and venous thromboembolism.
DB00087AlemtuzumabA monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis.
DB00089Capromab pendetideA monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue.
DB00092AlefaceptA recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
DB00093FelypressinFor use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
DB00094UrofollitropinA form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure.
DB00095EfalizumabA monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis.
DB00098Antithymocyte immunoglobulin (rabbit)A purified form of rabbit anti-thymocyte antibodies used for immunosuppression in patients receiving kidney transplants.
DB00099FilgrastimA form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy.
DB00102BecaplerminA recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area.
DB00103Agalsidase betaA form of recombinant human alpha-galactosidase A enzyme used to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide.
DB00104OctreotideA peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors.
DB00106AbarelixFor palliative treatment of advanced prostate cancer.
DB00107OxytocinA recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding.
DB00108NatalizumabA monoclonal anti-integrin antibody which binds to the alpha 4 subunit of integrins to prevent migration of immune cells, and is used to treat Crohn's disease or multiple sclerosis.
DB00109EnfuvirtideAn HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals.
DB00110PalivizumabA monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients.
DB00111DaclizumabA monoclonal anti-CD25 antibody that blocks the interleukin-2 receptor which is used to treat relapsing forms of multiple sclerosis.
DB00112BevacizumabA monoclonal anti-vascular endothelial growth factor antibody used in the treatment of many cancer types in combination with other antineoplastics.
DB00113Technetium Tc-99m arcitumomabFor imaging colorectal tumors
DB00117HistidineAn amino acid commonly found as a component of total parenteral nutrition.
DB00118AdemetionineS-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as...
DB00120L-PhenylalanineAn amino acid commonly found as a component of total parenteral nutrition.
DB00123L-LysineAn amino acid commonly found as a component of total parenteral nutrition.
DB00125ArginineAn amino acid commonly found as a component of total parenteral nutrition.
DB00128Aspartic acidAn amino acid commonly found as a component in total parenteral nutrition.
DB00130L-GlutamineAn amino acid commonly found as a component in total parenteral nutrition.
DB00133SerineAn amino acid commonly found as a component in total parenteral nutrition.
DB00134MethionineAn amino acid commonly found as a component in total parenteral nutrition.
DB00135TyrosineAn amino acid commonly found as a component in total parenteral nutrition.
DB00138CystineAn oxidated derivative of the amino acid cysteine found in various nutritional products and creams to treat cervical injury or inflammation.
DB00142Glutamic acidAn amino acid commonly found as a component in total parenteral nutrition.
DB00143GlutathioneFor nutritional supplementation, also for treating dietary shortage or imbalance
DB00145GlycineAn amino acid commonly used as a component of total parenteral nutrition and is also used as irrigation during surgery.
DB00148CreatineFor nutritional supplementation, also for treating dietary shortage or imbalance.
DB00149L-LeucineAn amino acid commonly found as a component of total parenteral nutrition.
DB00150L-TryptophanAn amino acid commonly found as a component of total parenteral nutrition.
DB00151L-CysteineAn amino acid commonly found as a component of total parenteral nutrition and used as an antidote for acetaminophen overdose.
DB00155CitrullineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00156L-ThreonineAn amino acid commonly found as a component of total parenteral nutrition.
DB00160L-AlanineAn amino acid commonly found as a component of total parenteral nutrition.
DB00161L-ValineAn amino acid commonly found as a component of total parenteral nutrition.
DB00167IsoleucineAn amino acid commonly found as a component of total parenteral nutrition.
DB00168AspartameUsed as a diet supplement and sugar substitute.
DB00172ProlineAn amino acid commonly found as a component of total parenteral nutrition.
DB00174AsparagineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00181BaclofenA GABA-ergic agonist used to manage severe spasticity of cerebral or spinal origin in adult and pediatric patients.
DB00183PentagastrinA gastrin-like molecule used as a diagnostic aid for the evaluation of gastric acid secretory function, gastric hypersecretion, and Zollinger-Ellison tumors.
DB00230PregabalinAn anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.
DB00260CycloserineA broad-spectrum antibiotic used in the treatment of tuberculosis and certain urinary tract infections (UTI).
DB00290BleomycinA chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others.
DB00314CapreomycinAn aminoglycoside antibiotic used as an adjunct drug in tuberculosis.
DB00362AnidulafunginAn antifungal used in the treatment of several types of candida infections.
DB00403CeruletideCaerulein is used in the treatment of paralytic ileus and as diagnostic aid in pancreatic malfunction.
DB00420PromazineA phenothiazine used to manage schizophrenia.
DB00451LevothyroxineA synthetic T4 hormone used to treat hypothyroidism that can be used along with surgery and radioiodine therapy to manage thyrotropin-dependent well-differentiated thyroid cancer.
DB00492FosinoprilAn ACE inhibitor used to treat mild to moderate hypertension, congestive heart failure, and to slow the progression of renal disease in hypertensive diabetics.
DB00509DextrothyroxineA thyroid hormone used to treat hyperlipidemia.
DB00512VancomycinA glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.
DB00513Aminocaproic acidAn antifibrinolytic agent used to induce clotting postoperatively.
DB00520CaspofunginAn echinocandin used to treat a variety of fungal infections.
DB00556PerflutrenA diagnostic medication to improve contrast during echocardiograms.
DB00577ValaciclovirAn guanine nucleoside antiviral used to treat herpes exacerbations.
DB00584EnalaprilA prodrug of an ACE inhibitor used to treat hypertension and congestive heart failure.
DB00626BacitracinA cyclic polypeptide antibiotic used to prevent wound infections, treat pneumonia and empyema in infants, and to treat skin and eye infections.
DB00642PemetrexedA folate analog used to treat mesothelioma and non-small cell lung cancer.
DB00644GonadorelinA synthetic GnRH used to test the function of gonadotropes and the pituitary.
DB00666NafarelinA gonadotropin releasing hormone agonist used to treat central precocious puberty.
DB00722LisinoprilAn ACE inhibitor used to treat hypertension, heart failure, and acute myocardial infarction.
DB00731NateglinideA meglitinide used to treat non insulin dependent diabetes mellitus.
DB00765MetyrosineA tyrosine 3-monooxygenase inhibitor used to treat excessive sympathetic stimulation in pheochromocytoma.
DB00775TirofibanA platelet aggregation inhibitor used to prevent thrombotic events in non-ST elevated acute coronary syndrome.
DB00803ColistinA polymyxin antibiotic used to treat bacterial infections caused by susceptible Gram negative bacteria.
DB00837ProgabideIndicated for the treatment of epilepsy.
DB00855Aminolevulinic acidA porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma.
DB00859PenicillamineA chelator used to treat Wilson's disease, cystinuria, and rheumatoid arthritis.
DB00968MethyldopaAn alpha-2 adrenergic agonist used to treat hypertension.
DB00970DactinomycinAn actinomycin used to treat a wide variety of cancers.
DB00992Methyl aminolevulinateA porphyrin precursor used to treat non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp.
DB00996GabapentinAn anticonvulsant medication used in the management of peripheral neuropathic pains, postherpetic neuralgia, and partial-onset seizures.
DB01042MelphalanAn alkylating antineoplastic agent used to treat multiple myeloma and ovarian carcinoma.
DB01055MimosineMimosine is an antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.
DB01072AtazanavirAn antiviral protease inhibitor used in combination with other antiretrovirals for the treatment of HIV.
DB01080VigabatrinAn irreversible GABA transaminase inhibitor used as an adjunct to treat refractory complex partial seizures in patients ≥10 years unresponsive to alternatives. May also be used as monotherapy to treat infantile spasms in infants 1 month to 2 years.
DB01111ColistimethateAn antibiotic indicated for treatment of infections caused by susceptible strains of certain gram-negative bacilli. It is particularly useful for targeting sensitive strains of Pseudomonas aeruginosa.
DB01141MicafunginAn antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation.
DB01197CaptoprilAn ACE inhibitor used for the management of essential or renovascular hypertension, congestive heart failure, left ventricular dysfunction following myocardial infarction, and nephropathy.
DB01221KetamineA rapid-acting general anesthetic and NMDA receptor antagonist used for induction of anesthesia diagnostic and surgical procedures typically in combination with a muscle relaxant.
DB01235LevodopaA dopamine precursor used in the management of Parkinson's disease, often in combination with carbidopa, as well as other conditions associated with parkinsonism.
DB01257EculizumabA recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
DB01269PanitumumabA recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens.
DB01270RanibizumabA recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.
DB01276ExenatideA GLP-1 agonist used in the management of type 2 diabetes mellitus.
DB01277MecaserminA recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH.
DB01278PramlintideAn amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
DB01279GalsulfaseA recombinant human enzyme used as replacement enzyme therapy for the treatment of of adults and children with Mucopolysaccharidosis VI, a rare genetic disorder caused by a deficiency of a lysosomal enzyme.
DB01281AbataceptA disease-modifying antirheumatic drug (DMARD) used for the management of moderate-to-severe active rheumatoid arthritis and active polyarticular juvenile idiopathic arthritis as monotherapy or in combination with other DMARDs.
DB01282CarbetocinAn oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth.
DB01284TetracosactideA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
DB01285CorticotropinA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
DB01306Insulin aspartA rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
DB01307Insulin detemirA long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
DB01309Insulin GlulisineA short-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
DB01348SpiraprilSpirapril is an ACE inhibitor class drug used to treat hypertension.
DB01369QuinupristinAn antibiotic agent used in the treatment of serious vancomycin-resistant Enterococcus faecium bacteremia as well as complicated skin and skin structure infections.
DB01373CalciumA mineral found in over-the-counter supplements or prescription formulations used for the treatment of specific medical conditions related to calcium deficiency.
DB01423SteproninStrepronin is a mucolytic (expectorant) drug.
DB01583LiotrixMay be used to treat primary, secondary or tertiary hypothyroidism. May also be used to suppress thyroid stimulating hormone (TSH) secretion in patients with simple (nontoxic) goiter, subacute or chronic...
DB01584ThyroglobulinFor the treatment of hypothyroidism (deficiency in the production of thyroid hormone).
DB01646N-AcetylmethionineNot Available
DB01669Virginiamycin M1For the treatment of bacterial infections.
DB01683ChymostatinNot Available
DB01686N,N-dimethylarginineAsymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. It is a metabolic by-product of continual protein modification processes in the cytoplasm of all human cells which...
DB01764DalfopristinAn antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.
DB01783Pantothenic acidA vitamin B5 found in various nutritional supplements.
DB01853Bacteriochlorophyll AA specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.
DB02011N-(Phosphonoacetyl)-L-OrnithineNot Available
DB02083N,N-dimethylglycineNot Available
DB02109HadacidinNot Available
DB02123Glycochenodeoxycholic AcidA bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed....
DB02137Molybdenum cofactorAbsence of molybdenum cofactor leads to accumulation of toxic levels of sulphite and neurological damage usually leading to death within months of birth, due to the lack of active sulfite...
DB02216S-MethylcysteineNot Available
DB02235L-methionine (R)-S-oxideNot Available
DB02236Glycinamide RibonucleotideNot Available
DB02255GM6001Not Available
DB02261Platelet Activating FactorNot Available
DB022747-Keto-8-Aminopelargonic AcidNot Available
DB02307N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-AsparagineNot Available
DB02341Mdl 101,146Not Available
DB02345SelenocysteineA naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and...
DB02386Leucine Phosphonic AcidNot Available
DB02518N-AcetylalanineNot Available
DB02543Pyrrole-2-CarboxylateNot Available
DB02557PhosphoramidonNot Available
DB02578Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-AlanineNot Available
DB02595Bulgecin ANot Available
DB026014-HydroxyphenylglycineNot Available
DB02608N-Acetyl-P-NitrophenylserinolNot Available
DB02638TerlipressinCommonly used to stop bleeding of varices in the food pipe (oesophagus).
DB02655D-Aspartic AcidThe D-isomer of aspartic acid. [PubChem]
DB02810N-(2-Acetamido)Iminodiacetic AcidNot Available
DB02821CanalineNot Available
DB02855N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineNot Available
DB02952Alpha-Aminoisobutyric AcidNot Available
DB02959OxitriptanFor use as an antidepressant, appetite suppressant, and sleep aid.
DB02975GE-2270ANot Available
DB02978Beta-HydroxyleucineNot Available
DB02999QuisqualateAn agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound...
DB03032S-OctylglutathioneNot Available
DB03088Pidolic acidThere is currently no clinically approved and/or marketed medicine that relies upon pidolic acid as an active ingredient for any formal therapeutic indication. Although pidolic acid may be sold in...
DB03107Beta-AlanineAn amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a...
DB03144N-Omega-Hydroxy-L-ArginineNot Available
DB03157N,O-Didansyl-L-TyrosineNot Available
DB03214VinylglycineVinylglycine is an irreversible inhibitor of aspartate aminotransferase.
DB03223DiphthamideNot Available
DB03251RWJ-51084Not Available
DB03295GlutathionylspermidineNot Available
DB03360N-AcetylprolineNot Available
DB03380L-tyrosinamideNot Available
DB03395EnalkirenNot Available
DB03408gamma-GlutamylcysteineNot Available
DB03424UbenimexAn adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia.
DB034252s,4r-4-MethylglutamateNot Available
DB03436GallichromeNot Available
DB03458N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acidN(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.
DB03459Sparfosic acidSparfosic acid is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen...
DB03470TrypanothioneNot Available
DB03535Z-Pro-ProlinalNot Available
DB03544S-PhosphocysteineNot Available
DB035523-TyrosineNot Available
DB03632ArgifinNot Available
DB03640Beta-Hydroxyaspartic AcidNot Available
DB036604-Iodo-L-phenylalanineNot Available
DB03709BicineNot Available
DB03799TrifluoromethionineNot Available
DB03817L-2,4-diaminobutyric acidNot Available
DB03880BatimastatNot Available
DB03889S-(N-Hydroxy-N-Bromophenylcarbamoyl)GlutathioneNot Available
DB03940Oxamic AcidAmino-substituted glyoxylic acid derivative. [PubChem]
DB04029Phenylalanine AmideNot Available
DB04092ApstatinNot Available
DB04111BalhimycinBalhimycin is a novel glycopeptide antibiotic.
DB04129WillardiineWillardiine is a compound isolated from seeds of Acacia willariana.
DB04132S-HexylglutathioneNot Available
DB04167AceglutamideNot Available
DB04185NorvalineNorvaline is an isomer of the more common amino acid valine.
DB04189N2-(Carboxyethyl)-L-ArginineNot Available
DB04191Skf 107457Not Available
DB04217L-2-amino-3-butynoic acidNot Available
DB04223NitroarginineAn inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in...
DB04269Cyclotheonamide ANot Available
DB04284L-proline betaineNot Available
DB04291OxfenicineOxfenicine in an inhibitor of myocardial metabolism of nonesterified fatty acids (NEFA).
DB04308D-4-hydroxyphenylglycineNot Available
DB043346-hydroxydopa quinoneNot Available
DB04350ArgadinNot Available
DB04370S-sulphocysteineNot Available
DB04391Aeruginosin 98-BNot Available
DB04418Adenylosuccinic acidNot Available
DB04454Alpha-Aminobutyric AcidNot Available
DB04464N-FormylmethionineEffective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in...
DB04495RU81843Not Available
DB04498Aspartate SemialdehydeNot Available
DB04527beta-HydroxyasparagineNot Available
DB04539GlyphosateNot Available
DB04584PhenyldehydroalanineNot Available
DB04620CycloleucineCycloleucine is non-metabolisable amino acid formed by cyclization of leucine. It is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.
DB04676DansyllysineNot Available
DB04738MotuporinMotuporin is a toxin isolated from the marine sponge Thenonella swinhoie grey.
DB04798THIO-ATPANot Available
DB04805Virginiamycin S1One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. It is used to treat infections...
DB04847RoxadustatIn clinical development for the treatment of anemia of chronic inflammatory disease.
DB04869OlcegepantFor the treatment of migraine headaches.
DB04894VapreotideFor the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.
DB04897LucinactantIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
DB04899NesiritideA recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
DB04900ThymalfasinIndicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate...
DB04901GaliximabInvestigated for use/treatment in lymphoma (non-hodgkin's), psoriasis and psoriatic disorders, bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.
DB04911OritavancinAn antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria.
DB04914G17DTIntended for the treatment of various forms of cancer.
DB04921DirucotideFor the treatment of multiple sclerosis (MS).
DB04925DesmoteplaseInvestigated for use/treatment in cerebral ischemia and strokes.
DB04931AfamelanotideAn injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP).
DB04945HemoglobinAn iron-containing protein found in all red blood cells (RBCs) for proper binding of oxygen and transport throughout the body, included in blood transfusions in severe hemorrhage.
DB04949PexelizumabFor the treatment of inflammation during cardiac surgery.
DB04952RamoplaninFor the treatment of bacterial infections.
DB04956AfelimomabInvestigated for use/treatment in sepsis and septicemia.
DB04958EpratuzumabInvestigated for use/treatment in leukemia (lymphoid), lymphoma (non-hodgkin's), and systemic lupus erythematosus.
DB04962BectumomabInvestigated for use/treatment in lymphoma (non-hodgkin's).
DB04964OregovomabInvestigated for use/treatment in ovarian cancer.
DB04972CanfosfamideIntended for the treatment of various forms of cancer.
DB04977PlitidepsinIntended for the treatment of various forms of cancer.
DB04985TigapotideFor the treatment of late stage Hormone Refractory Prostate Cancer (HRPC) for which no effective therapy currently exists.
DB04988IGN311Intended for the treatment of various forms of cancer.
DB05006AdecatumumabInvestigated for use/treatment in breast cancer and prostate cancer.
DB05012XEN2174For the treatment of chronic cancer pain.
DB05029LancovutideInvestigated for use/treatment in cystic fibrosis and eye disorders/infections.
DB05032REV131Investigated for use/treatment in allergic reaction, allergic rhinitis, and cataracts.
DB05034UlaritideInvestigated for use/treatment in congestive heart failure.
DB05084AbaloparatideA parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in postmenopausal women with a high risk of fracture.
DB05092CDP323Investigated for use/treatment in multiple sclerosis.
DB05096LY2140023Investigated for use/treatment in psychosis and schizophrenia and schizoaffective disorders.
DB05097LabetuzumabLabetuzumab is a humanized monoclonal antibody used to treat cancer. Retrieved from "http://en.wikipedia.org/wiki/Labetuzumab"
DB05098LeptinInvestigated for use/treatment in lipodystrophy and obesity.
DB05101MatuzumabInvestigated for use/treatment in cervical dysplasia/cancer, colorectal cancer, gastric cancer, and lung cancer.
DB05111FontolizumabInvestigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.
DB05115NN344Investigated for use/treatment in diabetes mellitus type 1 and 2.
DB05128AminocandinInvestigated for use/treatment in fungal infections.
DB05130INCB3284Investigated for use/treatment in inflammatory disorders (unspecified).
DB05136BavituximabInvestigated for use/treatment in breast cancer, cancer/tumors (unspecified), HIV infection, hepatitis (viral, C), and solid tumors.
DB05139CR002Investigated for use/treatment in nephropathy.
DB05155CR665Investigated for use/treatment in pain (acute or chronic).
DB05158PM02734Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
DB05160TopsalysinInvestigated for use/treatment in benign prostatic hyperplasia, cancer/tumors (unspecified), prostate cancer, prostate disorders, and solid tumors.
DB05161ElafinInvestigated for use/treatment in inflammatory disorders (unspecified).
DB05199LX1031Irritable bowel syndrome (IBS) and other gastrointestinal disorders
DB05209RozrolimupabInvestigated for use/treatment in thrombocytopenia.
DB05210SF1126For the treatment of various forms of cancer.
DB05258Interferon alfaInvestigated for use/treatment in hepatitis (viral, C), leukemia (lymphoid), leukemia (myeloid), leukemia (unspecified), and melanoma.
DB05259GlatiramerAn immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS).
DB05276Hepatitis B Immune GlobulinAn injection of immunoglobulin G (IgG) antibodies to prevent the development of chronic Hepatitis B infection.
DB05299keyhole limpet hemocyaninInvestigated for use/treatment in bladder cancer and solid tumors.
DB05305Cintredekin BesudotoxInvestigated for use/treatment in brain cancer.
DB05311EcallantideA kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE).
DB05319Oportuzumab monatoxInvestigated for use/treatment in bladder cancer and head and neck cancer.
DB05332RomiplostimA fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP).
DB05336ObiltoxaximabA monoclonal antibody used for prophylaxis or treatment of inhalational anthrax.
DB05344Ciliary neurotrophic factorInvestigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).
DB05393NOV-002Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer.
DB05394CorticorelinInvestigated for use/treatment in brain cancer and neurologic disorders.
DB05396Albinterferon Alfa-2BInvestigated for use/treatment in hepatitis (viral, C).
DB05405XTL-001Investigated for use/treatment in hepatitis (viral, B).
DB05413TifuvirtideInvestigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.
DB05434ABT-510Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.
DB05437NAV 1800Investigated for use/treatment in colorectal cancer and solid tumors.
DB05446LJP 1082Investigated for use/treatment in autoimmune diseases, strokes, and thrombosis.
DB05459BriakinumabInvestigated for use/treatment in autoimmune diseases, crohn's disease, multiple sclerosis, psoriasis and psoriatic disorders, and rheumatoid arthritis.
DB05460EzatiostatInvestigated for use/treatment in myelodysplastic syndrome.
DB05475GolotimodInvestigated for use/treatment in hepatitis (viral, C), infectious and parasitic disease (unspecified), and tuberculosis.
DB05476WX-UK1Investigated for use/treatment in solid tumors.
DB05496OtelixizumabInvestigated for use/treatment in diabetes mellitus type 1, pediatric indications, and psoriasis and psoriatic disorders.
DB05507VX-765Investigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders.
DB05518Managlinat dialanetilInvestigated for use/treatment in diabetes mellitus type 2.
DB05521TelaprevirAn NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections.
DB05540AlanosineInvestigated for use/treatment in brain cancer and cancer/tumors (unspecified).
DB05545AMG 108Investigated for use/treatment in osteoarthritis and rheumatoid arthritis.
DB05550IratumumabInvestigated for use/treatment in lymphoma (unspecified).
DB05555EnokizumabInvestigated for use/treatment in asthma.
DB05560DelcasertibInvestigated for use/treatment in myocardial infarction.
DB05578RamucirumabAn antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply.
DB05584PraconaseInvestigated for use/treatment in spinal cord injuries.
DB05595FarletuzumabInvestigated for use/treatment in ovarian cancer.
DB05599Fibroblast growth factor-1Investigated for use/treatment in coronary artery disease and peripheral vascular disease.
DB05625CTCE-9908Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and sarcoma.
DB05633GlypromateInvestigated for use/treatment in neurologic disorders.
DB05645LarazotideInvestigated for use/treatment in autoimmune diseases, diabetes mellitus type 1, and gastrointestinal diseases and disorders (miscellaneous).
DB05656VeltuzumabInvestigated for use/treatment in lymphoma (non-hodgkin's).
DB05660D-JNKI-1Investigated for use/treatment in hearing loss.
DB05668PalifosfamideInvestigated for use/treatment in cancer/tumors (unspecified), lymphoma (unspecified), and sarcoma.
DB05675EP-2104RInvestigated for use/treatment in cardiovascular disorders and thrombosis.
DB05679UstekinumabA targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.
DB05687BL-1020Investigated for use/treatment in schizophrenia and schizoaffective disorders.
DB05713LY-517717Investigated for use/treatment in thrombosis and venous thromboembolism.
DB05714FlovagatranInvestigated for use/treatment in thrombosis.
DB05718Maxy-G34Investigated for use/treatment in adverse effects (chemotherapy) and neutropenics.
DB05735CefilavancinInvestigated for use/treatment in bacterial infection, skin infections/disorders, and staph bacterial infections.
DB05739CYT006-AngQbInvestigated for use/treatment in hypertension.
DB05773Trastuzumab emtansineAn antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer.
DB05777Thrombomodulin AlfaInvestigated for use/treatment in blood preservative, blood (blood forming organ disorders, unspecified), sepsis and septicemia, and thrombosis.
DB05779OglufanideInvestigated for use/treatment in hepatitis (viral, C).
DB05793PRO-542Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications.
DB05797TNX-901Investigated for use/treatment in allergic reaction.
DB05819NBI-6024Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
DB05829Parathyroid hormoneAn analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism.
DB05864PPI-2458Investigated for use/treatment in lymphoma (non-hodgkin's) and solid tumors.
DB05889Inotuzumab ozogamicinAn antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL).
DB05892RI 624Investigated for use/treatment in pain (acute or chronic).
DB05915MYO-029Investigated for use/treatment in muscular dystrophy.
DB05931PegdinetanibInvestigated for use/treatment in cancer/tumors (unspecified) and macular degeneration.
DB05934CTCE-0214Investigated for use/treatment in adverse effects (chemotherapy), blood (blood forming organ disorders, unspecified), cancer/tumors (unspecified), neutropenics, and vascular diseases.
DB05941LeronlimabInvestigated for use/treatment in HIV infection.
DB05942GI-5005Investigated for use/treatment in hepatitis (viral, C).
DB05996Glembatumumab vedotinInvestigated for use/treatment in melanoma.
DB06043OlaratumabA platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS).
DB06045TrofinetideInvestigated for use/treatment in traumatic brain injuries.
DB06049IPH 2101Investigated for use/treatment in leukemia (myeloid) and multiple myeloma.
DB06050TB-402Investigated for use/treatment in atrial fibrillation and thrombosis.
DB06081CaplacizumabA von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP).
DB06087Friulimicin BInvestigated for use/treatment in bacterial infection.
DB06101IMC-1C11Investigated for use/treatment in cancer/tumors (unspecified).
DB06116EldelumabInvestigated for use/treatment in ulcerative colitis.
DB06138IRL-1620Investigated for use/treatment in cancer/tumors (unspecified).
DB06149TeicoplaninFor the treatment of bacterial infections caused by susceptible microorganisms.
DB06151AcetylcysteineA medication that can be used as a mucolytic in patients with certain lung conditions and as an antidote for acetaminophen overdose.
DB06162LumiliximabInvestigated for use/treatment in asthma and leukemia (lymphoid).
DB06168CanakinumabAn interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA).
DB06171Paclitaxel trevatideInvestigated for use/treatment in brain cancer.
DB06176RomidepsinA histone deacetylase (HDAC) inhibitor used to treat cutaneous and peripheral T-cell lymphoma.
DB06178TalotrexinInvestigated for use/treatment in solid tumors, lung cancer, leukemia (unspecified), and leukemia (lymphoid).
DB06179DarinaparsinInvestigated for use/treatment in blood (blood forming organ disorders, unspecified), cancer/tumors (unspecified), solid tumors, multiple myeloma, and liver cancer.
DB06182TalabostatInvestigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), lung cancer, melanoma, and pancreatic cancer.
DB06186IpilimumabA human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.
DB06192NimotuzumabInvestigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.
DB06196IcatibantA bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE).
DB06219DalbavancinAn antibacterial used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible strains of Gram-positive bacteria.
DB06241ClenoliximabInvestigated for use/treatment in rheumatoid arthritis.
DB06243EflornithineA medication used topically to reduce unwanted facial hair growth in women. The postulated mechanism of action is through irreversible inhibition of ornithine decarboxylase (ODC) in the skin.
DB06244TraferminInvestigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers.
DB06245LanoteplaseInvestigated for use/treatment in myocardial infarction.
DB06260AviptadilNot Annotated
DB06261HexaminolevulinateAn optical imaging agent used to perform Blue Light Cystoscopy (BLC™) in order to detect carcinoma of the bladder.
DB06262DroxidopaA medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
DB06273TocilizumabAn interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA).
DB06285TeriparatideA recombinant parathyroid hormone used for the treatment of osteoporosis.
DB06304BIIB015Investigated for use/treatment in solid tumors.
DB06310MotavizumabInvestigated for use/treatment in viral infection and pediatric indications.
DB06317ElotuzumabAn antineoplastic agent and SLAMF7-directed immunostimulatory antibody used for the treatment of refractory multiple myeloma in combination with other antineoplastic agents.
DB06318AVE9633Investigated for use/treatment in leukemia (myeloid).
DB06322CarotuximabInvestigated for use/treatment in solid tumors.
DB06323AZX-100Investigated for use/treatment in scar tissue.
DB06324XmAb 2513Investigated for use/treatment in lymphoma (unspecified) and lymphoma (non-hodgkin's).
DB06335SaxagliptinAn DPP-4 inhibitor used for the management of type 2 diabetes mellitus.
DB06342Coltuximab ravtansineInvestigated for use/treatment in lymphoma (non-hodgkin's).
DB06343TeprotumumabInvestigated for use/treatment in solid tumors.
DB06360LucatumumabInvestigated for use/treatment in leukemia (lymphoid), multiple myeloma, and lymphoma (unspecified).
DB06366PertuzumabAn antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents.
DB06371SiplizumabInvestigated for use/treatment in psoriasis and psoriatic disorders, transplant (rejection), graft versus host disease, lymphoma (unspecified), and leukemia (unspecified).
DB06372RilonaceptAn IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder.
DB06379Calcitonin gene-related peptideInvestigated for use/treatment in myocardial infarction, heart disease, and asthma.
DB06399AtaciceptInvestigated for use/treatment in autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, multiple myeloma, lymphoma (non-hodgkin's), and leukemia (lymphoid).
DB06404Human C1-esterase inhibitorA C1 inhibitor used to prevent angioedema attacks associated with hereditary angioedema.
DB06423EndostatinInvestigated for use/treatment in cancer/tumors (unspecified), macular degeneration, and diabetic retinopathy.
DB06434RepiferminInvestigated for use/treatment in bone marrow transplant, ulcers, and inflammatory bowel disease.
DB06437TifacoginInvestigated for use/treatment in sepsis and septicemia and pneumonia.
DB06467ApolizumabInvestigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), and solid tumors.
DB06474SibrotuzumabInvestigated for use/treatment in cancer/tumors (unspecified), colorectal cancer, and lung cancer.
DB06493VelaferminInvestigated for use/treatment in adverse effects (chemotherapy).
DB06495OnerceptInvestigated for use/treatment in psoriasis and psoriatic disorders and crohn's disease.
DB06508GW-559090Investigated for use/treatment in asthma and allergic rhinitis.
DB06510MuraglitazarInvestigated for use/treatment in diabetes mellitus type 2.
DB06511AMGN-0007Investigated for use/treatment in osteoporosis and bone metastases.
DB06534ThrombopoietinInvestigated for use/treatment in thrombocytopenia.
DB06535EtilevodopaInvestigated for use/treatment in parkinson's disease.
DB06549LabradimilInvestigated for use/treatment in brain cancer and pediatric indications.
DB06550BivatuzumabInvestigated for use/treatment in cancer/tumors (unspecified) and head and neck cancer.
DB06557LerdelimumabInvestigated for use/treatment in glaucoma and cataracts.
DB06562EmfilerminInvestigated for use/treatment in adverse effects (chemotherapy), reproductive health, and infertility.
DB06576BaminerceptInvestigated for use/treatment in rheumatoid arthritis.
DB06584TG4010Investigated for use/treatment in breast cancer, renal cell carcinoma, prostate cancer, and lung cancer.
DB06599LexatumumabInvestigated for use/treatment in cancer/tumors (unspecified).
DB06602ReslizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
DB06606TeplizumabInvestigated for use/treatment in diabetes mellitus type 1.
DB06607CatumaxomabFor use in the management of malignant ascites tumours via intraperitoneal infusion where standard therapy is not available or feasible [FDA Label].
DB06611PegsunerceptInvestigated for use/treatment in rheumatoid arthritis.
DB06612MepolizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
DB06643DenosumabA RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures.
DB06645AnamorelinInvestigated for use/treatment in cachexia and anorexia.
DB06647VolociximabInvestigated for use/treatment in solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer.
DB06650OfatumumabA CD20 inhibitor used for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and alemtuzumab.
DB06654SafinamideA MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson's disease during "off" episodes.
DB06655LiraglutideA GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes.
DB06657ValrocemideInvestigated for use/treatment in epilepsy.
DB06663PasireotideA somatostatin analog used in the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery is not appropriate.
DB06674GolimumabA TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
DB06679AmediplaseInvestigated for use/treatment in myocardial infarction and thrombosis.
DB06681BelataceptA selective T-cell costimulation blocker used in the prophylaxis of organ rejection in adult patients receiving a kidney transplant.
DB06692AprotininA serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery.
DB06699DegarelixA GnRH receptor antagonist used in the management of advanced prostate cancer.
DB06719BuserelinA LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females.
DB06763SaralasinNot Annotated
DB06775Carglumic acidAn analog of N-acetylglutamate (NAG) used for the treatment of acute and chronic hyperammonemia in patients with N-acetylglutamate synthase (NAGS) deficiency.
DB06785GanirelixA GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
DB06788HistrelinA GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
DB06791LanreotideA somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly.
DB06794LodoxamideAn ophthalmic agent used for the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
DB06823TioproninA thiol agent indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria.
DB06825TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
DB06827ViomycinViomycin is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis.
DB07744Z-Val-Ala-Asp fluoromethyl ketoneNon-methylated, competitive, and irreversible inhibitor of caspase 1, as well as other caspases,1 which can be used directly with purified enzymes. It does not require an esterase to hydrolyze the...
DB08508N-BENZOYL-D-ALANINENot Available
DB08626ThiorphanA potent inhibitor of membrane metalloendopeptidase (enkephalinase). Thiorphan potentiates morphine-induced analgesia and attenuates naloxone-precipitated withdrawal symptoms.
DB08847HydroxyprolineUsed in France as a combination product for the treatment of small, superficial wounds.
DB08856DADLEA delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.
DB08861DPDPEA heterodetic cyclic peptide that is a cyclic enkephalin analogue, having D-penicillaminyl residues located at positions 2 and 5, which form the heterocycle via a disulfide bond.
DB08862CholecystokininFor use as a diagnostic aid for evaluation of gallbladder disorders. It is also used in conjunction with secretin in pancreatic insufficiency .
DB08869TesamorelinA growth hormone releasing factor (GRF) analog used to reduce excessive abdominal fat in HIV patients who have developed lipodystrophy.
DB08870Brentuximab vedotinA CD30-directed antibody-drug conjugate used to treat various types of lymphoma.
DB08872Gabapentin enacarbilA gabapentin prodrug used to treat Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
DB08873BoceprevirA hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy.
DB08879BelimumabA B-lymphocyte stimulator (BLyS)-specific inhibitor that indirectly inhibits B cell survival, and is used to treat patients with autoantibody positive, active systemic lupus erythematosus.
DB08885AfliberceptA vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy.
DB08888OcriplasminA proteolytic enzyme used to treat symptomatic vitreomacular adhesion by dissolving the protein matrix responsible for the adhesion between the vitreous and macula.
DB08889CarfilzomibA proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.
DB08890LinaclotideA guanylate cyclase-C agonist used to treat constipation associated with irritable bowel syndrome or that is idiopathic in nature.
DB08892Arbaclofen PlacarbilInvestigated for the treatment of spasticity in multiple sclerosis, acute back spasms, and GERD.
DB08894PeginesatidePeginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis
DB08900TeduglutideA glucagon-like peptide-2 (GLP-2) analog used to treat patients with Short Bowel Syndrome (SBS) who require parenteral nutritional support.
DB08902RaxibacumabA monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate.
DB08904Certolizumab pegolA tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis.
DB08935ObinutuzumabAn antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.
DB08993EnviomycinCyclic basic peptide related to viomycin. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
DB09029SecukinumabAn immunomodulating agent and interleukin antagonist used to manage moderate to severe plaque psoriasis and active psoriatic arthritis or ankylosing spondylitis.
DB09033VedolizumabAn integrin blocker and anti-inflammatory agent used to manage ulcerative colitis and Crohn's disease in adults with inadequate clinical response to immunomodulators.
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09036SiltuximabAn interleukin antagonist used to treat multicentric Castleman's disease (MCD) in patients who are HIV and HHV-8 negative.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DB09043AlbiglutideA GLP-1 agonist used to manage type 2 diabetes mellitus.
DB09045DulaglutideA GLP-1 agonist used to manage type 2 diabetes mellitus.
DB09046MetreleptinA leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
DB09052BlinatumomabAn antineoplastic antibody used to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
DB09059AtosibanAn inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations.
DB09066Corifollitropin alfaA FSH analogue indicated for Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.
DB09067Corticorelin ovine triflutateA synthetic corticotropin-releasing hormone used for diagnostic purposes in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
DB09077DinutuximabAn immunotherapeutic agent used in combination with other immunomodulating agents to treat high-risk neuroblastoma in pediatric patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
DB09098SomatremA recombinant growth hormone used to treat adult growth hormone deficiency and treat disrupted growth in children due to growth hormone insufficiency or deficiency, turner's syndrome, chronic renal failure, and small stature for gestational age.
DB09099SomatostatinA naturally-occurring peptide hormone used for the symptomatic treatment of acute bleeding from esophageal varices.
DB09103AncestimA human stem cell factor used in combination with filgrastim during autologous peripheral blood progenitor cell (PBPC) transplantation to increase PBPC mobilization for improved collection.
DB09105Asfotase alfaAn enzyme replacement therapy used for the treatment of perinatal/infantile and juvenile onset hypophosphatasia (HPP).
DB09107Methoxy polyethylene glycol-epoetin betaA synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease.
DB09109Turoctocog alfaAn antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency).
DB09122Peginterferon beta-1aAn interferon beta used to treat relapsing forms of multiple sclerosis.
DB09126Chorionic Gonadotropin (Human)A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women.
DB09137Technetium Tc-99m mebrofeninA diagnostic radiopharmaceutical agent used during hepatobiliary imaging tests.
DB09141Protamine sulfateA blood factor used when the reversal of the anticoagulant effect of heparin is necessary and for the treatment of heparin overdose.
DB09142SincalideA diagnostic agent used to stimulate gallbladder contraction or pancreatic secretion during diagnostic tests, and accelerate fluoroscopy and x-ray examination of the intestinal tract.
DB09164Technetium Tc-99m disofeninA radiopharmaceutical diagnostic agent used for hepatobiliary scans.
DB09218ClonixinIndicated for use in the management of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
DB09221PolaprezincPeptic ulcer disease, dyspepsia .
DB09222Fibrinogen HumanA hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
DB09230AzelnidipineFor the treatment of hypertension.
DB09264IdarucizumabAn antibody that binds dabigatran for the reversal of anticoagulant effects of dabigatran.
DB09265LixisenatideA GLP-1 receptor agonist used for the management of type 2 diabetes mellitus.
DB09272EluxadolineA mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea.
DB09292SacubitrilA neprilysin inhibitor used in combination with valsartan as an adjunct to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.
DB09302AlirocumabA PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C).
DB09303EvolocumabA PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures.
DB09331DaratumumabA CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma.
DB09349Gastric intrinsic factorIntrinsic factor is not currently available in any FDA or Health Canada approved products. However, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic...
DB09357DexpanthenolAn alcoholic analogue of D-pantothenic acid that is used as a supplement or application to support a healthy epithelium and is also used to prevent vitamin deficiency in patients receiving total parenteral nutrition (TPN).
DB09393Amino acidsMixture of amino acids ; used for parenteral nutrition in infants.
DB09421ProtirelinA synthetic analogue of thyrotropin-releasing hormone that has been used during diagnostic tests to evaluate function of the thyroid gland.
DB09477EnalaprilatAn antihypertensive agent used for the management of hypertension when oral therapy is not practical.
DB09527Secretin porcineA secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts.
DB09559NecitumumabA monoclonal antibody used to treat metastatic squamous non-small cell lung cancer.
DB09564Insulin DegludecA long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus.
DB09570IxazomibA monoclonal antibody used with other medications to treat multiple myeloma in patients who have received one other therapy already.
DB10516CaseinAn extract from Casein used in allergy testing.
DB10789Bordetella pertussis pertactin antigenBordetella pertussis pertactin antigen is a vaccine for the prophylaxis of whooping cough that contains pertactin, a membrane-associated antigen of Bordetella pertussis .
DB11091Hydrogen peroxideA compound used as a disinfectant and sterilizer.
DB11095DesirudinIndicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
DB11102N-acetyltyrosineAn amino acid used in total parenteral nutrition.
DB11142SelenomethionineSelenomethionine is a naturally occuring amino acid in some plant materials such as cereal grains, soybeans and enriched yeast but it cannot be synthesized from animals or humans. It can...
DB11209Iron protein succinylateNot Annotated
DB11210Ferrous bisglycinateFerrous bisglycinate is a chelate that is used as a source of dietary iron. Forming a ring structure when reacting with glycine, ferrous bisglycinate acts as both a chelate and...
DB11242GelatinGelatin is used for weight loss and for treating osteoarthritis, rheumatoid arthritis, and brittle bones (osteoporosis). Some people also use it for strengthening bones, joints, and fingernails. Gelatin is also...
DB11256Levomefolic acidA folate supplement used to prevent neural tube defects in pregnancy or folate deficiency.
DB11296PrezatideCommonly used in cosmetic products for the skin and hair .
DB11298ThioredoxinThioredoxin is a small dithiol protein and specific reductant for major allergenic proteins present in foods from animal and plant products. It is a 12-kD oxidoreductase enzyme encoded by TXN...
DB11300ThrombinA coagulation factor used to stop bleeding during surgery.
DB11311ProthrombinA coagulation factor used for emergency reversal of vitamin K antagonist therapy.
DB11312Protein CA medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis.
DB11330Factor IX Complex (Human)A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy.
DB11332SinapultideA synthetic lung surfactant used to treat infant respiratory distress syndrome.
DB11364PidotimodFor use as immunostimulant therapy for treatment of cell-mediated immunosuppression with respiratory or urinary infections .
DB11403EmodepsideEmodepside is an anthelmintic drug that is effective against a number of gastrointestinal nematodes, is licensed for use in cats and belongs to the class of drugs known as the...
DB11467ThiostreptonThiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii. Thiostrepton is a natural product of the ribosomally synthesized and post-translationally...
DB11476VirginiamycinVirginiamycin is a streptogramin antibiotic similar to pristinamycin and quinupristin/dalfopristin. It is a combination of pristinamycin IIA and virginiamycin S1. Virginiamycin is used in the fuel ethanol industry to prevent...
DB11510DeslorelinDeslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH agonist. It stops the production of sex hormones.
DB11567Insulin peglisproNot Annotated
DB11569IxekizumabA monoclonal antibody used to treat moderate to severe plaque psoriasis.
DB11595AtezolizumabA monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy.
DB11598Antithrombin III humanAn alpha-2-glycoprotein used to prevent thromboembolisms in patients with hereditary antithrombin III deficiency.
DB11611LifitegrastA medication used to treat dry eye disease.
DB11621Human Varicella-Zoster Immune GlobulinA solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
DB11624Epoetin deltaEpoetin Delta is an ingredient in the EMA-withdrawn product Dynepo.
DB11628DepreotideDepreotide is an ingredient in the EMA-withdrawn product NeoSpect.
DB11631Eptotermin AlfaA bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin Alfa is an ingredient in...
DB11639Dibotermin alfaindicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. indicated for single-level...
DB11646ConatumumabConatumumab has been used in trials studying the treatment of Sarcoma, Lymphoma, Oncology, Colon Cancer, and Rectal Cancer, among others.
DB11653BremelanotideBremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of...
DB11656RebamipideRebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
DB11657TabalumabTabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others.
DB11668Rusalatide acetateChrysalin has been used in trials studying the treatment of Radius Fracture.
DB11680FiclatuzumabFiclatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute Myeloid...
DB11682DaprodustatDaprodustat has been used in trials studying the other, treatment, and basic science of Anaemia, Wound Healing, Tendon Injuries, Surgical Procedures, and Vascular Disease, Peripheral.
DB11685FigitumumabFigitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
DB11690VonapanitaseVonapanitase is under investigation for the treatment of Chronic Kidney Disease.
DB11695CarnosineCarnosine has been investigated for the treatment of Gulf War Illness.
DB11696RacecadotrilRacecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.
DB11700SetmelanotideSetmelanotide has been investigated for the treatment of Obese and Overweight.
DB11706RaxatrigineRaxatrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.
DB11709Acetyl hexapeptide-3Argireline has been used in trials studying the treatment of wrinkles.
DB11714DurvalumabA monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer.
DB11715BapineuzumabBapineuzumab has been investigated for the treatment of Alzheimer's Disease.
DB11724BombesinBombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and...
DB11746OnartuzumabOnartuzumab has been used in trials studying the treatment of Neoplasms, Lung Cancer, Glioblastoma, Gastric Cancer, and Colorectal Cancer, among others.
DB11756SolanezumabSolanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
DB11767SarilumabA monoclonal antibody used to treat moderate to severe rheumatoid arthritis who have responded poorly or are intolerant of other DMARDs.
DB11771TremelimumabTremelimumab is under investigation for the treatment of Mesothelioma, Liver Cancer, Liver Neoplasms, Liver Cell Caricinoma, and HepatoCellular Carcinoma. Tremelimumab has been investigated in Part C: Malignant Mesothelioma and Part...
DB11776BrodalumabA monoclonal antibody used to treat moderate to severe plaque psoriasis.
DB11777CenderitideCenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
DB11781TosedostatTosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the...
DB11782BirinapantBirinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
DB11788Neuropeptide YNeuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.
DB11803SirukumabSirukumab has been used in trials studying the treatment and basic science of Giant Cell Arteritis and Arthritis, Rheumatoid.
DB11808FaldaprevirFaldaprevir has been investigated for the treatment of Chronic Hepatitis C.
DB11815TilarginineTilarginine has been investigated for the basic science, treatment, and diagnostic of Obesity, Type 2 Diabetes, Ocular Physiology, and Regional Blood Flow.
DB11821DanegaptideDanegaptide has been investigated for the treatment of Focus of Study is STEMI.
DB11826LampalizumabLampalizumab has been used in trials studying the treatment of Geographic Atrophy.
DB11834GuselkumabA monoclonal antibody used to treat moderate to severe plaque psoriasis.
DB11840DalotuzumabDalotuzumab has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.
DB11842Angiotensin IIA peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock.
DB11849EmibetuzumabEmibetuzumab has been used in trials studying the treatment of Advanced Cancer, Renal Cell Carcinoma, Hepatocellular Cancer, Gastric Adenocarcinoma, and Non-Small Cell Lung Cancer, among others.
DB11854AstodrimerAstodrimer has been used in trials studying the treatment and prevention of Bacterial Vaginosis. It is a lysine-based dendrimer with naphthalene disulfonic acid surface groups.
DB11856LigelizumabLigelizumab has been used in trials studying the basic science and treatment of Asthma, Allergy, Peanut Allergy, Allergic Asthma, and Atopic Dermatitis, among others.
DB11857SeribantumabSeribantumab has been used in trials studying the treatment of NSCLC, Heregulin, Adenocarcinoma, Colorectal Cancer, and Solid Tumor Cancers, among others.
DB11862LandogrozumabLandogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
DB11865Brivanib alaninateBrivanib alaninate has been investigated for the treatment of Colorectal Cancer.
DB11866RomosozumabA monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments.
DB11869ValspodarValspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.
DB11876Alanyl GlutamineAlanyl Glutamine is under investigation in clinical trial NCT00338221 (Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition).
DB11882BPC-157Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).
DB11895LenomorelinLenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.
DB11906AcylineAcyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.
DB11915ValbenazineA vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia.
DB11928VosoritideVosoritide has been used in trials studying the treatment of Achondroplasia.
DB11945AvelumabA monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma.
DB11955AvoterminJuvista has been investigated for the treatment, prevention, and basic science of Scars, Keloid, and Cicatrix.
DB11956DelanzomibDelanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin.
DB11958BrivanibBrivanib is under investigation for the treatment of HepatoCellular Carcinoma. Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC).
DB11959CrenezumabCrenezumab has been used in trials studying the treatment of Alzheimer's Disease.
DB11972RilotumumabRilotumumab has been investigated for the treatment of Cancer, Lung Cancer, Solid Tumors, Gastric Cancer, and Prostate Cancer, among others.
DB11975TAK-448TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
DB11976AnifrolumabAnifrolumab has been investigated for the treatment of Scleroderma.
DB11981ElamipretideElamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
DB11988OcrelizumabA CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis.
DB11991OprozomibOprozomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, Waldenstrom Macroglobulinemia, Advanced Hepatocellular Carcinoma, and Advanced Non-Central Nervous System (CNS) Malignancies.
DB11997Interleukin-7Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
DB12003Thymosin beta-4Thymosin Beta 4 has been investigated for the treatment of STEMI, Dry Eye, Diabetes, Pressure Ulcers, and Dry Eye Syndrome, among others.
DB12005NirogacestatNirogacestat has been used in trials studying the treatment of Breast Cancer, HIV Infection, Desmoid Tumors, Advanced Solid Tumors, and Aggressive Fibromatosis, among others.
DB12034GantenerumabGantenerumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
DB12038UlinastatinUlinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
DB12042IbodutantIbodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel Syndrome With Diarrhea.
DB12044MK-0893MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.
DB12053VisilizumabVisilizumab has been investigated for the treatment of Ulcerative Colitis.
DB12054BQ-123BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.
DB12056TrebananibTrebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon...
DB12075NagrestipenNagrestipen has been used in trials studying the treatment of CANCER, Neoplasm, Metastasis, Radiation Oncology, and Neoplasm Metastasis.
DB12076SurotomycinSurotomycin has been used in trials studying the treatment of Diarrhea and Clostridium Difficile Infection.
DB12088TT-232Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
DB12089Lorvotuzumab mertansineLorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.
DB12090PatritumabPatritumab has been used in trials studying the treatment of LUNG CANCER, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms, and Non-small Cell Lung Cancer, among others.
DB12095Telotristat ethylA tryptophan hydroxylase inhibitor used to treat carcinoid syndrome.
DB12099UK-396,082UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.
DB12102FulranumabFulranumab has been used in trials studying the treatment of Pain, Cystitis, Neuralgia, Joint Pain, and Arthralgia, among others.
DB12104TarextumabTarextumab has been used in trials studying the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.
DB12105ImagabalinImagabalin has been investigated in Generalized Anxiety Disorder.
DB12118SotaterceptSotatercept has been used in trials studying the supportive care and treatment of Anemia, Leukemia, Solid Tumors, Bladder Cancer, and multiple myeloma, among others.
DB12119GevokizumabGevokizumab has been used in trials studying the treatment of Acne Vulgaris, Osteoarthritis, Behcet's Uveitis, Pyoderma Gangrenosum, and Behcet's Disease Uveitis, among others. Gevokizumab acts as a modulator of cytokine...
DB12126BradykininBradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
DB12132Vanutide cridificarVanutide cridificar has been investigated for the treatment of Alzheimer Disease.
DB12139AlisporivirAlisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.
DB12142DuligotuzumabDuligotuzumab has been used in trials studying the treatment of Neoplasms, Colorectal Cancer, Head and Neck Cancer, and Epithelial Tumors, Malignant.
DB12146RigosertibRigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others.
DB12159DupilumabA monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults.
DB12160BucillamineBucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.
DB12169TralokinumabTralokinumab is under investigation for the treatment of Alopecia Areata. Tralokinumab has been investigated for the treatment of Asthma.
DB12182BinetrakinBinetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among others.
DB12189EtrolizumabEtrolizumab has been used in trials studying the treatment of Crohn Disease and Ulcerative Colitis.
DB12205GanitumabGanitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.
DB12213EtaracizumabEtaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
DB12224Oxothiazolidinecarboxylic acidProcysteine has been used in trials studying the treatment of HIV Infections.
DB12240Polatuzumab vedotinThis medication is indicated to treat adults with relapsed or refractory diffuse large B-cell lymphoma in combination with bendamustine and rituximab that has returned of progressed after 2 or more...
DB12246InclacumabInclacumab has been used in trials studying the treatment and prevention of Myocardial Infarction, Peripheral Arterial Disease (PAD), and Coronary Heart Disease, Graft Occlusion, Vascular.
DB12250CixutumumabCixutumumab has been used in trials studying the treatment of Lung Cancer, Malignant Neoplasm, Leukemia, Mast-Cell, Non-Small-Cell Lung Carcinoma, and Adenocarcinoma of the Prostate. Cixutumumab is a highly specific recombinant...
DB12261AscrinvacumabAscrinvacumab has been used in trials studying the treatment and basic science of Neoplasms, Advanced Solid Tumors, Carcinoma, Hepatocellular, and Malignant Pleural Mesothelioma.
DB12271ORE-1001ORE1001 has been used in trials studying the treatment of Mild to Moderate Ulcerative Colitis. It is an ACE2 inhibitor.
DB12274AducanumabAducanumab has been used in trials studying the treatment of Alzheimer's Disease.
DB12279OBP-801OBP-801 has been used in trials studying the treatment of Solid Tumor.
DB12292BarusibanBarusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF) Treatment.
DB12304EntolimodEntolimod has been used in trials studying the treatment of Mucositis, Tongue Cancer, Colorectal Cancer, Stage IVA Verrucous Carcinoma of the Larynx, and Stage IVB Verrucous Carcinoma of the Larynx,...
DB12330BlisibimodBlisibimod has been used in trials studying the treatment of IgA Nephropathy, Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Granulomatosis With Polyangiitis.
DB12335TanezumabTanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.
DB12349DulanerminDulanermin has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.
DB12363DusigitumabDusigitumab has been used in trials studying the treatment of Cancer, Advanced Solid Malignancies, Unresectable or Metastatic Hepatocellular Carcinoma (HCC), and Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer.
DB12370IpamorelinIpamorelin has been investigated for the treatment of Ileus.
DB12373IsunakinraIsunakinra has been investigated for the treatment of Dry Eye and Allergic Conjunctivitis (AC).
DB12396FresolimumabFresolimumab has been used in trials studying the treatment of Primary Brain Tumors, Metastatic Breast Cancer, Diffuse Systemic Sclerosis, Pleural Malignant Mesothelioma, and Primary Focal Segmental Glomerulosclerosis.
DB12409Vatreptacog alfaVatreptacog Alfa (Activated) has been used in trials studying the treatment of Haemophilia B, Haemophilia A, Congenital Bleeding Disorder, Haemophilia A With Inhibitors, and Haemophilia B With Inhibitors.
DB12431MuplestimMuplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in...
DB12444TheanineTheanine is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).
DB12451SCY-635SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.
DB12456BococizumabBococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.
DB12460ConberceptConbercept has been investigated for the basic science of Age-related Macular Degeneration.
DB12463SemagacestatSemagacestat has been used in trials studying the treatment of Alzheimer Disease.
DB12486ElobixibatElobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
DB12489Mirvetuximab SoravtansineMirvetuximab Soravtansine has been used in trials studying the treatment of Ovarian cancer, Endometrial Cancer, Fallopian tube cancer, Epithelial Ovarian Cancer, and Primary Peritoneal Cancer, among others.
DB12490ForigerimodForigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.
DB12493PD-217014PD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.
DB12495SelepressinSelepressin has been used in trials studying the treatment of Septic Shock.
DB12498MogamulizumabA monoclonal antibody used to treat relapsed or refractory mycosis fungoides or Sézary syndrome after attempting one other therapy.
DB12514Iofolastat I-123Iofolastat I-123 is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer).
DB12519SarcosineSarcosine has been investigated for the treatment of Schizophrenia.
DB12525MolgramostimMolgramostim has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis.
DB12530InebilizumabInebilizumab has been used in trials studying the treatment of Blood Cancer, B-cell Malignancies, Advanced B Cell Malignancies, Chronic Lymphocytic Leukemia (CLL), and Diffuse Large B-Cell Lymphoma (DLBCL).
DB12534MavrilimumabMavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
DB12538NepadutantNepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.
DB12560BlosozumabBlosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis, Postmenopausal.
DB12566DecernotinibDecernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.
DB12568TecemotideTecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung.
DB12584BimagrumabBimagrumab has been used in trials studying the treatment and supportive care of Sarcopenia, Skeletal Muscle, Mechanical Ventilation, Sporadic Inclusion Body Myositis, and Sporadic Inclusion Body Myositis (sIBM), among others.
DB12589DacetuzumabInvestigated for use/treatment in lymphoma (non-hodgkin's) and multiple myeloma.
DB12602PentetreotidePentetreotide has been used in trials studying the diagnostic of cushing syndrome.
DB12609TovetumabTovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.
DB12613DavunetideDavunetide has been used in trials studying the treatment of Progressive Nonfluent Aphasia, Progressive Supranuclear Palsy, Predicted Tauopathies, Including, Corticobasal Degeneration Syndrome, and Frontotemporal Dementia With Parkinsonism Linked to Chromosome...
DB12616SpriferminSprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.
DB12620Nerve Growth FactorNerve Growth Factor has been used in trials studying the prevention and treatment of Mental Handicap, Alzheimer's Disease, Traumatic Brain Injury, Cerebral Palsy Children, and Delayed Speech Development, among others.
DB126293,5-diiodothyropropionic acidDITPA has been investigated in Congestive Heart Failure.
DB12648Nona-arginineNona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
DB12652Endothelin-1Endothelin 1 is under investigation in clinical trial NCT00745693 (The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin).
DB12677SoblidotinSoblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult Solid Tumor, Protocol Specific.
DB12678RelamorelinRelamorelin has been investigated for the treatment and basic science of Gastroparesis, Gastric Motility, Diabetes Mellitus, Parkinson's Disease, and Chronic Constipation, among others.
DB12684AviscumineCy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).
DB12697MethylselenocysteineMethylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.
DB12698IbalizumabA CD4-specific antibody used to treat HIV infections.
DB12699BalugrastimBalugrastim has been used in trials studying the treatment of Solid Tumors.
DB12701IntetumumabIntetumumab has been used in trials studying the treatment of Melanoma.
DB12711LTX-109LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive, Skin Infections.
DB12718CarlumabCarlumab has been used in trials studying the treatment of Cancer and Prostate Cancer.
DB12726MonteplaseMonteplase has been used in trials studying the treatment of Pulmonary Embolism.
DB12730Dolastatin 10Dolastatin 10 has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Liver Cancer, and Kidney Cancer, among others.
DB12732FirategrastFirategrast has been used in trials studying the treatment of Multiple Sclerosis.
DB12734DemcizumabDemcizumab is under investigation for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.
DB12738TiplimotideTiplimotide has been used in trials studying the treatment of Multiple Sclerosis.
DB12748LTX-315LTX-315 has been used in trials studying the treatment of Cancer, Lymphoma, Melanoma, Carcinoma, and Breast Cancer, among others.
DB12750N-omega-nitro-L-arginine methyl esterL-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.
DB12755Zoptarelin doxorubicinZoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
DB12762RabacfosadineRabacfosadine has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia.
DB12775AbituzumabAbituzumab has been used in trials studying the treatment of Prostate Cancer Metastatic.
DB12777SomatoprimSomatoprim is under investigation for the treatment of Acromegaly.
DB12795CMX-2043CMX-2043 has been used in trials studying the treatment and prevention of Non STEMI, Unstable Angina, Stable Coronary Artery Disease, and Percutaneous Coronary Intervention.
DB12807Naptumomab EstafenatoxNaptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.
DB12815CrotedumabCrotedumab has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
DB12820ConcizumabConcizumab has been used in trials studying the treatment of Haemophilia A and Congenital Bleeding Disorder.
DB12822Pancreatic PolypeptidePancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.
DB12826DepatuxizumabDepatuxizumab has been used in trials studying the treatment and diagnostic of Adenocarcinoma and Advanced Solid Tumors.
DB12827IndoximodIndoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.
DB12835Olipudase alfaOlipudase alfa has been used in trials studying the treatment of Sphingomyelin Lipidosis and Human Acid Sphingomyelinase Deficiency.
DB12844RontalizumabRontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus.
DB12845AmatuximabAmatuximab has been used in trials studying the treatment and basic science of Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Pancreatic Cancer, and Mesothelioma, Malignant, among others.
DB12849ClazakizumabClazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
DB12863SivelestatSivelestat has been used in trials studying the treatment of Acute Lung Injury and Respiratory Distress Syndrome, Adult.
DB12865EtelcalcetideA calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis.
DB12870Buthionine SulfoximineButhionine Sulfoximine has been used in trials studying the treatment of Neuroblastoma and Melanoma (Skin).
DB12876GS-9256GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.
DB12878AV-101AV-101 has been used in trials studying the treatment of Neuropathic Pain.
DB12880Interleukin-10Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis, Bile Duct Diseases, Pancreatic Diseases, and Gallbladder Diseases, among others.
DB12882OmbrabulinOmbrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.
DB12891OzanezumabOzanezumab has been used in trials studying the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.
DB12893Sacituzumab govitecanSacituzumab govitecan has been used in trials studying the treatment of Breast Cancer, Cervical Cancer, Renal Cell Cancer, Colorectal Cancer, and Esophageal Cancer, among others.
DB12909Factor XIII (human)A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency.
DB12938IsoxaflutoleBalance has been investigated for the treatment of Chronic Renal Failure and Peritoneal Membrane Disorder.
DB12943MilatuzumabMilatuzumab has been used in trials studying the treatment of Lupus Nephritis, Multiple Myeloma (MM), GVHD (Acute or Chronic), Myelodysplastic Syndrome, and Chronic Lymphocytic Leukemia, among others.
DB12951PivagabinePivagabine has been used in trials studying the treatment of Stress and Anxiety.
DB12976RobatumumabRobatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.
DB12992Bleomycin A6Bleomycin A6 has been used in trials studying the treatment of Squamous Cell Lung Cancer.
DB13006CibinetideCibinetide has been used in trials studying the basic science of Depression.
DB13033Urocortin-2Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
DB13045RacotumomabRacotumomab has been used in trials studying the treatment of Glioma, Wilm's Tumor, Neuroblastoma, Retinoblastoma, and Ewing's Sarcoma.
DB13067RotigaptideRotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.
DB130689-(N-methyl-L-isoleucine)-cyclosporin A9-(N-methyl-L-isoleucine)-cyclosporin A (NIM811) has been used in trials studying the treatment of Chronic Hepatitis C Genotype-1 Relapse.
DB13074MacimorelinA medication used to treat adult growth hormone deficiency.
DB13091TiropramideTiropramide is under investigation in clinical trial NCT01629212 (Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome).
DB13127OlokizumabOlokizumab has been used in trials studying the treatment of Crohn's Disease.
DB13133Von Willebrand Factor HumanA complex of von Willebrand Factor and Factor VIII used to treat bleeding episodes in von Willebrand disease.
DB13144LenograstimThe drug is used to reduce the risk of life-threatening infection in patients with neutropenia, particularly after cytotoxic chemotherapy. Lenograstim is indicated as a treatment to reduce the duration of...
DB13148Coagulation factor X humanA coagulation factor used to treat Factor X deficiency to control bleeding.
DB13149Protein S humanA medication used for emergency reversal of coagulation factor deficiency in vitamin K antagonist therapy.
DB13150Coagulation factor VII humanA coagulation factor used to treat bleeding disorders such as hemophilia and Glanzmann's thrombasthenia.
DB13166ZofenoprilZofenopril is employed as both a cardioprotective and anti-hypertensive agent. It is an angiotensin-converting enzyme (ACE) inhibitor.
DB13191PhosphocreatinePhosphocreatine is a naturally occuring substance that is found predominantly in the skeletal muscles of vertebrates. Its primary utility within the body is to serve in the maintanence and recycling...
DB13192Antihemophilic factor humanA Factor VIII replacement therapy used to treat hemophilia A.
DB13197KallidinogenaseNot Annotated
DB13200LipegfilgrastimA medication used to reduce the duration of chemotherapy-induced neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy.
DB13201Trenonacog alfaHuman coagulation factor IX (EC 3.4.21.22, Christmas factor, plasma thromboplastin component), produced in CHO cells.
DB13207Arginine glutamateNot Annotated
DB13226AcetylleucineUsed for treating vestibular-related imbalance and vertigo.
DB13233AlaproclateAlaproclate was developed as one of the first selective serotonin reuptake inhibitor (SSRI) antidepressants by Astra AB (now AstraZeneca) in the 1970s. Development was discontinued due to concerns over hepatotoxicity...
DB13257Ferrous sulfate anhydrousAn iron supplement used to prevent iron deficiency anemia.
DB13298AlsactideNot Annotated
DB13299SulglicotideNot Annotated
DB13313MelevodopaNot Annotated
DB13363OxaceprolNot Annotated
DB13375EdrecolomabNot Annotated
DB13431ProglumideNot Annotated
DB13447PrethcamideNot Annotated
DB13455PhenibutNot Annotated
DB13464OrnipressinNot Annotated
DB13503TyrothricinA topical antibiotic with broad spectrum activity against Gram positive bacteria and some fungal infections.
DB13517AngiotensinamideNot Annotated
DB13535NebacumabNot Annotated
DB13590Calcium pangamateNot Annotated
DB13615MifamurtideA muramyl dipeptide derivative used to treat high grade, resectable, non-metastatic osteosarcoma after surgical resection.
DB13626Aluminium glycinateNot Annotated
DB13646SaruplaseNot Annotated
DB13704PristinamycinNot Annotated
DB13738CamylofinNot Annotated
DB13742ElcatoninNot Annotated
DB13798DemoxytocinNot Annotated
DB13809Paclitaxel poliglumexNot Annotated
DB13864Hemoglobin crosfumarilHemoglobin in which the alpha-subunit are cross-linked intramolecularly.
DB13886Human cytomegalovirus immune globulinA solution of immune globulin G against cytomegalovirus used to prevent transmission of cytomegalovirus after organ transplants.
DB13923EmicizumabAn antibody against Factor IXa and Factor X used to treat hemophilia A.
DB13928SemaglutideA glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus.
DB13931NetarsudilA rho kinase inhibitor used to reduce intraocular pressure in patients with open angle glaucoma or ocular hypertension.
DB13933Nonacog beta pegolA recombinant coagulation Factor IX derivative used to treat hemophilia B.
DB13968Plasma protein fraction (human)A plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures.
DB13972RacemethionineA preparation of methionine that includes a mixture of D-methionine and L-methionine isomers.
DB13976SulesomabMarket product is Tc99m-labeled murine antibody fragment for nuclear imaging of activated granulocytes.
DB13979BesilesomabA monoclonal antibody bound to technetium-99 used to find infection and inflammation in patients with suspected osteomyelitis.
DB13985Lutetium Lu 177 dotatateA radiolabeled somatostatin analog used to treat somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.
DB13999Moroctocog alfaA recombinant Factor VIII used to treat hemophilia A to control bleeding.
DB14004TildrakizumabAn interleukin-23 antagonist used to treat moderate to severe plaque psoriasis.
DB14027TaspoglutideTaspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche. In September 2010 Roche halted...
DB14028NordazepamAn intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
DB14039ErenumabA calcitonin-gene related peptide antagonist used to prevent migraines.
DB14041FremanezumabA calcitonin-gene related peptide antagonist used to prevent migraines.
DB14044Hopantenic acidHopantenic acid (Pantogam) is a central nervous system depressant. Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating) in the absence of addiction, hyperstimulation or withdrawal...
DB05624TeverelixInvestigated for use/treatment in benign prostatic hyperplasia, endometriosis, and prostate cancer.
DB14057ValinomycinA cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately...
DB14058BasifunginBasifungin, also known as aureuobacidin A, is a phosphorylceramide synthase inhibitor , .
DB14072Reversin 121Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
DB14076Interleukin-1 alpha, human recombinantNot Annotated
DB14103Methionine sulfoximineNot Annotated
DB14127SacubitrilatA metabolite of LCZ696 with neprilysin inhibitory activity.
DB14131Basic Fibroblast Growth FactorBasic Fibroblast Growth Factor is not currently approved for any FDA or Health Canada approved indications.
DB14145NepiderminNot Annotated
DB14207FosinoprilatFosinoprilat is the active phosphinic acid metabolite of prodrug fosinopril, which is activated by esterases in vivo. It binds zinc with phosphinic acid group.
DB14211FanolesomabAn anti-SSEA-1 monoclonal antibody used for imaging of the appendix and to diagnose appendicitis.
DB14218TelotristatA tryptophan hydroxylase inhibitor. Telotristat ethyl (brand name Xermelo) is a prodrug of telotristat.
DB14472Insulin-like growth factor IIThe insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth...
DB14473Beroctocog alfaNot Annotated
DB14480Acetylcysteine amideNot Available
DB14493Zinc glycinateGlycoprotein marker of gastrointestinal cancer.
DB09532Secretin humanA secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts.
DB14562Andexanet alfaA recombinant Factor Xa used to reverse anticoagulation caused by rivaroxaban and apixaban.
DB14597LanadelumabA plasma kallikrein inhibitor used to treat attacks of hereditary angioedema.
DB09329Antihemophilic Factor (Recombinant), PEGylatedFor the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)...
DB14642LypressinNot Annotated
DB12688Moxetumomab PasudotoxA CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment.
DB08766ZofenoprilatNot Available
DB06111AB192Investigated for use/treatment in diabetes mellitus type 2.
DB14042GalcanezumabA calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches.
DB07558acetylleucyl-leucyl-norleucinalNot Available
DB00129OrnithineAn amino acid commonly found as a component in total parenteral nutrition.
DB01752S-adenosyl-L-homocysteine5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
DB02458S-(2,4-dinitrophenyl)glutathioneNot Available
DB02530gamma-Aminobutyric acidThe most common inhibitory neurotransmitter in the central nervous system.
DB02691Glycocholic acidThe glycine conjugate of cholic acid. It acts as a detergent to solubilize fats for absorption and is itself absorbed.
DB02751GlycocyamineNot Available
DB03310Glutathione disulfideAn ingredient of ophthalmic irrigation solutions used during ophthalmological procedures.
DB03604TiratricolA metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.
DB038103-Methylglutamic acidNot Available
DB11693VoclosporinVoclosporin is a novel cyclosporine analog and immunosuppressive compound currently being investigated for the treatment of psoriasis and for the prevention of organ rejection in kidney transplant patients. All studies...
DB11835Indium In-111 pentetreotideIndium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome.
DB11914LebrikizumabLebrikizumab has been used in trials studying the treatment of Asthma, Allergic Asthma, Atopic Dermatitis, Idiopathic Pulmonary Fibrosis, and COPD, Chronic Obstructive Pulmonary Disease.
DB12023BenralizumabA monoclonal antibody used to treat eosinophilic asthma.
DB12202ZalutumumabZalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell...
DB12520PlozalizumabPlozalizumab has been investigated for the treatment of Atherosclerosis. Plozalizumab, a novel humanized monoclonal antibody, specifically targets CCR2 chemokine receptors found on the surface of certain white blood cells including...
DB12581OzarelixOzarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).
DB12664IndantadolIndantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.
DB12773SifalimumabSifalimumab is a fully human monoclonal antibody targeting interferon-alpha. The levels of interferon-alpha are elevated in many patients with active systemic lupus erythematosus (SLE, or lupus) and other autoimmune disorders,...
DB13170PlecanatideA laxative used to treat chronic idiopathic constipation and IBS with constipation.
DB14724EmapalumabAn interferon gamma blocking antibody used to treat primary hemophagocytic lymphohistiocytosis.
DB05004Peptide YY (3-36)Investigated for use/treatment in metabolic disease and obesity.
DB14731TagraxofuspA CD123-directed cytotoxin used to treat plasmacytoid dendritic cell neoplasm.
DB00091CyclosporineA steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis.
DB06651DiaPep 277Investigated for use/treatment in diabetes mellitus type 1, autoimmune diseases, and diabetes mellitus type 2.
DB14738Turoctocog alfa pegolTuroctocog alfa pegol (N8-GP) is indicated for use in adults and children of all ages with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis in reducing the frequency of...
DB14741Luteinizing hormoneNot Annotated
DB00781Polymyxin BA polymyxin antibiotic used to treat a wide variety of infections in the body.
DB02446Glutamine hydroxamateNot Available
DB033145-fluorotryptophan5-fluorotryptophan can be used as substrate analogue to study enzyme mechanisms by NMR spectroscopy.
DB06400VitespenInvestigated for use/treatment in kidney cancer, melanoma, renal cell carcinoma, lymphoma (unspecified), colorectal cancer, and brain cancer.
DB05304GirentuximabInvestigated for use/treatment in gall bladder cancer and renal cell carcinoma.
DB14760NarlaprevirNot Annotated
DB14761RemdesivirNot Annotated
DB14762RisankizumabAn interleukin-23 antagonist used to treat moderate to severe plaque psoriasis.
DB05386RegramostimInvestigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
DB05875Sar9, Met (O2)11-Substance PInvestigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
DB14767Peginterferon lambda-1aPeginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).
DB14786NerofeNerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS).
DB14806AvexitideAvexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).
DB14807Demplatin pegraglumerDemplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).
DB14809Anetumab ravtansineAnetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).
DB14811IsatuximabIsatuximab is under investigation in clinical trial NCT02514668 (A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma).
DB14812ProcalcitoninProcalcitonin is under investigation in clinical trial NCT03440060 (Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD).
DB14824IcrucumabIcrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).
DB14852PRM-151PRM-151 is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis).
DB14865Human interleukin-2Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).
DB14877LintuzumabLintuzumab is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).
DB14880UteroglobinUteroglobin is under investigation in clinical trial NCT01473264 (Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)).
DB14891VobarilizumabVobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).
DB14905EmactuzumabEmactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).
DB14907Bevacizumab zirconium Zr-89Bevacizumab zirconium Zr-89 is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).
DB14908RefanezumabRefanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).
DB14940Aspartyl-alanyl-diketopiperazineAspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
DB14941BMS-817399BMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).
DB14952PamrevlumabPamrevlumab is under investigation in clinical trial NCT00913393 (Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy).
DB14956DavalintideDavalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects).
DB14988DalanterceptDalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).
DB14997PateclizumabPateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in...
DB14999Human interferon betaHuman interferon beta is under investigation in clinical trial NCT02584829 (Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic...
DB15015Recombinant CD40-ligandRecombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
DB15022ApomabApomab is under investigation in clinical trial NCT00851136 (A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and...
DB15045IpafriceptIpafricept is under investigation in clinical trial NCT01608867 (A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors).
DB15076AbrilumabAbrilumab is under investigation in clinical trial NCT01290042 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.).
DB15084GS-9191GS-9191 is under investigation in clinical trial NCT00499967 (Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts).
DB15093SomapacitanSomapacitan is under investigation in clinical trial NCT01706783 (A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily...
DB15094AnfibatideAnfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).
DB15095LeridistimLeridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
DB15101TigatuzumabTigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).
DB15112Somatropin pegolSomatropin pegol is under investigation in clinical trial NCT00715689 (Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083).
DB15113UtomilumabUtomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).
DB15118ZolbetuximabZolbetuximab is under investigation in clinical trial NCT01630083 (Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer).
DB15131Interferon alfa-2cInterferon alfa-2c is under investigation in clinical trial NCT00485563 (A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma).
DB15135PonezumabPonezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
DB15150FibronectinFibronectin is under investigation in clinical trial NCT01812239 (Vaginal Progesterone in Twins With Short Cervix).
DB15160AsunerceptAsunercept is under investigation in clinical trial NCT02853565 (A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme).
DB15166AlbuvirtideAlbuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).
DB15172SuvratoxumabSuvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).
DB15217Gastric inhibitory polypeptideGastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
DB15225MitazalimabMitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).
DB15228AvidinAvidin is under investigation in clinical trial NCT00345618 (Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach).
DB15231BrimapitideBrimapitide is under investigation in clinical trial NCT01570205 (Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers).
DB15251AntipainAntipain is under investigation in clinical trial NCT02891785 (Praxis Evaluation of a Pain Self-management Support Intervention for Oncology Patients: A Stepped Wedge Design Study).
DB15253BleselumabBleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant...
DB15263ThyrotropinThyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).
DB15272EdratideEdratide is under investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus).
DB15301BevifimodBevifimod is under investigation in clinical trial NCT01749787 (Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis).
DB15313DAS-181DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).
DB15319VM4-037VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037).
DB15336Valanafusp alfaValanafusp alfa is under investigation in clinical trial NCT03071341 (Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I).
DB15355PL-3994PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).
DB15363IstiratumabIstiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).
DB15383PidilizumabPidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).
DB15386ALT-801ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).
DB15397GMA-161GMA-161 is under investigation in clinical trial NCT00244257 (Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)).
DB15402Tucotuzumab celmoleukinTucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous...
DB15409Ladiratuzumab vedotinLadiratuzumab vedotin is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).
DB15415TomaralimabTomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
DB15428VesencumabVesencumab is under investigation in clinical trial NCT00747734 (A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors).
DB15432Pinatuzumab vedotinPinatuzumab vedotin is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With...
DB15441Lulizumab pegolLulizumab pegol is under investigation in clinical trial NCT02843659 (Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome).
DB15443Lorukafusp alfaLorukafusp alfa is under investigation in clinical trial NCT01334515 (Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma).
DB15453Naratuximab emtansineNaratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).
DB15458NorleucineNorleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).
DB05433rGLP-1Investigated for use/treatment in congestive heart failure and diabetes mellitus type 2.
DB05916CT-011Investigated for use/treatment in cancer/tumors (unspecified).
DB05950Contulakin-GInvestigated for use/treatment in pain (acute or chronic).
DB06305SonepcizumabInvestigated for use/treatment in solid tumors.
DB06402TelavancinAn antibacterial agent used in the treatment of complicated skin and skin structure infections and types of hospital-acquired bacterial pneumonia.
DB06610OmigananInvestigated for use/treatment in bacterial infection and rosacea.
DB08898GlucarpidaseA carboxypeptidase enzyme used to treat toxic plasma methotrexate concentrations by providing an alternate elimination pathway for methotrexate in patients who have impaired renal function.
DB08965FusafungineFusafungine is an antibiotic from Fusarium lateririum, and is used for the treatment of respiratory infections.
DB11204PanthenolAn ingredient used in skin, hair care, and nutritional products but is not an approved medication.
DB11572Thrombin alfaA platelet activating factor used to treat minor bleeding.
DB11580RavulizumabA monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria.
DB11608Eftrenonacog alfaA recombinant Factor IX used to treat and prevent bleeding in hemophilia B.
DB11720Angiotensin 1-7TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
DB11727EndostarEndostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.
DB11731Depatuxizumab mafodotinNo approved indication.
DB11801RapastinelRapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).
DB11850UblituximabUblituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
DB11879DusquetideDusquetide has been used in trials studying the treatment of Oral Mucositis.
DB11884Vadastuximab TalirineVadastuximab Talirine has been used in trials studying the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.
DB11930VarlilumabVarlilumab has been used in trials studying the treatment of MELANOMA, Skin Ulcer, Burkett's Lymphoma, Mantle cell lymphoma, and Any T-cell Malignancy, among others.
DB12077UrelumabUrelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. Urelumab is a fully human antibody...
DB12136SolnatideSolnatide has been used in trials studying the treatment of Acute Lung Injury.
DB12152SimtuzumabSimtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.
DB12157FasinumabFasinumab has been used in trials studying the basic science and treatment of Sciatica, Back Pain, Low Back Pain, Osteoarthritis, Hip, and Abdominal Pain Upper, among others.
DB12255VadadustatVadadustat has been used in trials studying the treatment of Anemia and Non-dialysis-dependent Chronic Kidney Disease.
DB12258Abicipar PegolAbicipar Pegol has been used in trials studying the treatment of Macular Edema and Macular Degeneration.
DB12281LuspaterceptAn erythroid maturation agent used to treat anemia secondary to beta thalassemia in patients requiring regular red blood cell transfusions.
DB12296GS-5745GS-5745 has been used in trials studying the treatment of Tumors, Breast Cancer, Crohn's Disease, Colorectal Cancer, and Pancreatic Cancer, among others.
DB12317VanucizumabVanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.
DB12331Labetuzumab govitecanLabetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, and Metastatic Colorectal Cancer.
DB12342EnsituximabEnsituximab has been used in trials studying the treatment of Pancreatic Cancer, Adult, Metastatic Colorectal Cancer, and Metastatic Pancreatic Cancer.
DB12344FezakinumabFezakinumab has been used in trials studying the treatment of Atopic Dermatitis and Rheumatoid Arthritis.
DB12413Indusatumab vedotinIndusatumab vedotin has been used in trials studying the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal Carcinoma, among others.
DB12631AclerastideAclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.
DB12683LumretuzumabLumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.
DB12797EcromeximabEcromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
DB12839PegvaliaseAn enzyme used to treat phenylketonuria in patients with phenylalanine levels that are too high on current treatment.
DB12840PirnabinePirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation.
DB12917BimekizumabBimekizumab has been used in trials studying the treatment of Psoriatic arthritis, Ankylosing Spondylitis, Chronic Plaque Psoriasis, and Mild to Moderate Psoriasis.
DB12950AlbusomatropinAlbusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.
DB13000PCI-27483PCI-27483 has been used in trials studying the treatment of Pancreatic Cancer, Ductal Adrenocarcinoma, and Exocrine Pancreatic Cancer.
DB13017Rovalpituzumab TesirineRovalpituzumab Tesirine has been used in trials studying the treatment of GLIOBLASTOMA, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer, among others.
DB13037NamilumabNamilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
DB13073TregalizumabTregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
DB13112DolcanatideDolcanatide has been investigated in Exposure.
DB13138Neladenoson bialanateNeladenoson bialanate has been investigated for the treatment of Heart Failure.
DB13140BezlotoxumabA monoclonal antibody used to reduce the recurrence of Clostridium difficile infections.
DB13151Anti-inhibitor coagulant complexA medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B.
DB13173Cerliponase alfaAn enzyme replacement therapy used to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency.
DB13848Fluorodopa (18F)Not Annotated
DB13881TisagenlecleucelA CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma.
DB13884Albutrepenonacog alfaA recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B.
DB14012BurosumabA fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia.
DB14040EptinezumabUse of eptinezumab is intended for migraine prevention [A33105, A33106, A33108].
DB14051Malacidin AMalacidin A is being investigated for its antibiotic action and has potential for use as an antibacterial agent in the future .
DB14052Malacidin BMalacidin B is being investigated for its antibiotic action and has potential for use as an antibacterial agent in the future .
DB14568IvosidenibAn isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia with a susceptible mutation.
DB14580BAN-2401BAN-2401 is an experimental drug that is currently in clinical trials for the treament of Alzheimer's disease.
DB14707CemiplimabA programmed death receptor-1 blocking antibody used to treat metastatic cutaneous squamous cell carcinoma.
DB14754SolriamfetolSolriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744].
DB14776CamrelizumabCamrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
DB14777MurepavadinMurepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
DB14778SetrusumabSetrusumab is under investigation in clinical trial NCT01406548 (Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density).
DB14784GancotamabGancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
DB14843CodrituzumabCodrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).
DB14864BrolucizumabAn anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration.
DB14871XentuzumabXentuzumab is under investigation in clinical trial NCT02191891 (Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)).
DB14897ParsatuzumabParsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous...
DB14906AdafosbuvirAdafosbuvir is under investigation in clinical trial NCT02894905 (A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335).
DB14919RozanolixizumabRozanolixizumab is under investigation in clinical trial NCT03861481 (A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy).
DB14939MotixafortideMotixafortide is under investigation in clinical trial NCT01838395 (Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients).
DB14959OpicinumabOpicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).
DB14962Trastuzumab deruxtecanTrastuzumab deruxtecan is under investigation in clinical trial NCT02564900 (Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors).
DB14967MargetuximabMargetuximab is under investigation in clinical trial NCT03133988 (Margetuximab Expanded Access Program).
DB15014GremubamabGremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).
DB15044TafasitamabTafasitamab is under investigation in clinical trial NCT02005289 (Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated...
DB15065PF-06291874PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus).
DB15089FrovocimabFrovocimab is under investigation in clinical trial NCT01671085 (A Study of LY3015014 in Healthy Participants With High Cholesterol).
DB15090TezepelumabTezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma).
DB15104Telisotuzumab vedotinTelisotuzumab vedotin is under investigation in clinical trial NCT02099058 (A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors.).
DB15128RemtolumabRemtolumab is under investigation in clinical trial NCT02433340 (Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study).
DB15140BempegaldesleukinBempegaldesleukin is under investigation in clinical trial NCT03729245 (A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib...
DB15158BPI-3016BPI-3016 is under investigation in clinical trial NCT03188848 (Dose Escalating Study of BPI-3016 in Healthy Subjects).
DB15162PegilodecakinPegilodecakin is under investigation in clinical trial NCT03382912 (Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer).
DB15171TirzepatideTirzepatide is under investigation in clinical trial NCT03311724 (A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes).
DB15194CotadutideCotadutide is under investigation in clinical trial NCT03444584 (Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Subject With Type 2 Diabetes).
DB15195MibenratideMibenratide is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).
DB15199CiraparantagCiraparantag is under investigation in clinical trial NCT01826266 (Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban).
DB15252NemolizumabNemolizumab is under investigation in clinical trial NCT03921411 (A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)).
DB15277GedivumabGedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).
DB15331Vocimagene amiretrorepvecVocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca...
DB15349Sofituzumab vedotinSofituzumab vedotin is under investigation in clinical trial NCT01335958 (Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer).
DB15354EvinacumabEvinacumab is under investigation in clinical trial NCT03146416 (Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers).
DB15365PegbelferminPegbelfermin is under investigation in clinical trial NCT03486899 (A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis).
DB15366SOR-C13SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).
DB15370BalixafortideBalixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
DB15466TallimustineAn alkylating agent previously investigated for it's antitumor activity but was stopped due to severe myelotoxicity.
DB13925Dotatate gallium Ga-68Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine...
DB15531Silk sericinNot Annotated
DB15559ZenocutuzumabZenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
DB02668JE-2147Not Available
DB01833CanavanineNot Available
DB01934Arylomycin A2Not Available
DrugDrug NameTargetType
DB00001LepirudinProthrombintarget
DB00002CetuximabEpidermal growth factor receptortarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00002CetuximabComplement C1r subcomponenttarget
DB00002CetuximabComplement C1q subcomponent subunit Atarget
DB00002CetuximabComplement C1q subcomponent subunit Btarget
DB00002CetuximabComplement C1q subcomponent subunit Ctarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00002CetuximabComplement C1s subcomponenttarget
DB00002CetuximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00003Dornase alfaDNAtarget
DB00004Denileukin diftitoxInterleukin-2 receptor subunit alphatarget
DB00004Denileukin diftitoxCytokine receptor common subunit gammatarget
DB00004Denileukin diftitoxInterleukin-2 receptor subunit betatarget
DB00005EtanerceptTumor necrosis factortarget
DB00005EtanerceptLymphotoxin-alphatarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00005EtanerceptComplement C1r subcomponenttarget
DB00005EtanerceptComplement C1q subcomponent subunit Atarget
DB00005EtanerceptComplement C1q subcomponent subunit Btarget
DB00005EtanerceptComplement C1q subcomponent subunit Ctarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00005EtanerceptComplement C1s subcomponenttarget
DB00005EtanerceptHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00005EtanerceptTumor necrosis factor receptor superfamily member 1Btarget
DB00006BivalirudinProthrombintarget
DB00006BivalirudinMyeloperoxidaseenzyme
DB00007LeuprolideGonadotropin-releasing hormone receptortarget
DB00007LeuprolideCytochrome P450 3A4enzyme
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 2target
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 1target
DB00008Peginterferon alfa-2aCytochrome P450 1A2enzyme
DB00009AlteplaseUrokinase plasminogen activator surface receptortarget
DB00009AlteplaseFibrinogen alpha chaintarget
DB00009AlteplasePlasminogentarget
DB00009AlteplasePlasminogen activator inhibitor 1target
DB00010SermorelinGrowth hormone-releasing hormone receptortarget
DB00011Interferon alfa-n1Interferon alpha/beta receptor 2target
DB00011Interferon alfa-n1Interferon alpha/beta receptor 1target
DB00011Interferon alfa-n1Cytochrome P450 1A2enzyme
DB00012Darbepoetin alfaErythropoietin receptortarget
DB00013UrokinaseUrokinase plasminogen activator surface receptortarget
DB00013UrokinasePlasminogentarget
DB00013UrokinaseUrokinase-type plasminogen activatortarget
DB00013UrokinaseTissue-type plasminogen activatortarget
DB00013UrokinasePlasminogen activator inhibitor 2target
DB00013UrokinasePlasminogen activator inhibitor 1target
DB00013UrokinasePlasma serine protease inhibitortarget
DB00013UrokinaseNidogen-1target
DB00013UrokinaseLow-density lipoprotein receptor-related protein 2target
DB00013UrokinaseSuppressor of tumorigenicity 14 proteintarget
DB00014GoserelinLutropin-choriogonadotropic hormone receptortarget
DB00014GoserelinGonadotropin-releasing hormone receptortarget
DB00015ReteplaseUrokinase plasminogen activator surface receptortarget
DB00015ReteplaseFibrinogen alpha chaintarget
DB00015ReteplasePlasminogentarget
DB00015ReteplasePlasminogen activator inhibitor 1target
DB00016ErythropoietinErythropoietin receptortarget
DB00017Salmon CalcitoninCalcitonin receptortarget
DB00018Interferon alfa-n3Interferon alpha/beta receptor 1target
DB00018Interferon alfa-n3Interferon alpha/beta receptor 2target
DB00018Interferon alfa-n3Cytochrome P450 1A2enzyme
DB00019PegfilgrastimGranulocyte colony-stimulating factor receptortarget
DB00019PegfilgrastimNeutrophil elastaseenzyme
DB00020SargramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
DB00020SargramostimBone marrow proteoglycantarget
DB00020SargramostimInterleukin-3 receptor subunit alphatarget
DB00020SargramostimCytokine receptor common subunit betatarget
DB00020SargramostimSyndecan-2target
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 1target
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 2target
DB00022Peginterferon alfa-2bCytochrome P450 1A2enzyme
DB00022Peginterferon alfa-2bCytochrome P450 2D6enzyme
DB00022Peginterferon alfa-2bCytochrome P450 2C9enzyme
DB00024Thyrotropin alfaThyrotropin receptortarget
DB00025Antihemophilic factor, human recombinantCoagulation factor Xtarget
DB00025Antihemophilic factor, human recombinantPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB00025Antihemophilic factor, human recombinantCoagulation factor IXtarget
DB00025Antihemophilic factor, human recombinantAsialoglycoprotein receptor 2target
DB00025Antihemophilic factor, human recombinant78 kDa glucose-regulated proteintarget
DB00025Antihemophilic factor, human recombinantCalreticulintarget
DB00025Antihemophilic factor, human recombinantCalnexintarget
DB00025Antihemophilic factor, human recombinantProtein ERGIC-53target
DB00025Antihemophilic factor, human recombinantProlow-density lipoprotein receptor-related protein 1target
DB00025Antihemophilic factor, human recombinantMultiple coagulation factor deficiency protein 2target
DB00025Antihemophilic factor, human recombinantvon Willebrand factortarget
DB00025Antihemophilic factor, human recombinantProthrombinenzyme
DB00025Antihemophilic factor, human recombinantVitamin K-dependent protein Cenzyme
DB00026AnakinraInterleukin-1 receptor type 1target
DB00027Gramicidin DP-glycoprotein 1transporter
DB00028Immune globulin humanLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00028Immune globulin humanLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00028Immune globulin humanHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00028Immune globulin humanLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00028Immune globulin humanLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00028Immune globulin humanLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00028Immune globulin humanHigh affinity immunoglobulin gamma Fc receptor IBtarget
DB00028Immune globulin humanComplement C3target
DB00028Immune globulin humanComplement C4-Atarget
DB00028Immune globulin humanComplement C4-Btarget
DB00028Immune globulin humanComplement C5target
DB00029AnistreplaseUrokinase plasminogen activator surface receptortarget
DB00029AnistreplaseFibrinogen alpha chaintarget
DB00029AnistreplasePlasminogentarget
DB00029AnistreplasePlasminogen activator inhibitor 1target
DB00030Insulin humanInsulin receptortarget
DB00030Insulin humanRetinoblastoma-associated proteintarget
DB00030Insulin humanInsulin-like growth factor 1 receptortarget
DB00030Insulin humanInsulin-degrading enzymeenzyme
DB00030Insulin humanNeuroendocrine convertase 2enzyme
DB00030Insulin humanNeuroendocrine convertase 1enzyme
DB00030Insulin humanCytochrome P450 1A2enzyme
DB00030Insulin humanCarboxypeptidase Etarget
DB00031TenecteplaseUrokinase plasminogen activator surface receptortarget
DB00031TenecteplasePlasminogen activator inhibitor 1target
DB00031TenecteplaseFibrinogen alpha chaintarget
DB00031TenecteplasePlasminogen activator inhibitor 2target
DB00031TenecteplaseTetranectintarget
DB00031TenecteplaseKeratin, type II cytoskeletal 8target
DB00031TenecteplaseAnnexin A2target
DB00031TenecteplaseCalreticulintarget
DB00031TenecteplaseCalnexintarget
DB00031TenecteplaseProlow-density lipoprotein receptor-related protein 1target
DB00031TenecteplasePlasminogentarget
DB00032MenotropinsFollicle-stimulating hormone receptortarget
DB00032MenotropinsLutropin-choriogonadotropic hormone receptortarget
DB00033Interferon gamma-1bInterferon gamma receptor 1target
DB00033Interferon gamma-1bInterferon gamma receptor 2target
DB00033Interferon gamma-1bCytochrome P450 1A2enzyme
DB00035DesmopressinVasopressin V1a receptortarget
DB00035DesmopressinVasopressin V1b receptortarget
DB00035DesmopressinVasopressin V2 receptortarget
DB00035DesmopressinProstaglandin G/H synthase 1enzyme
DB00035DesmopressinProstaglandin G/H synthase 2enzyme
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor Xtarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factortarget
DB00036Coagulation factor VIIa Recombinant HumanSerine protease hepsintarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factor pathway inhibitortarget
DB00036Coagulation factor VIIa Recombinant HumanVitamin K-dependent gamma-carboxylasetarget
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor VIItarget
DB00038OprelvekinInterleukin-11 receptor subunit alphatarget
DB00039PaliferminFibroblast growth factor receptor 2target
DB00039PaliferminNeuropilin-1target
DB00039PaliferminFibroblast growth factor receptor 1target
DB00039PaliferminFibroblast growth factor receptor 4target
DB00039PaliferminFibroblast growth factor receptor 3target
DB00039PaliferminBasement membrane-specific heparan sulfate proteoglycan core proteintarget
DB00040GlucagonGlucagon receptortarget
DB00040GlucagonGlucagon-like peptide 2 receptortarget
DB00040GlucagonGlucagon-like peptide 1 receptortarget
DB00041AldesleukinInterleukin-2 receptor subunit betatarget
DB00041AldesleukinInterleukin-2 receptor subunit alphatarget
DB00041AldesleukinCytokine receptor common subunit gammatarget
DB00041AldesleukinProstaglandin G/H synthase 2enzyme
DB00041AldesleukinCytosolic phospholipase A2enzyme
DB00041AldesleukinCytochrome P450 3A4enzyme
DB00041AldesleukinXanthine dehydrogenase/oxidaseenzyme
DB00041AldesleukinCytochrome P450 2E1enzyme
DB00042Botulinum Toxin Type BVesicle-associated membrane protein 1target
DB00042Botulinum Toxin Type BVesicle-associated membrane protein 2target
DB00042Botulinum Toxin Type BSynaptotagmin-2target
DB00043OmalizumabHigh affinity immunoglobulin epsilon receptor subunit alphatarget
DB00043OmalizumabHigh affinity immunoglobulin epsilon receptor subunit betatarget
DB00046Insulin lisproInsulin receptortarget
DB00046Insulin lisproInsulin-like growth factor 1 receptortarget
DB00046Insulin lisproCytochrome P450 1A2enzyme
DB00047Insulin glargineInsulin receptortarget
DB00047Insulin glargineInsulin-like growth factor 1 receptortarget
DB00047Insulin glargineCytochrome P450 1A2enzyme
DB00050CetrorelixLutropin-choriogonadotropic hormone receptortarget
DB00050CetrorelixGonadotropin-releasing hormone receptortarget
DB00051AdalimumabTumor necrosis factortarget
DB00052SomatotropinGrowth hormone receptortarget
DB00052SomatotropinProlactin receptortarget
DB00054AbciximabIntegrin beta-3target
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00054AbciximabComplement C1r subcomponenttarget
DB00054AbciximabComplement C1q subcomponent subunit Atarget
DB00054AbciximabComplement C1q subcomponent subunit Btarget
DB00054AbciximabComplement C1q subcomponent subunit Ctarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00054AbciximabComplement C1s subcomponenttarget
DB00054AbciximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00054AbciximabIntegrin alpha-IIbtarget
DB00054AbciximabVitronectintarget
DB00055Drotrecogin alfaCoagulation factor VIIItarget
DB00055Drotrecogin alfaCoagulation factor Vtarget
DB00055Drotrecogin alfaPlasminogen activator inhibitor 1target
DB00055Drotrecogin alfaThrombomodulintarget
DB00055Drotrecogin alfaVitamin K-dependent protein Starget
DB00055Drotrecogin alfaCeruloplasmintarget
DB00055Drotrecogin alfaProthrombintarget
DB00055Drotrecogin alfaPlatelet factor 4target
DB00055Drotrecogin alfaPlasma serine protease inhibitortarget
DB00055Drotrecogin alfaSerpin B6target
DB00055Drotrecogin alfaVitamin K-dependent gamma-carboxylasetarget
DB00055Drotrecogin alfaEndothelial protein C receptortarget
DB00056Gemtuzumab ozogamicinMyeloid cell surface antigen CD33target
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00056Gemtuzumab ozogamicinComplement C1r subcomponenttarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Atarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Btarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Ctarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00056Gemtuzumab ozogamicinComplement C1s subcomponenttarget
DB00056Gemtuzumab ozogamicinHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00057Indium In-111 satumomab pendetideTumor-associated glycoprotein 72 (TAG-72)target
DB00058Alpha-1-proteinase inhibitorNeutrophil elastasetarget
DB00060Interferon beta-1aInterferon alpha/beta receptor 1target
DB00060Interferon beta-1aInterferon alpha/beta receptor 2target
DB00060Interferon beta-1aCytochrome P450 1A2enzyme
DB00062Human Serum AlbuminNitric oxidetarget
DB00063EptifibatideIntegrin beta-3target
DB00065InfliximabTumor necrosis factortarget
DB00066FollitropinFollicle-stimulating hormone receptortarget
DB00067VasopressinVasopressin V1a receptortarget
DB00067VasopressinVasopressin V2 receptortarget
DB00067VasopressinVasopressin V1b receptortarget
DB00067VasopressinCanalicular multispecific organic anion transporter 1transporter
DB00068Interferon beta-1bInterferon alpha/beta receptor 1target
DB00068Interferon beta-1bInterferon alpha/beta receptor 2target
DB00068Interferon beta-1bCytochrome P450 1A2enzyme
DB00069Interferon alfacon-1Interferon alpha/beta receptor 1target
DB00069Interferon alfacon-1Interferon alpha/beta receptor 2target
DB00069Interferon alfacon-1Cytochrome P450 1A2enzyme
DB00071Insulin PorkInsulin receptortarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ alpha 2 chaintarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ beta 1 chaintarget
DB00071Insulin PorkRetinoblastoma-associated proteintarget
DB00071Insulin PorkCathepsin Dtarget
DB00071Insulin PorkInsulin-like growth factor 1 receptortarget
DB00071Insulin PorkInsulin-degrading enzymetarget
DB00071Insulin PorkNeuroendocrine convertase 2target
DB00071Insulin PorkCarboxypeptidase Etarget
DB00071Insulin PorkNeuroendocrine convertase 1target
DB00071Insulin PorkProtein NOV homologtarget
DB00071Insulin PorkLow-density lipoprotein receptor-related protein 2target
DB00071Insulin PorkInsulin-like growth factor-binding protein 7target
DB00071Insulin PorkSynaptotagmin-like protein 4target
DB00071Insulin PorkCytochrome P450 1A2enzyme
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00072TrastuzumabComplement C1r subcomponenttarget
DB00072TrastuzumabComplement C1q subcomponent subunit Atarget
DB00072TrastuzumabComplement C1q subcomponent subunit Btarget
DB00072TrastuzumabComplement C1q subcomponent subunit Ctarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00072TrastuzumabComplement C1s subcomponenttarget
DB00072TrastuzumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00072TrastuzumabReceptor tyrosine-protein kinase erbB-2target
DB00072TrastuzumabEpidermal growth factor receptortarget
DB00073RituximabB-lymphocyte antigen CD20target
DB00074BasiliximabInterleukin-2 receptor subunit alphatarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00074BasiliximabComplement C1r subcomponenttarget
DB00074BasiliximabComplement C1q subcomponent subunit Atarget
DB00074BasiliximabComplement C1q subcomponent subunit Btarget
DB00074BasiliximabComplement C1q subcomponent subunit Ctarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00074BasiliximabComplement C1s subcomponenttarget
DB00074BasiliximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00074BasiliximabInterleukin-2 receptor subunit betatarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00075MuromonabT-cell surface glycoprotein CD3 epsilon chaintarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00075MuromonabComplement C1r subcomponenttarget
DB00075MuromonabComplement C1q subcomponent subunit Atarget
DB00075MuromonabComplement C1q subcomponent subunit Btarget
DB00075MuromonabComplement C1q subcomponent subunit Ctarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00075MuromonabComplement C1s subcomponenttarget
DB00075MuromonabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00075MuromonabT-cell surface glycoprotein CD3 delta chaintarget
DB00075MuromonabT-cell surface glycoprotein CD3 gamma chaintarget
DB00075MuromonabT-cell surface glycoprotein CD3 zeta chaintarget
DB00078Ibritumomab tiuxetanB-lymphocyte antigen CD20target
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00078Ibritumomab tiuxetanComplement C1r subcomponenttarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Atarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Btarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Ctarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00078Ibritumomab tiuxetanComplement C1s subcomponenttarget
DB00078Ibritumomab tiuxetanHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00080DaptomycinBacterial outer membranetarget
DB00081TositumomabB-lymphocyte antigen CD20target
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00081TositumomabComplement C1r subcomponenttarget
DB00081TositumomabComplement C1q subcomponent subunit Atarget
DB00081TositumomabComplement C1q subcomponent subunit Btarget
DB00081TositumomabComplement C1q subcomponent subunit Ctarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00081TositumomabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00082PegvisomantGrowth hormone receptortarget
DB00082PegvisomantSterol 26-hydroxylase, mitochondrialenzyme
DB00082PegvisomantGlutamine synthetaseenzyme
DB00082PegvisomantCytochrome P450 2C18enzyme
DB00082PegvisomantCytochrome P450 3A4enzyme
DB00082PegvisomantCholinesteraseenzyme
DB00082PegvisomantCytochrome P450 4A11enzyme
DB00083Botulinum toxin type ASynaptosomal-associated protein 25target
DB00083Botulinum toxin type ARho-related GTP-binding protein RhoBtarget
DB00086StreptokinasePlasminogentarget
DB00086StreptokinaseProteinase-activated receptor 1target
DB00086StreptokinaseCytosolic phospholipase A2enzyme
DB00087AlemtuzumabCAMPATH-1 antigentarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00087AlemtuzumabComplement C1r subcomponenttarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Atarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Btarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Ctarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00087AlemtuzumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00089Capromab pendetideGlutamate carboxypeptidase 2target
DB00092AlefaceptT-cell surface antigen CD2target
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00092AlefaceptComplement C1r subcomponenttarget
DB00092AlefaceptComplement C1q subcomponent subunit Atarget
DB00092AlefaceptComplement C1q subcomponent subunit Btarget
DB00092AlefaceptComplement C1q subcomponent subunit Ctarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00092AlefaceptHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00093FelypressinVasopressin V1a receptortarget
DB00094UrofollitropinFollicle-stimulating hormone receptortarget
DB00095EfalizumabIntegrin alpha-Ltarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00095EfalizumabComplement C1r subcomponenttarget
DB00095EfalizumabComplement C1q subcomponent subunit Atarget
DB00095EfalizumabComplement C1q subcomponent subunit Btarget
DB00095EfalizumabComplement C1q subcomponent subunit Ctarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00095EfalizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00098Antithymocyte immunoglobulin (rabbit)T-cell surface glycoprotein CD1atarget
DB00098Antithymocyte immunoglobulin (rabbit)Major histocompatibility complex class I-related gene proteintarget
DB00098Antithymocyte immunoglobulin (rabbit)Integrin alpha-Ltarget
DB00098Antithymocyte immunoglobulin (rabbit)T-lymphocyte activation antigen CD86target
DB00098Antithymocyte immunoglobulin (rabbit)Low affinity immunoglobulin gamma Fc region receptor II-btarget
DB00098Antithymocyte immunoglobulin (rabbit)T-cell surface glycoprotein CD4target
DB00098Antithymocyte immunoglobulin (rabbit)Integrin beta-1target
DB00098Antithymocyte immunoglobulin (rabbit)Integrin alpha-Vtarget
DB00098Antithymocyte immunoglobulin (rabbit)Integrin beta-3target
DB00099FilgrastimGranulocyte colony-stimulating factor receptortarget
DB00099FilgrastimNeutrophil elastasetarget
DB00102BecaplerminPlatelet-derived growth factor receptor betatarget
DB00102BecaplerminAlpha-2-macroglobulintarget
DB00102BecaplerminPlatelet-derived growth factor receptor alphatarget
DB00103Agalsidase betaGlobotriaosylceramidetarget
DB00104OctreotideSomatostatin receptor type 1target
DB00104OctreotideSomatostatin receptor type 5target
DB00104OctreotideSomatostatin receptor type 2target
DB00104OctreotideMyeloperoxidaseenzyme
DB00104OctreotideCytochrome P450 3A4enzyme
DB00106AbarelixGonadotropin-releasing hormone receptortarget
DB00107OxytocinOxytocin-neurophysin 1target
DB00107OxytocinOxytocin receptortarget
DB00107OxytocinProlyl endopeptidaseenzyme
DB00108NatalizumabIntegrin alpha-4target
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00108NatalizumabComplement C1r subcomponenttarget
DB00108NatalizumabComplement C1q subcomponent subunit Atarget
DB00108NatalizumabComplement C1q subcomponent subunit Btarget
DB00108NatalizumabComplement C1q subcomponent subunit Ctarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00108NatalizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00108NatalizumabIntercellular adhesion molecule 1target
DB00109EnfuvirtideEnvelope glycoproteintarget
DB00109EnfuvirtideCytochrome P450 2C19enzyme
DB00109EnfuvirtideCytochrome P450 2E1enzyme
DB00110PalivizumabFusion glycoprotein F0target
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00110PalivizumabComplement C1r subcomponenttarget
DB00110PalivizumabComplement C1q subcomponent subunit Atarget
DB00110PalivizumabComplement C1q subcomponent subunit Btarget
DB00110PalivizumabComplement C1q subcomponent subunit Ctarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00110PalivizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00111DaclizumabInterleukin-2 receptor subunit alphatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00111DaclizumabComplement C1r subcomponenttarget
DB00111DaclizumabComplement C1q subcomponent subunit Atarget
DB00111DaclizumabComplement C1q subcomponent subunit Btarget
DB00111DaclizumabComplement C1q subcomponent subunit Ctarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00111DaclizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00111DaclizumabInterleukin-2 receptor subunit betatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00112BevacizumabComplement C1r subcomponenttarget
DB00112BevacizumabComplement C1q subcomponent subunit Atarget
DB00112BevacizumabComplement C1q subcomponent subunit Btarget
DB00112BevacizumabComplement C1q subcomponent subunit Ctarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00112BevacizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00112BevacizumabVascular endothelial growth factor Atarget
DB00113Technetium Tc-99m arcitumomabCarcinoembryonic antigen-related cell adhesion molecule 1target
DB00117HistidineHistidine decarboxylasetarget
DB00117HistidineHistidine--tRNA ligase, cytoplasmictarget
DB00117HistidineSodium-coupled neutral amino acid transporter 3target
DB00117HistidineHistidine ammonia-lyasetarget
DB00117HistidineMonocarboxylate transporter 10transporter
DB00118AdemetionineGlycine N-methyltransferasetarget
DB00118AdemetionineS-adenosylmethionine decarboxylase proenzymetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-2target
DB00118AdemetionineCystathionine beta-synthasetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-1target
DB00118AdemetionineCytochrome P450 2E1enzyme
DB00118AdemetionineCatechol O-methyltransferasetarget
DB00118AdemetionineSpermidine synthaseenzyme
DB00118AdemetionineCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1target
DB00118AdemetionineArsenite methyltransferasetarget
DB00120L-PhenylalanineTyrosine aminotransferasetarget
DB00120L-PhenylalanineLarge neutral amino acids transporter small subunit 2target
DB00120L-PhenylalaninePhenylalanine--tRNA ligase alpha subunittarget
DB00120L-PhenylalaninePhenylalanine-4-hydroxylasetarget
DB00120L-PhenylalaninePhenylalanine--tRNA ligase, mitochondrialtarget
DB00120L-PhenylalaninePhenylalanine--tRNA ligase beta subunittarget
DB00120L-PhenylalanineTyrosine 3-monooxygenasetarget
DB00120L-PhenylalanineMonocarboxylate transporter 10transporter
DB00123L-LysineHigh affinity cationic amino acid transporter 1target
DB00123L-LysineCationic amino acid transporter 4target
DB00123L-LysineCationic amino acid transporter 3target
DB00123L-LysineLow affinity cationic amino acid transporter 2target
DB00123L-LysineLysine--tRNA ligasetarget
DB00123L-LysineMonocarboxylate transporter 10transporter
DB00123L-LysineSolute carrier family 22 member 4transporter
DB00125ArginineCationic amino acid transporter 3target
DB00125ArginineArginine decarboxylasetarget
DB00125ArginineArgininosuccinate lyasetarget
DB00125ArginineNitric oxide synthase, inducibletarget
DB00125ArginineHigh affinity cationic amino acid transporter 1target
DB00125ArginineArginase-2, mitochondrialtarget
DB00125ArginineCationic amino acid transporter 4target
DB00125ArginineArgininosuccinate synthasetarget
DB00125ArginineNitric oxide synthase, endothelialtarget
DB00125ArginineSolute carrier family 22 member 5transporter
DB00125ArginineMonocarboxylate transporter 10transporter
DB00125ArginineSolute carrier family 22 member 4transporter
DB00128Aspartic acidCalcium-binding mitochondrial carrier protein Aralar2target
DB00128Aspartic acidAspartate aminotransferase, cytoplasmictarget
DB00128Aspartic acidAspartoacylasetarget
DB00128Aspartic acidAsparagine synthetase [glutamine-hydrolyzing]target
DB00128Aspartic acidArgininosuccinate synthasetarget
DB00128Aspartic acidAminoacylase-1target
DB00128Aspartic acidAspartate aminotransferase, mitochondrialtarget
DB00128Aspartic acidAspartate--tRNA ligase, cytoplasmictarget
DB00128Aspartic acidCalcium-binding mitochondrial carrier protein Aralar1target
DB00128Aspartic acidAspartyl/asparaginyl beta-hydroxylasetarget
DB00128Aspartic acidMultifunctional protein ADE2target
DB00128Aspartic acidCAD proteintarget
DB00128Aspartic acidAdenylosuccinate synthetase isozyme 2target
DB00128Aspartic acidExcitatory amino acid transporter 3target
DB00128Aspartic acidAspartate aminotransferasetarget
DB00128Aspartic acidArgininosuccinate synthetase, isoform CRA_atarget
DB00128Aspartic acidAspartate--tRNA ligase, mitochondrialtarget
DB00128Aspartic acidIsoaspartyl peptidase/L-asparaginasetarget
DB00128Aspartic acidAdenylosuccinate synthetase isozyme 1target
DB00128Aspartic acidAspartoacylase-2target
DB00128Aspartic acidRibonuclease pancreatictarget
DB00128Aspartic acidLysozyme Ctarget
DB00128Aspartic acidMonocarboxylate transporter 10transporter
DB00130L-GlutamineCTP synthase 1target
DB00130L-GlutamineAmidophosphoribosyltransferasetarget
DB00130L-GlutamineGlutamine synthetasetarget
DB00130L-GlutamineMonocarboxylate transporter 10transporter
DB00130L-GlutamineCoagulation factor XIII A chainenzyme
DB00130L-GlutamineGlutaminase kidney isoform, mitochondrialenzyme
DB00130L-GlutamineGlutaminase liver isoform, mitochondrialenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 2enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 5enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 6enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Kenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 4enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Eenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Zenzyme
DB00130L-GlutamineSodium-coupled neutral amino acid transporter 3transporter
DB00130L-GlutamineNeutral amino acid transporter B(0)transporter
DB00130L-GlutamineGMP synthase [glutamine-hydrolyzing]enzyme
DB00130L-GlutamineAsparagine synthetase [glutamine-hydrolyzing]enzyme
DB00130L-GlutamineKynurenine--oxoglutarate transaminase 1enzyme
DB00130L-GlutaminePhosphoribosylformylglycinamidine synthaseenzyme
DB00130L-GlutamineGlutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrialenzyme
DB00130L-GlutamineGlutamine--fructose-6-phosphate aminotransferase [isomerizing] 2enzyme
DB00130L-GlutamineCAD proteinenzyme
DB00130L-GlutamineGlutamine--tRNA ligaseenzyme
DB00130L-GlutamineGlutamine-dependent NAD(+) synthetaseenzyme
DB00130L-GlutamineLarge neutral amino acids transporter small subunit 2transporter
DB00133SerineCystathionine beta-synthasetarget
DB00133SerineL-serine dehydratase/L-threonine deaminasetarget
DB00133SerineSerine racemasetarget
DB00133SerineSerine palmitoyltransferase 2target
DB00133SerineSerine palmitoyltransferase 1target
DB00133SerineSerine--tRNA ligase, cytoplasmictarget
DB00133SerineSerine--pyruvate aminotransferasetarget
DB00133SerineMonocarboxylate transporter 10transporter
DB00134MethionineMethionine synthase reductasetarget
DB00134MethionineMethionine synthasetarget
DB00134MethionineMethionine aminopeptidase 2target
DB00134MethionineBetaine--homocysteine S-methyltransferase 1target
DB00134MethionineS-methylmethionine--homocysteine S-methyltransferase BHMT2target
DB00134MethionineGlutamine synthetaseenzyme
DB00134MethionineMethylenetetrahydrofolate reductaseenzyme
DB00134MethionineMonocarboxylate transporter 10transporter
DB00134MethionineS-adenosylmethionine synthase isoform type-2enzyme
DB00134MethionineMethionine-R-sulfoxide reductase B2, mitochondrialenzyme
DB00134MethionineS-adenosylmethionine synthase isoform type-1enzyme
DB00134MethionineMethionine-R-sulfoxide reductase B1enzyme
DB00134MethionineMitochondrial peptide methionine sulfoxide reductaseenzyme
DB00134MethionineMethionine--tRNA ligase, cytoplasmicenzyme
DB00134MethionineMethionine--tRNA ligase, mitochondrialenzyme
DB00134MethionineMethionine adenosyltransferase 2 subunit betaenzyme
DB00135TyrosineTyrosine 3-monooxygenasetarget
DB00135TyrosineTyrosine--tRNA ligase, mitochondrialtarget
DB00135TyrosineTyrosine--tRNA ligase, cytoplasmictarget
DB00135TyrosineTyrosine aminotransferasetarget
DB00135TyrosineMonocarboxylate transporter 8transporter
DB00135TyrosineMonocarboxylate transporter 10transporter
DB00138CystineCystine/glutamate transportertarget
DB00138CystineCystinosintarget
DB00138CystineB(0,+)-type amino acid transporter 1target
DB00138CystineNeutral and basic amino acid transport protein rBATtarget
DB00138CystineMonocarboxylate transporter 10transporter
DB00142Glutamic acidGlutamate dehydrogenase 1, mitochondrialtarget
DB00142Glutamic acidGlutamate receptor ionotropic, kainate 1target
DB00142Glutamic acidGlutamate receptor 1target
DB00142Glutamic acidGlutamate--cysteine ligase regulatory subunittarget
DB00142Glutamic acidGlutamate carboxypeptidase 2target
DB00142Glutamic acidGlutamate decarboxylase 2target
DB00142Glutamic acidGlutamate decarboxylase 1target
DB00142Glutamic acidFormimidoyltransferase-cyclodeaminasetarget
DB00142Glutamic acidGlutamate receptor 2target
DB00142Glutamic acidGlutamate receptor 3target
DB00142Glutamic acidGlutamate receptor 4target
DB00142Glutamic acidDelta-1-pyrroline-5-carboxylate synthasetarget
DB00142Glutamic acidGlutamate receptor ionotropic, kainate 2target
DB00142Glutamic acidGlutamate receptor ionotropic, kainate 3target
DB00142Glutamic acidMetabotropic glutamate receptor 1target
DB00142Glutamic acidMetabotropic glutamate receptor 4target
DB00142Glutamic acidGlutamate receptor ionotropic, kainate 4target
DB00142Glutamic acidGlutamate receptor ionotropic, kainate 5target
DB00142Glutamic acidMetabotropic glutamate receptor 7target
DB00142Glutamic acidMetabotropic glutamate receptor 8target
DB00142Glutamic acidExcitatory amino acid transporter 5target
DB00142Glutamic acid5-oxoprolinasetarget
DB00142Glutamic acidPhosphoribosylformylglycinamidine synthasetarget
DB00142Glutamic acidBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 2Dtarget
DB00142Glutamic acidGlutamate receptor ionotropic, delta-2target
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 3Btarget
DB00142Glutamic acidGlutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrialtarget
DB00142Glutamic acidGlutaminase kidney isoform, mitochondrialtarget
DB00142Glutamic acidAspartate aminotransferase, mitochondrialtarget
DB00142Glutamic acidBifunctional glutamate/proline--tRNA ligasetarget
DB00142Glutamic acidAsparagine synthetase [glutamine-hydrolyzing]target
DB00142Glutamic acidGlutamine synthetasetarget
DB00142Glutamic acidAspartate aminotransferase, cytoplasmictarget
DB00142Glutamic acidTyrosine aminotransferasetarget
DB00142Glutamic acidAlanine aminotransferase 1target
DB00142Glutamic acidVitamin K-dependent gamma-carboxylasetarget
DB00142Glutamic acidExcitatory amino acid transporter 1target
DB00142Glutamic acidExcitatory amino acid transporter 2target
DB00142Glutamic acidExcitatory amino acid transporter 3target
DB00142Glutamic acidGlutamate--cysteine ligase catalytic subunittarget
DB00142Glutamic acidExcitatory amino acid transporter 4target
DB00142Glutamic acidGlutamate dehydrogenase 2, mitochondrialtarget
DB00142Glutamic acidGMP synthase [glutamine-hydrolyzing]target
DB00142Glutamic acidBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00142Glutamic acid4-aminobutyrate aminotransferase, mitochondrialtarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 1target
DB00142Glutamic acidFolylpolyglutamate synthase, mitochondrialtarget
DB00142Glutamic acidGlutamyl aminopeptidasetarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 2Atarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 2Btarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 2Ctarget
DB00142Glutamic acidAspartate aminotransferasetarget
DB00142Glutamic acidProbable glutamate--tRNA ligase, mitochondrialtarget
DB00142Glutamic acidLengsintarget
DB00142Glutamic acidGlutamine-dependent NAD(+) synthetasetarget
DB00142Glutamic acidKynurenine--oxoglutarate transaminase 3target
DB00142Glutamic acidN-acetylglutamate synthase, mitochondrialtarget
DB00142Glutamic acidKynurenine/alpha-aminoadipate aminotransferase, mitochondrialtarget
DB00142Glutamic acidGlutamate receptor ionotropic, NMDA 3Atarget
DB00142Glutamic acidAlanine aminotransferase 2target
DB00142Glutamic acidMitochondrial glutamate carrier 2target
DB00142Glutamic acidMitochondrial glutamate carrier 1target
DB00142Glutamic acidAlpha-aminoadipic semialdehyde synthase, mitochondrialtarget
DB00142Glutamic acidGlutaminase liver isoform, mitochondrialtarget
DB00142Glutamic acidAspartyl aminopeptidasetarget
DB00142Glutamic acidGlutamate receptor ionotropic, delta-1target
DB00142Glutamic acidCystine/glutamate transportertarget
DB00142Glutamic acidCarboxypeptidase Qtarget
DB00142Glutamic acidPhosphoserine aminotransferasetarget
DB00142Glutamic acidMonocarboxylate transporter 10transporter
DB00142Glutamic acidMonocarboxylate transporter 1transporter
DB00143GlutathioneGlutathione reductase, mitochondrialtarget
DB00143GlutathioneGlutathione synthetasetarget
DB00143GlutathioneGlutathione S-transferase Mu 1target
DB00143GlutathioneGlutathione S-transferase kappa 1target
DB00143GlutathioneGlutathione S-transferase A3target
DB00143GlutathioneGlutathione S-transferase Mu 3target
DB00143GlutathioneGlutathione S-transferase A4target
DB00143GlutathioneGlutathione S-transferase Mu 4target
DB00143GlutathioneGlutathione S-transferase A5target
DB00143GlutathioneGlutathione S-transferase Ptarget
DB00143GlutathioneGlutathione S-transferase omega-1target
DB00143GlutathioneGlutathione peroxidase 1target
DB00143GlutathioneGlutathione peroxidase 2target
DB00143GlutathioneGlutathione S-transferase theta-1target
DB00143GlutathioneMaleylacetoacetate isomerasetarget
DB00143GlutathioneEpididymal secretory glutathione peroxidasetarget
DB00143GlutathioneGlutathione peroxidase 3target
DB00143GlutathioneLactoylglutathione lyasetarget
DB00143GlutathioneLeukotriene C4 synthasetarget
DB00143GlutathioneMicrosomal glutathione S-transferase 3target
DB00143GlutathioneHematopoietic prostaglandin D synthasetarget
DB00143GlutathioneThioredoxin domain-containing protein 12target
DB00143GlutathioneGlutathione S-transferase A1target
DB00143GlutathioneGlutathione S-transferase A2target
DB00143GlutathioneMicrosomal glutathione S-transferase 1target
DB00143GlutathioneS-formylglutathione hydrolasetarget
DB00143GlutathioneGamma-glutamyltranspeptidase 1target
DB00143GlutathioneGlutathione S-transferase Mu 2target
DB00143GlutathioneGlutaredoxin-1target
DB00143GlutathionePhospholipid hydroperoxide glutathione peroxidase, mitochondrialtarget
DB00143GlutathioneGlutathione S-transferase Mu 5target
DB00143GlutathioneGlutathione peroxidase 6target
DB00143GlutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
DB00143GlutathioneGlutathione peroxidasetarget
DB00143GlutathioneProbable glutathione peroxidase 8target
DB00143GlutathioneGlutathione peroxidase 7target
DB00143GlutathioneMicrosomal glutathione S-transferase 2target
DB00143GlutathioneGlutathione S-transferase omega-2target
DB00143GlutathioneGlutaredoxin-2, mitochondrialtarget
DB00143GlutathioneGlutathione S-transferase A2enzyme
DB00143GlutathioneGlutathione S-transferase A1enzyme
DB00143GlutathioneMultidrug resistance-associated protein 1transporter
DB00143GlutathioneCanalicular multispecific organic anion transporter 1transporter
DB00143GlutathioneCanalicular multispecific organic anion transporter 2transporter
DB00143GlutathioneMultidrug resistance-associated protein 4transporter
DB00143GlutathioneMultidrug resistance-associated protein 5transporter
DB00143GlutathioneAldose reductasetarget
DB00143GlutathioneMatrix metalloproteinase-9target
DB00143GlutathioneCytochrome P450 3A4target
DB00145GlycineGlutathione synthetasetarget
DB00145GlycineGlycine receptor subunit alpha-1target
DB00145GlycineSerine--pyruvate aminotransferasetarget
DB00145GlycineGlycine receptor subunit betatarget
DB00145GlycineSerine hydroxymethyltransferase, cytosolictarget
DB00145GlycineGlycine receptor subunit alpha-3target
DB00145GlycineGlycine receptor subunit alpha-2target
DB00145GlycineGlycine N-methyltransferasetarget
DB00145GlycineGlycine amidinotransferase, mitochondrialtarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 3Btarget
DB00145GlycineGlycine dehydrogenase [decarboxylating], mitochondrialtarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 1target
DB00145Glycine2-amino-3-ketobutyrate coenzyme A ligase, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, nonspecific, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, erythroid-specific, mitochondrialtarget
DB00145GlycineGlycine cleavage system H protein, mitochondrialtarget
DB00145GlycineGlycine--tRNA ligasetarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Atarget
DB00145GlycineBile acid-CoA:amino acid N-acyltransferasetarget
DB00145GlycineN-arachidonyl glycine receptortarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Ctarget
DB00145GlycineSerine hydroxymethyltransferasetarget
DB00145GlycineGlycine N-acyltransferasetarget
DB00145GlycineProton-coupled amino acid transporter 1target
DB00145GlycineSerine hydroxymethyltransferase, mitochondrialtarget
DB00145GlycineGlycine N-acyltransferase-like protein 2target
DB00145GlycineGlycine N-acyltransferase-like protein 1target
DB00145GlycineAlanine--glyoxylate aminotransferase 2, mitochondrialtarget
DB00145GlycineVesicular inhibitory amino acid transportertarget
DB00145GlycinePeroxisomal sarcosine oxidasetarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 2target
DB00145GlycineMonocarboxylate transporter 10transporter
DB00148CreatineSodium- and chloride-dependent creatine transporter 1target
DB00148CreatineGuanidinoacetate N-methyltransferasetarget
DB00148CreatineCreatine kinase M-typetarget
DB00148CreatineCreatine kinase U-type, mitochondrialtarget
DB00148CreatineCreatine kinase B-typetarget
DB00148CreatineCreatine kinase S-type, mitochondrialtarget
DB00148CreatineSolute carrier family 22 member 5transporter
DB00149L-LeucineProbable leucine--tRNA ligase, mitochondrialtarget
DB00149L-LeucineLeucine carboxyl methyltransferase 2target
DB00149L-LeucineLeucine carboxyl methyltransferase 1target
DB00149L-LeucineLeucine--tRNA ligase, cytoplasmictarget
DB00149L-LeucineBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00149L-LeucineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00149L-LeucineMonocarboxylate transporter 10transporter
DB00149L-LeucineMonocarboxylate transporter 8transporter
DB00150L-TryptophanTryptophan--tRNA ligase, cytoplasmictarget
DB00150L-TryptophanTryptophan--tRNA ligasetarget
DB00150L-TryptophanTryptophan--tRNA ligase, mitochondrialtarget
DB00150L-TryptophanTryptophan 2,3-dioxygenaseenzyme
DB00150L-TryptophanAromatic-L-amino-acid decarboxylaseenzyme
DB00150L-TryptophanMonocarboxylate transporter 8transporter
DB00150L-TryptophanMonocarboxylate transporter 10transporter
DB00150L-TryptophanTryptophan--tRNA ligaseenzyme
DB00150L-TryptophanTryptophan--tRNA ligase, mitochondrialenzyme
DB00150L-TryptophanTryptophan 5-hydroxylase 1enzyme
DB00150L-TryptophanTryptophan 5-hydroxylase 2enzyme
DB00150L-TryptophanTryptophan--tRNA ligase, cytoplasmicenzyme
DB00150L-TryptophanIndoleamine 2,3-dioxygenase 1enzyme
DB00151L-CysteineCysteine--tRNA ligase, cytoplasmictarget
DB00151L-CysteineGlutamate--cysteine ligase regulatory subunittarget
DB00151L-CysteineGlutamate--cysteine ligase catalytic subunittarget
DB00151L-CysteineAspartate aminotransferase, cytoplasmictarget
DB00151L-CysteineCystathionine gamma-lyasetarget
DB00151L-CysteineCystathionine beta-synthasetarget
DB00151L-CysteineCysteine dioxygenase type 1target
DB00151L-CysteineMethylated-DNA--protein-cysteine methyltransferasetarget
DB00151L-CysteineGlutathione synthetasetarget
DB00151L-CysteineThiamine transporter 2target
DB00151L-CysteineProbable cysteine--tRNA ligase, mitochondrialtarget
DB00151L-CysteineCysteine sulfinic acid decarboxylasetarget
DB00151L-CysteineCysteine desulfurase, mitochondrialtarget
DB00151L-CysteineMonocarboxylate transporter 10transporter
DB00155CitrullineNitric oxide synthase, endothelialtarget
DB00155CitrullineArgininosuccinate synthasetarget
DB00155CitrullineN(G),N(G)-dimethylarginine dimethylaminohydrolase 2target
DB00155CitrullineArgininosuccinate synthetase, isoform CRA_atarget
DB00155CitrullineN(G),N(G)-dimethylarginine dimethylaminohydrolase 1target
DB00155CitrullineOrnithine carbamoyltransferase, mitochondrialtarget
DB00155CitrullineNitric oxide synthase, braintarget
DB00155CitrullineNitric oxide synthase, inducibletarget
DB00155CitrullineProtein-arginine deiminase type-4target
DB00155CitrullineProtein-arginine deiminase type-6target
DB00155CitrullineProtein-arginine deiminase type-1target
DB00155CitrullineProtein-arginine deiminase type-3target
DB00155CitrullineProtein-arginine deiminase type-2target
DB00155CitrullineSolute carrier family 22 member 6transporter
DB00156L-ThreonineThreonine synthase-like 1target
DB00156L-ThreonineThreonine--tRNA ligase, cytoplasmictarget
DB00156L-ThreonineThreonine--tRNA ligase, mitochondrialtarget
DB00156L-ThreonineMonocarboxylate transporter 10transporter
DB00160L-AlanineSerine--pyruvate aminotransferasetarget
DB00160L-AlanineAlanine aminotransferase 1target
DB00160L-AlanineCysteine desulfurase, mitochondrialtarget
DB00160L-AlanineProton-coupled amino acid transporter 1target
DB00160L-AlanineLarge neutral amino acids transporter small subunit 2target
DB00160L-AlanineAlanine--glyoxylate aminotransferase 2, mitochondrialtarget
DB00160L-AlanineAlanine--tRNA ligase, cytoplasmictarget
DB00160L-AlanineNeutral amino acid transporter Atarget
DB00160L-Alanine4-aminobutyrate aminotransferase, mitochondrialtarget
DB00160L-AlanineKynureninasetarget
DB00160L-AlanineAlanine--tRNA ligase, mitochondrialtarget
DB00160L-Alanine5-phosphohydroxy-L-lysine phospho-lyasetarget
DB00160L-AlanineAlanine aminotransferase 2target
DB00160L-AlanineMonocarboxylate transporter 10transporter
DB00161L-ValinePropionyl-CoA carboxylase beta chain, mitochondrialtarget
DB00161L-ValineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00161L-ValineValine--tRNA ligasetarget
DB00161L-ValineMonocarboxylate transporter 10transporter
DB00161L-ValineValine--tRNA ligaseenzyme
DB00161L-ValinePropionyl-CoA carboxylase beta chain, mitochondrialenzyme
DB00161L-ValineBranched-chain-amino-acid aminotransferase, cytosolicenzyme
DB00167IsoleucineShort/branched chain specific acyl-CoA dehydrogenase, mitochondrialtarget
DB00167IsoleucineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00167IsoleucineBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00167IsoleucineIsoleucine--tRNA ligase, cytoplasmictarget
DB00167IsoleucineIsoleucine--tRNA ligase, mitochondrialtarget
DB00167IsoleucineMonocarboxylate transporter 10transporter
DB00168AspartameTaste receptor type 1 member 2target
DB00168AspartameTransient receptor potential cation channel subfamily V member 1target
DB00168AspartameSolute carrier family 22 member 6transporter
DB00168AspartameSolute carrier family 22 member 8transporter
DB00168AspartameSolute carrier family 22 member 11transporter
DB00168AspartameTaste receptor type 1 member 3target
DB00172ProlinePyrroline-5-carboxylate reductase 1, mitochondrialtarget
DB00172ProlineBifunctional glutamate/proline--tRNA ligasetarget
DB00172ProlineSodium- and chloride-dependent neutral and basic amino acid transporter B(0+)target
DB00172ProlineSodium-dependent proline transportertarget
DB00172ProlinePyrroline-5-carboxylate reductase 2target
DB00172ProlineProlyl 4-hydroxylase subunit alpha-2target
DB00172ProlineProline dehydrogenase 1, mitochondrialtarget
DB00172ProlinePeptidyl-prolyl cis-trans isomerase Htarget
DB00172ProlineProline synthase co-transcribed bacterial homolog proteintarget
DB00172ProlineProlyl 4-hydroxylase subunit alpha-1target
DB00172ProlinePeptidyl-prolyl cis-trans isomerase Btarget
DB00172ProlinePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
DB00172ProlinePeptidyl-prolyl cis-trans isomerase Ctarget
DB00172ProlinePeptidyl-prolyl cis-trans isomerase Atarget
DB00172ProlinePeptidyl-prolyl cis-trans isomerase Gtarget
DB00172ProlineProlyl 3-hydroxylase 1target
DB00172ProlinePyrroline-5-carboxylate reductasetarget
DB00172ProlineProbable proline--tRNA ligase, mitochondrialtarget
DB00172ProlineProlyl 3-hydroxylase 2target
DB00172ProlineProlyl 3-hydroxylase 3target
DB00172ProlinePyrroline-5-carboxylate reductase 3target
DB00172ProlineTrans-L-3-hydroxyproline dehydratasetarget
DB00172ProlineProline dehydrogenase 1, mitochondrialenzyme
DB00172ProlineMonocarboxylate transporter 10transporter
DB00174AsparagineNeutral amino acid transporter B(0)target
DB00174AsparagineAsparagine synthetase [glutamine-hydrolyzing]target
DB00174AsparagineAsparagine--tRNA ligase, cytoplasmictarget
DB00174AsparagineIsoaspartyl peptidase/L-asparaginasetarget
DB00174AsparagineProbable asparagine--tRNA ligase, mitochondrialtarget
DB00174AsparagineSodium-coupled neutral amino acid transporter 3target
DB00174AsparagineMonocarboxylate transporter 10transporter
DB00181BaclofenGamma-aminobutyric acid type B receptor subunit 1target
DB00181BaclofenGamma-aminobutyric acid type B receptor subunit 2target
DB00183PentagastrinGastrin/cholecystokinin type B receptortarget
DB00183PentagastrinCholinesteraseenzyme
DB00230PregabalinExcitatory amino acid transporter 3transporter
DB00230PregabalinVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB00230PregabalinLarge neutral amino acids transporter small subunit 1transporter
DB00260CycloserineD-alanine--D-alanine ligase Atarget
DB00260CycloserineAlanine racemasetarget
DB00260CycloserineAromatic-L-amino-acid decarboxylaseenzyme
DB00260CycloserineProton-coupled amino acid transporter 2transporter
DB00290BleomycinDNA ligase 3target
DB00290BleomycinDNA ligase 1target
DB00290BleomycinDNAtarget
DB00290BleomycinBleomycin hydrolaseenzyme
DB00314Capreomycin16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyAtarget
DB00362Anidulafungin1,3-beta-glucan synthase component FKS1target
DB00403CeruletideCholecystokinin receptor type Atarget
DB00420PromazineDopamine D2 receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M4target
DB00420PromazineMuscarinic acetylcholine receptor M2target
DB00420PromazineMuscarinic acetylcholine receptor M3target
DB00420PromazineAlpha-1B adrenergic receptortarget
DB00420PromazineDopamine D1 receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M5target
DB00420Promazine5-hydroxytryptamine receptor 2Atarget
DB00420Promazine5-hydroxytryptamine receptor 2Ctarget
DB00420PromazineAlpha-1A adrenergic receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M1target
DB00420PromazineDopamine D4 receptortarget
DB00420PromazineHistamine H1 receptortarget
DB00420PromazineAlpha-1D adrenergic receptortarget
DB00420PromazineCytochrome P450 2C19enzyme
DB00420PromazineCytochrome P450 1A2enzyme
DB00420PromazineCytochrome P450 3A4enzyme
DB00420PromazineCytochrome P450 2C9enzyme
DB00420PromazineCytochrome P450 2D6enzyme
DB00451LevothyroxineThyroid hormone receptor alphatarget
DB00451LevothyroxineThyroid hormone receptor betatarget
DB00451LevothyroxineCytochrome P450 2C8enzyme
DB00451LevothyroxineTransthyretincarrier
DB00451LevothyroxineSerum albumincarrier
DB00451LevothyroxineThyroxine-binding globulincarrier
DB00451LevothyroxineP-glycoprotein 1transporter
DB00451LevothyroxineMonocarboxylate transporter 8transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1C1transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1A2transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1B1transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1B3transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 4A1transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 4C1transporter
DB00451LevothyroxineLarge neutral amino acids transporter small subunit 1transporter
DB00451LevothyroxineUDP-glucuronosyltransferase 1-1enzyme
DB00451LevothyroxineSolute carrier organic anion transporter family member 2B1transporter
DB00451LevothyroxineIntegrin alpha-Vtarget
DB00451LevothyroxineIntegrin beta-3target
DB00451LevothyroxineP-glycoprotein 1enzyme
DB00492FosinoprilAngiotensin-converting enzymetarget
DB00492FosinoprilSolute carrier family 15 member 1transporter
DB00492FosinoprilSolute carrier family 15 member 2transporter
DB00509DextrothyroxineThyroid hormone receptor alphatarget
DB00509DextrothyroxineThyroid hormone receptor betatarget
DB00509DextrothyroxineThyroid peroxidasetarget
DB00509DextrothyroxineSolute carrier organic anion transporter family member 1B1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 1C1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 4A1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 4C1transporter
DB00509DextrothyroxineLarge neutral amino acids transporter small subunit 1transporter
DB00512VancomycinD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DB00512VancomycinSerum albumincarrier
DB00512Vancomycinalpha1-acid glycoproteincarrier
DB00512VancomycinHistamine H1 receptorcarrier
DB00513Aminocaproic acidPlasminogentarget
DB00513Aminocaproic acidTissue-type plasminogen activatortarget
DB00513Aminocaproic acidApolipoprotein(a)target
DB00513Aminocaproic acidAldehyde oxidaseenzyme
DB00520CaspofunginSolute carrier family 22 member 1transporter
DB00520CaspofunginP-glycoprotein 1transporter
DB00520CaspofunginSolute carrier family 22 member 6transporter
DB00520CaspofunginSolute carrier organic anion transporter family member 1B1transporter
DB00520CaspofunginSolute carrier organic anion transporter family member 1B3transporter
DB00520CaspofunginCytochrome P450 3A4enzyme
DB00520Caspofungin1,3-beta-glucan synthase component FKS1target
DB00577ValaciclovirThymidine kinasetarget
DB00577ValaciclovirDNA polymerase catalytic subunittarget
DB00577ValaciclovirSolute carrier family 15 member 1transporter
DB00577ValaciclovirSolute carrier family 15 member 2transporter
DB00577ValaciclovirSolute carrier family 22 member 8transporter
DB00577ValaciclovirSolute carrier family 22 member 6transporter
DB00577ValaciclovirSodium- and chloride-dependent neutral and basic amino acid transporter B(0+)transporter
DB00577ValaciclovirIleal sodium/bile acid cotransportertransporter
DB00577ValaciclovirGuanylate kinaseenzyme
DB00577ValaciclovirThymidine kinaseenzyme
DB00584EnalaprilAngiotensin-converting enzymetarget
DB00584EnalaprilP-glycoprotein 1transporter
DB00584EnalaprilSolute carrier family 15 member 1transporter
DB00584EnalaprilSolute carrier family 22 member 6transporter
DB00584EnalaprilSolute carrier family 22 member 8transporter
DB00584EnalaprilSolute carrier family 22 member 7transporter
DB00584EnalaprilSolute carrier organic anion transporter family member 1A2transporter
DB00584EnalaprilSerum albumincarrier
DB00626BacitracinAlpha-2-macroglobulintarget
DB00626BacitracinInsulin-degrading enzymetarget
DB00626BacitracinC55-isoprenyl pyrophosphatetarget
DB00626BacitracinBacitracin transport ATP-binding protein BcrAtransporter
DB00626BacitracinBacitracin transport permease protein BCRBtransporter
DB00626BacitracinBacitracin transport permease protein BcrCtransporter
DB00642PemetrexedThymidylate synthasetarget
DB00642PemetrexedDihydrofolate reductasetarget
DB00642PemetrexedTrifunctional purine biosynthetic protein adenosine-3target
DB00642PemetrexedDeoxycytidine kinaseenzyme
DB00642PemetrexedBifunctional purine biosynthesis protein PURHtarget
DB00642PemetrexedEquilibrative nucleoside transporter 1enzyme
DB00642PemetrexedSolute carrier family 22 member 8transporter
DB00644GonadorelinGonadotropin-releasing hormone receptortarget
DB00644GonadorelinPutative gonadotropin-releasing hormone II receptortarget
DB00666NafarelinGonadotropin-releasing hormone receptortarget
DB00666NafarelinPutative gonadotropin-releasing hormone II receptortarget
DB00722LisinoprilAngiotensin-converting enzymetarget
DB00722LisinoprilSolute carrier family 15 member 1transporter
DB00722LisinoprilSolute carrier family 15 member 2transporter
DB00722LisinoprilRenintarget
DB00731NateglinideATP-binding cassette sub-family C member 8target
DB00731NateglinideCytochrome P450 3A4enzyme
DB00731NateglinideCytochrome P450 2C9enzyme
DB00731NateglinidePeroxisome proliferator-activated receptor gammatarget
DB00731NateglinideCytochrome P450 3A5enzyme
DB00731NateglinideCytochrome P450 3A7enzyme
DB00731NateglinideSolute carrier family 15 member 1transporter
DB00731NateglinideSolute carrier family 15 member 2transporter
DB00731NateglinideSolute carrier family 22 member 6transporter
DB00731NateglinideMonocarboxylate transporter 1transporter
DB00731NateglinideProstaglandin G/H synthase 1enzyme
DB00731NateglinideUDP-glucuronosyltransferase 1-9enzyme
DB00731NateglinideCytochrome P450 2D6enzyme
DB00731NateglinideMultidrug resistance-associated protein 4transporter
DB00731NateglinideSerum albumincarrier
DB00731NateglinideAlpha-1-acid glycoprotein 1carrier
DB00765MetyrosineTyrosine 3-monooxygenasetarget
DB00775TirofibanIntegrin alpha-IIbtarget
DB00775TirofibanIntegrin beta-3target
DB00803ColistinBacterial outer membranetarget
DB00837ProgabideGamma-aminobutyric acid receptor subunit alpha-1target
DB00837ProgabideGamma-aminobutyric acid type B receptor subunit 1target
DB00855Aminolevulinic acidDelta-aminolevulinic acid dehydratasetarget
DB00855Aminolevulinic acidSolute carrier family 15 member 1transporter
DB00855Aminolevulinic acidSolute carrier family 15 member 2transporter
DB00859PenicillamineSolute carrier organic anion transporter family member 1B1transporter
DB00859PenicillamineCoppertarget
DB00968MethyldopaAlpha-2A adrenergic receptortarget
DB00968MethyldopaCatechol O-methyltransferaseenzyme
DB00968MethyldopaSolute carrier family 15 member 1transporter
DB00968MethyldopaAromatic-L-amino-acid decarboxylasetarget
DB00970DactinomycinDNAtarget
DB00970DactinomycinSolute carrier family 22 member 5transporter
DB00970DactinomycinP-glycoprotein 1transporter
DB00970DactinomycinMultidrug resistance-associated protein 6transporter
DB00970DactinomycinMultidrug resistance-associated protein 1transporter
DB00970DactinomycinATP-binding cassette sub-family G member 2transporter
DB00970DactinomycinDNA topoisomerase 2target
DB00992Methyl aminolevulinateHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00996GabapentinAdenosine receptor A1target
DB00996GabapentinVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB00996GabapentinVoltage-dependent calcium channel subunit alpha-2/delta-2target
DB00996GabapentinBranched-chain-amino-acid aminotransferase, cytosolicenzyme
DB00996GabapentinLarge neutral amino acids transporter small subunit 1transporter
DB00996GabapentinVoltage-dependent N-type calcium channeltarget
DB00996GabapentinPotassium voltage-gated channel subfamily KQT member 3target
DB00996GabapentinPotassium voltage-gated channel subfamily KQT member 5target
DB01042MelphalanDNAtarget
DB01042MelphalanSolute carrier family 22 member 3transporter
DB01042MelphalanLarge neutral amino acids transporter small subunit 1transporter
DB01055MimosineSerine hydroxymethyltransferase, cytosolictarget
DB01055MimosineC-C motif chemokine 2target
DB01055MimosineTyrosinasetarget
DB01072AtazanavirHuman immunodeficiency virus type 1 proteasetarget
DB01072AtazanavirCytochrome P450 3A4enzyme
DB01072AtazanavirCytochrome P450 2C9enzyme
DB01072AtazanavirP-glycoprotein 1transporter
DB01072AtazanavirMultidrug resistance-associated protein 1transporter
DB01072AtazanavirSerum albumincarrier
DB01072AtazanavirUDP-glucuronosyltransferase 1-1enzyme
DB01072AtazanavirSolute carrier organic anion transporter family member 1B1transporter
DB01072AtazanavirSolute carrier organic anion transporter family member 1B3transporter
DB01072AtazanavirCytochrome P450 2C8enzyme
DB01072AtazanavirBile salt export pumptransporter
DB01072Atazanaviralpha1-acid glycoproteincarrier
DB01072AtazanavirCytochrome P450 1A2enzyme
DB01072AtazanavirSolute carrier organic anion transporter family member 2B1transporter
DB01080Vigabatrin4-aminobutyrate aminotransferase, mitochondrialtarget
DB01080VigabatrinGamma-aminobutyric acid type B receptor subunit 1target
DB01080VigabatrinProton-coupled amino acid transporter 1transporter
DB01080VigabatrinCytochrome P450 2C9enzyme
DB01111ColistimethateBacterial outer membranetarget
DB01141MicafunginArylsulfatase Aenzyme
DB01141MicafunginCatechol O-methyltransferaseenzyme
DB01141Micafungin1,3-beta-glucan synthase component FKS1target
DB01197CaptoprilAngiotensin-converting enzymetarget
DB01197CaptoprilSerum albumincarrier
DB01197Captopril72 kDa type IV collagenasetarget
DB01197CaptoprilMatrix metalloproteinase-9target
DB01197CaptoprilP-glycoprotein 1transporter
DB01197CaptoprilSolute carrier family 15 member 1transporter
DB01197CaptoprilSolute carrier family 22 member 6transporter
DB01197CaptoprilLeukotriene A-4 hydrolasetarget
DB01197CaptoprilB1 bradykinin receptortarget
DB01221KetamineGlutamate receptor ionotropic, NMDA 3Atarget
DB01221KetamineNeurokinin 1 receptortarget
DB01221KetamineCytochrome P450 2B6enzyme
DB01221KetamineCytochrome P450 2C9enzyme
DB01221KetamineCytochrome P450 3A4enzyme
DB01221KetamineDopamine D2 receptortarget
DB01221KetamineProstaglandin G/H synthase 1enzyme
DB01221KetamineCytochrome P450 2C8enzyme
DB01221KetamineDelta-type opioid receptortarget
DB01221KetamineSodium-dependent noradrenaline transportertarget
DB01221KetamineKappa-type opioid receptortarget
DB01221KetamineMu-type opioid receptortarget
DB01221KetamineMuscarinic acetylcholine receptortarget
DB01221Ketamine5-hydroxytryptamine receptor 2target
DB01221Ketamine5-hydroxytryptamine receptor 1target
DB01221Ketamine5-hydroxytryptamine receptor 3Atarget
DB01221KetamineAlpha-7 nicotinic cholinergic receptor subunittarget
DB01221KetamineCholinesterasetarget
DB01221KetamineNitric oxide synthase, braintarget
DB01235LevodopaDopamine D1 receptortarget
DB01235LevodopaDopamine D2 receptortarget
DB01235LevodopaAromatic-L-amino-acid decarboxylaseenzyme
DB01235LevodopaSolute carrier family 15 member 1transporter
DB01235LevodopaMonocarboxylate transporter 10transporter
DB01235LevodopaDopamine D3 receptortarget
DB01235LevodopaDopamine D4 receptortarget
DB01235LevodopaDopamine D5 receptortarget
DB01235LevodopaLarge neutral amino acids transporter small subunit 1transporter
DB01235LevodopaLarge neutral amino acids transporter small subunit 2transporter
DB01235LevodopaSerum albumincarrier
DB01257EculizumabComplement C5target
DB01269PanitumumabEpidermal growth factor receptortarget
DB01270RanibizumabVascular endothelial growth factor Atarget
DB01276ExenatideGlucagon-like peptide 1 receptortarget
DB01276ExenatideSerum albumincarrier
DB01276ExenatideDipeptidyl peptidase 4enzyme
DB01277MecaserminInsulin-like growth factor 1 receptortarget
DB01277MecaserminInsulin-like growth factor-binding protein 3target
DB01277MecaserminInsulin receptortarget
DB01277MecaserminCation-independent mannose-6-phosphate receptortarget
DB01277MecaserminInsulin-like growth factor-binding protein 3carrier
DB01277MecaserminInsulin-like growth factor-binding protein complex acid labile subunitcarrier
DB01277MecaserminInsulin-like growth factor-binding protein 1carrier
DB01277MecaserminInsulin-like growth factor-binding protein 2carrier
DB01277MecaserminInsulin-like growth factor-binding protein 4carrier
DB01277MecaserminInsulin-like growth factor-binding protein 5carrier
DB01277MecaserminInsulin-like growth factor-binding protein 6carrier
DB01278PramlintideReceptor activity-modifying protein 1target
DB01278PramlintideReceptor activity-modifying protein 2target
DB01278PramlintideReceptor activity-modifying protein 3target
DB01278PramlintideCalcitonin receptortarget
DB01279GalsulfasePerilipin-3target
DB01279GalsulfaseDermatan sulfatetarget
DB01281AbataceptT-lymphocyte activation antigen CD80target
DB01281AbataceptT-lymphocyte activation antigen CD86target
DB01282CarbetocinOxytocin receptortarget
DB01284TetracosactideAdrenocorticotropic hormone receptortarget
DB01285CorticotropinAdrenocorticotropic hormone receptortarget
DB01285CorticotropinCorticoliberintarget
DB01285Corticotropin3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
DB01285Corticotropin25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialenzyme
DB01285Corticotropin1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialenzyme
DB01285CorticotropinCytochrome P450 3A4enzyme
DB01306Insulin aspartInsulin receptortarget
DB01306Insulin aspartInsulin-like growth factor 1 receptortarget
DB01306Insulin aspartCytochrome P450 1A2enzyme
DB01307Insulin detemirInsulin receptortarget
DB01307Insulin detemirSerum albumincarrier
DB01307Insulin detemirInsulin-like growth factor 1 receptortarget
DB01307Insulin detemirCytochrome P450 1A2enzyme
DB01309Insulin GlulisineInsulin receptortarget
DB01309Insulin GlulisineInsulin-like growth factor 1 receptortarget
DB01309Insulin GlulisineCytochrome P450 1A2enzyme
DB01348SpiraprilAngiotensin-converting enzymetarget
DB01348SpiraprilSolute carrier family 15 member 1transporter
DB01348SpiraprilSolute carrier family 15 member 2transporter
DB01369Quinupristin23S ribosomal RNAtarget
DB01369Quinupristin50S ribosomal protein L10target
DB01369Quinupristin50S ribosomal protein L22target
DB01369QuinupristinCytochrome P450 3A4enzyme
DB01373CalciumProtein S100-Btarget
DB01373CalciumCalpastatintarget
DB01373CalciumCartilage oligomeric matrix proteintarget
DB01373CalciumCalmodulintarget
DB01373CalciumSpectrin beta chain, non-erythrocytic 1target
DB01373CalciumVoltage-dependent L-type calcium channel subunit alpha-1Ctarget
DB01373CalciumTroponin C, skeletal muscletarget
DB01373CalciumTroponin C, slow skeletal and cardiac musclestarget
DB01373CalciumCalcium-transporting ATPase type 2C member 1target
DB01373CalciumAmiloride-sensitive amine oxidase [copper-containing]target
DB01373CalciumProtein S100-A13target
DB01373CalciumAlkaline phosphatase, placental typetarget
DB01373CalciumProtein S100-A8target
DB01373CalciumProtein S100-A9target
DB01373CalciumProtein S100-A2target
DB01373CalciumCeruloplasmintarget
DB01373CalciumBone morphogenetic protein 4target
DB01373CalciumMatrix Gla proteintarget
DB01373CalciumProtocadherin-19target
DB01373CalciumProgrammed cell death protein 6target
DB01583LiotrixThyroid hormone receptor alphatarget
DB01583LiotrixThyroid hormone receptor betatarget
DB01583LiotrixCytochrome P450 2C8enzyme
DB01583LiotrixSolute carrier organic anion transporter family member 1A2transporter
DB01583LiotrixSolute carrier organic anion transporter family member 1B1transporter
DB01583LiotrixSolute carrier organic anion transporter family member 1B3transporter
DB01583LiotrixSolute carrier organic anion transporter family member 4C1transporter
DB01583LiotrixSodium/bile acid cotransportertransporter
DB01583LiotrixSolute carrier organic anion transporter family member 1C1transporter
DB01583LiotrixSolute carrier organic anion transporter family member 4A1transporter
DB01583LiotrixSolute carrier family 22 member 8transporter
DB01583LiotrixMonocarboxylate transporter 8transporter
DB01583LiotrixMonocarboxylate transporter 10transporter
DB01583LiotrixP-glycoprotein 1transporter
DB01583LiotrixTransthyretincarrier
DB01583LiotrixThyroxine-binding globulincarrier
DB01583LiotrixSerum albumincarrier
DB01583LiotrixCytochrome P450 3A4enzyme
DB01646N-AcetylmethionineN-acylamino acid racemasetarget
DB01646N-AcetylmethionineRhodopsintarget
DB01669Virginiamycin M1Streptogramin A acetyltransferasetarget
DB01683ChymostatinPeptide amidasetarget
DB01686N,N-dimethylarginineNitric oxide synthase, inducibletarget
DB01686N,N-dimethylarginineNitric oxide synthase, endothelialtarget
DB01764DalfopristinStreptogramin A acetyltransferasetarget
DB01764DalfopristinCytochrome P450 3A4enzyme
DB01783Pantothenic acidPantothenate kinasetarget
DB01853Bacteriochlorophyll ABacteriochlorophyll a proteintarget
DB01853Bacteriochlorophyll ABacteriochlorophyll a proteintarget
DB02011N-(Phosphonoacetyl)-L-OrnithineOrnithine carbamoyltransferase, mitochondrialtarget
DB02083N,N-dimethylglycineMonomeric sarcosine oxidasetarget
DB02109HadacidinAdenylosuccinate synthetasetarget
DB02109HadacidinAdenylosuccinate synthetase isozyme 1target
DB02109HadacidinAdenylosuccinate synthetasetarget
DB02123Glycochenodeoxycholic Acid7-alpha-hydroxysteroid dehydrogenasetarget
DB02123Glycochenodeoxycholic AcidBile salt export pumptransporter
DB02123Glycochenodeoxycholic AcidSolute carrier organic anion transporter family member 1A2transporter
DB02123Glycochenodeoxycholic AcidIleal sodium/bile acid cotransportertransporter
DB02123Glycochenodeoxycholic AcidSodium/bile acid cotransportertransporter
DB02137Molybdenum cofactorAldehyde oxidoreductasetarget
DB02216S-MethylcysteineCathepsin Dtarget
DB02216S-MethylcysteineFatty acid-binding protein, livercarrier
DB02216S-MethylcysteineMethylated-DNA--protein-cysteine methyltransferasetarget
DB02235L-methionine (R)-S-oxideCatalasetarget
DB02235L-methionine (R)-S-oxideProteasetarget
DB02235L-methionine (R)-S-oxideAmyloid beta A4 proteintarget
DB02236Glycinamide RibonucleotidePhosphoribosylglycinamide formyltransferase 2target
DB02236Glycinamide RibonucleotidePhosphoribosylglycinamide formyltransferasetarget
DB02236Glycinamide RibonucleotideTrifunctional purine biosynthetic protein adenosine-3target
DB02255GM6001Lethal factortarget
DB02255GM6001Disintegrin and metalloproteinase domain-containing protein 28target
DB02255GM6001Aggrecan core proteintarget
DB02261Platelet Activating FactorGanglioside GM2 activatortarget
DB02261Platelet Activating FactorP-glycoprotein 1transporter
DB02261Platelet Activating FactorPlatelet-activating factor receptortarget
DB022747-Keto-8-Aminopelargonic AcidAdenosylmethionine-8-amino-7-oxononanoate aminotransferasetarget
DB02307N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-AsparaginePseudolysintarget
DB02341Mdl 101,146Chymotrypsin-like elastase family member 1target
DB02341Mdl 101,146Neutrophil elastasetarget
DB02345SelenocysteineCathelicidin antimicrobial peptidetarget
DB02345SelenocysteineNucleoside diphosphate kinase Atarget
DB02345SelenocysteineFormate dehydrogenase Htarget
DB02345SelenocysteineCysteine desulfurasetarget
DB02386Leucine Phosphonic AcidBacterial leucyl aminopeptidasetarget
DB02386Leucine Phosphonic AcidCytosol aminopeptidasetarget
DB02518N-AcetylalanineAldose reductasetarget
DB02543Pyrrole-2-CarboxylateMonomeric sarcosine oxidasetarget
DB02557PhosphoramidonNeprilysintarget
DB02557PhosphoramidonKell blood group glycoproteintarget
DB02578Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-AlanineD-alanyl-D-alanine carboxypeptidasetarget
DB02595Bulgecin AMembrane-bound lytic murein transglycosylase Btarget
DB02595Bulgecin ASoluble lytic murein transglycosylasetarget
DB02608N-Acetyl-P-NitrophenylserinolChloramphenicol 3-O phosphotransferasetarget
DB02638TerlipressinVasopressin V1a receptortarget
DB02638TerlipressinVasopressin V2 receptortarget
DB02638TerlipressinVasopressin V1b receptortarget
DB02655D-Aspartic AcidThermolysintarget
DB02655D-Aspartic AcidL-asparaginasetarget
DB02810N-(2-Acetamido)Iminodiacetic AcidPeptide deformylasetarget
DB02821CanalineOrnithine aminotransferase, mitochondrialtarget
DB02855N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineCathepsin Btarget
DB02952Alpha-Aminoisobutyric AcidCorticoliberintarget
DB02952Alpha-Aminoisobutyric AcidPro-neuropeptide Ytarget
DB02952Alpha-Aminoisobutyric AcidMonocarboxylate transporter 10transporter
DB02959OxitriptanTryptophan--tRNA ligase 2target
DB02975GE-2270AElongation factor Tutarget
DB02999QuisqualateGlutamate receptor 2target
DB02999QuisqualateGlutamate receptor ionotropic, kainate 2target
DB03032S-OctylglutathioneGlutathione S-transferase Mu 4target
DB03088Pidolic acidAlpha-amylase 2Btarget
DB03088Pidolic acidAngiogenintarget
DB03088Pidolic acidChondroitinase-Btarget
DB03088Pidolic acidAlpha-amylase 1target
DB03088Pidolic acidVascular endothelial growth factor Atarget
DB03088Pidolic acidPancreatic alpha-amylasetarget
DB03088Pidolic acidIg lambda-1 chain C regionstarget
DB03088Pidolic acidIg lambda chain V-II region MGCtarget
DB03088Pidolic acidTrefoil factor 2target
DB03088Pidolic acidCytochrome c2target
DB03088Pidolic acidDisintegrin and metalloproteinase domain-containing protein 28target
DB03088Pidolic acidEndo-1,4-beta-xylanasetarget
DB03088Pidolic acidDissimilatory copper-containing nitrite reductasetarget
DB03088Pidolic acidKeratin-associated protein 5-2target
DB03088Pidolic acidOrexintarget
DB03088Pidolic acidC-C motif chemokine 8target
DB03088Pidolic acidCytochrome c'target
DB03088Pidolic acidPancreatic alpha-amylaseenzyme
DB03107Beta-AlaninePantothenate synthetasetarget
DB03107Beta-AlanineMonocarboxylate transporter 10transporter
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, endothelialtarget
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase oxygenasetarget
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, inducibletarget
DB03144N-Omega-Hydroxy-L-ArginineArginase-1target
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, braintarget
DB03157N,O-Didansyl-L-TyrosineThymidylate synthasetarget
DB03214VinylglycineL-amino-acid oxidasetarget
DB03214Vinylglycine1-aminocyclopropane-1-carboxylate synthase-like protein 1target
DB03223DiphthamideElongation factor 2target
DB03251RWJ-51084Trypsin-1target
DB03360N-Acetylproline(5R)-carbapenem-3-carboxylate synthasetarget
DB03380L-tyrosinamidePro-neuropeptide Ytarget
DB03380L-tyrosinamideValacyclovir hydrolasetarget
DB03395EnalkirenRenintarget
DB03408gamma-GlutamylcysteineGlutathione synthetasetarget
DB03424UbenimexBacterial leucyl aminopeptidasetarget
DB03424UbenimexLeukotriene A-4 hydrolasetarget
DB03424UbenimexSolute carrier family 15 member 1transporter
DB03424UbenimexSolute carrier family 15 member 2transporter
DB034252s,4r-4-MethylglutamateGlutamate receptor ionotropic, kainate 2target
DB03436GallichromeIron(3+)-hydroxamate-binding protein FhuDtarget
DB03459Sparfosic acidAspartate carbamoyltransferase catalytic chaintarget
DB03459Sparfosic acidCAD proteintarget
DB03470TrypanothioneTrypanothione reductasetarget
DB03535Z-Pro-ProlinalProlyl endopeptidasetarget
DB03535Z-Pro-ProlinalProlyl endopeptidasetarget
DB03544S-PhosphocysteineN,N'-diacetylchitobiose-specific phosphotransferase enzyme IIB componenttarget
DB03544S-PhosphocysteineEnamine/imine deaminasetarget
DB035523-TyrosineTyrosine 3-monooxygenasetarget
DB03632ArgifinChitotriosidase-1target
DB03632ArgifinChitinasetarget
DB03640Beta-Hydroxyaspartic AcidBeta-lactamase TEMtarget
DB036604-Iodo-L-phenylalanineLysozymetarget
DB036604-Iodo-L-phenylalaninePseudomonalisintarget
DB036604-Iodo-L-phenylalanineDipeptidyl peptidase 4target
DB036604-Iodo-L-phenylalanineAminopeptidase Starget
DB03709BicinePlasminogentarget
DB03709BicineMembrane-bound lytic murein transglycosylase Btarget
DB03709BicineUDP-galactopyranose mutasetarget
DB03799TrifluoromethionineMethionine--tRNA ligasetarget
DB03799TrifluoromethionineMethionine aminopeptidasetarget
DB03817L-2,4-diaminobutyric acidEnvelope glycoprotein gp160target
DB03880BatimastatNeutrophil collagenasetarget
DB03880BatimastatMacrophage metalloelastasetarget
DB03880BatimastatMatrix metalloproteinase-16target
DB03880BatimastatDisintegrin and metalloproteinase domain-containing protein 28target
DB03880BatimastatA disintegrin and metalloproteinase with thrombospondin motifs 5target
DB03889S-(N-Hydroxy-N-Bromophenylcarbamoyl)GlutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
DB03940Oxamic AcidL-lactate dehydrogenasetarget
DB03940Oxamic AcidL-lactate dehydrogenasetarget
DB03940Oxamic AcidL-lactate dehydrogenase A chaintarget
DB03940Oxamic AcidL-lactate dehydrogenase B chaintarget
DB03940Oxamic AcidFormate acetyltransferase 1target
DB03940Oxamic AcidD-lactate dehydrogenasetarget
DB03940Oxamic AcidMonocarboxylate transporter 4transporter
DB04029Phenylalanine AmideGenome polyproteintarget
DB04029Phenylalanine AmideGenome polyproteintarget
DB04029Phenylalanine AmideD-Amino acid amidasetarget
DB04092ApstatinXaa-Pro aminopeptidasetarget
DB04129WillardiineGlutamate receptor 2target
DB04132S-HexylglutathioneLactoylglutathione lyasetarget
DB04132S-HexylglutathioneGlutathione S-transferase Mu 4target
DB04132S-HexylglutathioneGlutathione S-transferase Ptarget
DB04132S-HexylglutathioneGlutathione S-transferasetarget
DB04132S-HexylglutathioneGlutathione S-transferase A1target
DB04132S-HexylglutathioneGlutathione S-transferase theta-2target
DB04132S-HexylglutathioneGlutathione S-transferase A1enzyme
DB04167AceglutamideN-acylamino acid racemasetarget
DB04185NorvalineGlycine amidinotransferase, mitochondrialtarget
DB04185NorvalineOrnithine carbamoyltransferase, mitochondrialtarget
DB04191Skf 107457Gag-Pol polyproteintarget
DB04217L-2-amino-3-butynoic acidCysteine desulfurasetarget
DB04217L-2-amino-3-butynoic acidCystathionine gamma-lyasetarget
DB04223NitroarginineNitric oxide synthase, endothelialtarget
DB04223NitroarginineNitric oxide synthase, braintarget
DB04269Cyclotheonamide ATrypsin-1target
DB04284L-proline betaineGlycine betaine-binding periplasmic proteintarget
DB043346-hydroxydopa quinoneMembrane primary amine oxidasetarget
DB043346-hydroxydopa quinonePrimary amine oxidasetarget
DB043346-hydroxydopa quinonePhenylethylamine oxidasetarget
DB04350ArgadinChitotriosidase-1target
DB04350ArgadinChitinasetarget
DB04391Aeruginosin 98-BTrypsin-1target
DB04418Adenylosuccinic acidAdenylosuccinate synthetase isozyme 1target
DB04454Alpha-Aminobutyric AcidGlycine amidinotransferase, mitochondrialtarget
DB04454Alpha-Aminobutyric AcidGag-Pol polyproteintarget
DB04454Alpha-Aminobutyric AcidPro-epidermal growth factortarget
DB04454Alpha-Aminobutyric AcidLantibiotic mersacidintarget
DB04464N-FormylmethionineGlutamate--cysteine ligasetarget
DB04464N-FormylmethionineRibonuclease pancreatictarget
DB04464N-FormylmethioninePutative ATP-dependent Clp protease proteolytic subunit, mitochondrialtarget
DB04464N-FormylmethionineGeranylgeranyl transferase type-2 subunit alphatarget
DB04464N-FormylmethionineGeranylgeranyl transferase type-2 subunit betatarget
DB04464N-FormylmethioninePhotosynthetic reaction center cytochrome c subunittarget
DB04464N-FormylmethionineReaction center protein H chaintarget
DB04464N-FormylmethionineReaction center protein L chaintarget
DB04464N-FormylmethionineReaction center protein M chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/820 alpha chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/820 beta chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/850 alpha chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/850 beta chaintarget
DB04464N-FormylmethionineAntithrombin-IIItarget
DB04464N-FormylmethionineBeta-2-microglobulintarget
DB04464N-FormylmethionineNADH-ubiquinone oxidoreductase chain 1target
DB04464N-FormylmethionineHLA class I histocompatibility antigen, B-27 alpha chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 alpha chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 beta chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 gamma chaintarget
DB04464N-FormylmethionineProtein S100-Gtarget
DB04464N-FormylmethionineRubredoxintarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 4 isoform 1, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 1target
DB04464N-FormylmethionineCytochrome c oxidase subunit 2target
DB04464N-FormylmethionineCytochrome c oxidase subunit 3target
DB04464N-FormylmethionineCytochrome c oxidase subunit 5A, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 5B, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6Ctarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 7B, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 7C, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 8A, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6A2, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6B1target
DB04464N-FormylmethionineCytochrome c oxidase subunit 7A1, mitochondrialtarget
DB04464N-FormylmethionineMethionyl-tRNA formyltransferasetarget
DB04464N-FormylmethionineStreptavidintarget
DB04464N-FormylmethionineProtein S100-Btarget
DB04464N-FormylmethionineDelta-hemolysintarget
DB04464N-FormylmethioninePolyubiquitin-Ctarget
DB04464N-FormylmethionineAtpHtarget
DB04464N-FormylmethionineProbable L-ascorbate-6-phosphate lactonase UlaGtarget
DB04464N-FormylmethionineImmunoglobulin G-binding protein Gtarget
DB04495RU81843Proto-oncogene tyrosine-protein kinase Srctarget
DB04498Aspartate SemialdehydeAspartate-semialdehyde dehydrogenasetarget
DB04527beta-HydroxyasparagineMannan-binding lectin serine protease 2target
DB04539Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
DB04539Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
DB04539GlyphosateCytochrome P450 19A1target
DB04539GlyphosateSerum albumincarrier
DB04620CycloleucineGlutamate receptor ionotropic, NMDA 1target
DB04676DansyllysineIg alpha-2 chain C regiontarget
DB04738MotuporinSerine/threonine-protein phosphatase PP1-gamma catalytic subunittarget
DB04798THIO-ATPAGlutamate receptor 2target
DB04805Virginiamycin S160S ribosomal protein L37target
DB04847RoxadustatEgl nine homolog 1target
DB04847RoxadustatEgl nine homolog 2target
DB04847RoxadustatEgl nine homolog 3target
DB04869OlcegepantCalcitonin gene-related peptide 1target
DB04869OlcegepantCalcitonin gene-related peptide type 1 receptortarget
DB04894VapreotideNeurokinin 1 receptortarget
DB04894VapreotideSomatostatin receptor type 2target
DB04894VapreotideSomatostatin receptor type 5target
DB04894VapreotideCytochrome P450 3A4enzyme
DB04899NesiritideAtrial natriuretic peptide receptor 1target
DB04899NesiritideAtrial natriuretic peptide receptor 2target
DB04899NesiritideAtrial natriuretic peptide receptor 3target
DB04901GaliximabT-lymphocyte activation antigen CD80target
DB04911OritavancinCytochrome P450 3A4enzyme
DB04911OritavancinCytochrome P450 2D6enzyme
DB04911OritavancinCytochrome P450 2C9enzyme
DB04911OritavancinCytochrome P450 2C19enzyme
DB04925DesmoteplasePlasminogentarget
DB04931AfamelanotideMelanocyte-stimulating hormone receptortarget
DB04956AfelimomabTumor necrosis factortarget
DB04958EpratuzumabB-cell receptor CD22target
DB04964OregovomabMucin-16target
DB04972CanfosfamideGlutathione S-transferase Ptarget
DB04977PlitidepsinCytochrome P450 3A4enzyme
DB04977PlitidepsinCytochrome P450 2A6enzyme
DB04977PlitidepsinCytochrome P450 2E1enzyme
DB04977PlitidepsinCytochrome P450 4A11enzyme
DB04985Tigapotide40S ribosomal protein SAtarget
DB04988IGN311Epidermal growth factor receptortarget
DB04988IGN311Receptor tyrosine-protein kinase erbB-2target
DB05012XEN2174Sodium-dependent noradrenaline transportertarget
DB05029LancovutideCytosolic phospholipase A2enzyme
DB05032REV131Histamine H4 receptortarget
DB05034UlaritideAtrial natriuretic peptide receptor 1target
DB05084AbaloparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05092CDP323Integrin alpha-4target
DB05096LY2140023Metabotropic glutamate receptor 2target
DB05096LY2140023Metabotropic glutamate receptor 3target
DB05097LabetuzumabCarcinoembryonic antigen-related cell adhesion molecule 5target
DB05098LeptinLeptin receptortarget
DB05101MatuzumabEpidermal growth factor receptortarget
DB05111FontolizumabInterferon gammatarget
DB05115NN344Insulin receptortarget
DB05115NN344Cytochrome P450 1A2enzyme
DB05130INCB3284C-C chemokine receptor type 2target
DB05139CR002Platelet-derived growth factor Dtarget
DB05155CR665Kappa-type opioid receptortarget
DB05161ElafinNeutrophil elastasetarget
DB05161ElafinMyeloblastintarget
DB05161ElafinMyeloperoxidaseenzyme
DB05199LX1031Tryptophan 5-hydroxylase 1target
DB05209RozrolimupabRhesus blood group D antigentarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit alphatarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit betatarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit gammatarget
DB05210SF1126DNA-dependent protein kinase catalytic subunittarget
DB05210SF1126Serine/threonine-protein kinase mTORtarget
DB05258Interferon alfaInterferon alpha/beta receptor 1target
DB05258Interferon alfaCytochrome P450 1A2enzyme
DB05259GlatiramerHLA class II histocompatibility antigen, DRB1-1 beta chaintarget
DB05276Hepatitis B Immune GlobulinHBsAgtarget
DB05299keyhole limpet hemocyaninInterleukin-2target
DB05305Cintredekin BesudotoxInterleukin-13target
DB05311EcallantidePlasma kallikreintarget
DB05319Oportuzumab monatoxEpithelial cell adhesion moleculetarget
DB05332RomiplostimThrombopoietin receptortarget
DB05394CorticorelinDopamine beta-hydroxylaseenzyme
DB05396Albinterferon Alfa-2BCytochrome P450 1A2enzyme
DB05413TifuvirtidePlasma serine protease inhibitortarget
DB05434ABT-510Fibroblast growth factor 2target
DB05434ABT-510Hepatocyte growth factortarget
DB05434ABT-510Vascular endothelial growth factor Atarget
DB05434ABT-510Interleukin-8target
DB05446LJP 1082Beta-2-glycoprotein 1target
DB05459BriakinumabInterleukin-12 subunit betatarget
DB05459BriakinumabInterleukin-23 subunit alphatarget
DB05460EzatiostatGlutathione S-transferase Ptarget
DB05475GolotimodToll-like receptor 2target
DB05475GolotimodToll-like receptor 4target
DB05475GolotimodToll-like receptor 7target
DB05475GolotimodToll-like receptor 9target
DB05476WX-UK1Urokinase plasminogen activator surface receptortarget
DB05507VX-765Caspase-1target
DB05507VX-765Interleukin-1 betatarget
DB05518Managlinat dialanetilFructose-1,6-bisphosphatase 1target
DB05521TelaprevirCytochrome P450 3A4enzyme
DB05521TelaprevirNS3/4A proteintarget
DB05521TelaprevirP-glycoprotein 1transporter
DB05521TelaprevirSerum albumincarrier
DB05521TelaprevirAlpha-1-acid glycoprotein 1carrier
DB05521TelaprevirSolute carrier organic anion transporter family member 1B1target
DB05521TelaprevirSolute carrier organic anion transporter family member 2B1target
DB05540AlanosineAspartate carbamoyltransferase catalytic chaintarget
DB05540AlanosineAdenylosuccinate synthetase isozyme 2target
DB05540AlanosineAdenylosuccinate synthetase isozyme 1target
DB05540AlanosineCystine/glutamate transportertransporter
DB05578RamucirumabVascular endothelial growth factor receptor 2target
DB05595FarletuzumabFolate receptor alphatarget
DB05668PalifosfamideDNA (cytosine-5)-methyltransferase 1target
DB05675EP-2104RFibrinogen alpha chaintarget
DB05679UstekinumabInterleukin-12 subunit betatarget
DB05679UstekinumabInterleukin-23target
DB05687BL-1020Dopamine D2 receptortarget
DB05687BL-10205-hydroxytryptamine receptor 2Atarget
DB05713LY-517717Coagulation factor Xtarget
DB05714FlovagatranProthrombintarget
DB05739CYT006-AngQbType-1 angiotensin II receptortarget
DB05739CYT006-AngQbType-2 angiotensin II receptortarget
DB05773Trastuzumab emtansineReceptor tyrosine-protein kinase erbB-2target
DB05773Trastuzumab emtansineP-glycoprotein 1transporter
DB05773Trastuzumab emtansineCytochrome P450 3A4enzyme
DB05773Trastuzumab emtansineCytochrome P450 3A5enzyme
DB05777Thrombomodulin AlfaCoagulation factor Vtarget
DB05777Thrombomodulin AlfaProthrombintarget
DB05793PRO-542Free fatty acid receptor 4target
DB05797TNX-901High affinity immunoglobulin epsilon receptor subunit alphatarget
DB05829Parathyroid hormoneParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05829Parathyroid hormoneParathyroid hormone 2 receptortarget
DB05864PPI-2458Methionine aminopeptidase 2target
DB05889Inotuzumab ozogamicinP-glycoprotein 1transporter
DB05889Inotuzumab ozogamicinB-cell receptor CD22target
DB05892RI 624Beta-nerve growth factortarget
DB05915MYO-029Growth/differentiation factor 8target
DB05931PegdinetanibVascular endothelial growth factor receptor 2target
DB05934CTCE-0214Stromal cell-derived factor 1target
DB05941LeronlimabC-C chemokine receptor type 5target
DB05996Glembatumumab vedotinTransmembrane glycoprotein NMBtarget
DB06043OlaratumabPlatelet-derived growth factor receptor alphatarget
DB06050TB-402Coagulation factor VIIItarget
DB06081Caplacizumabvon Willebrand factortarget
DB06101IMC-1C11Vascular endothelial growth factor receptor 1target
DB06101IMC-1C11Vascular endothelial growth factor receptor 2target
DB06101IMC-1C11Vascular endothelial growth factor receptor 3target
DB06116EldelumabC-X-C motif chemokine 10target
DB06138IRL-1620Endothelin B receptortarget
DB06149TeicoplaninD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DB06151AcetylcysteineSolute carrier organic anion transporter family member 1B1transporter
DB06151AcetylcysteineNAPQI (N-acetyl-p-benzoquinone imine)target
DB06151AcetylcysteineSolute carrier family 22 member 6transporter
DB06151AcetylcysteineAminoacylase-1target
DB06151AcetylcysteineInhibitor of nuclear factor kappa-B kinase subunit alphatarget
DB06151AcetylcysteineInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB06151AcetylcysteineGlutathione synthetasetarget
DB06151AcetylcysteineCystine/glutamate transportertarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Btarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 1target
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Atarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Dtarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 3Atarget
DB06162LumiliximabLow affinity immunoglobulin epsilon Fc receptortarget
DB06168CanakinumabInterleukin-1 betatarget
DB06176RomidepsinCytochrome P450 3A4enzyme
DB06176RomidepsinCytochrome P450 3A5enzyme
DB06176RomidepsinP-glycoprotein 1transporter
DB06176RomidepsinSolute carrier organic anion transporter family member 1B3transporter
DB06176RomidepsinCytochrome P450 1A1enzyme
DB06176RomidepsinCytochrome P450 2B6enzyme
DB06176RomidepsinCytochrome P450 2C19enzyme
DB06176RomidepsinHistone deacetylase 1target
DB06176RomidepsinHistone deacetylase 2target
DB06176RomidepsinHistone deacetylase 4target
DB06176RomidepsinHistone deacetylase 6target
DB06176RomidepsinMultidrug resistance-associated protein 1target
DB06186IpilimumabCytotoxic T-lymphocyte protein 4target
DB06196IcatibantB2 bradykinin receptortarget
DB06196IcatibantAminopeptidase Ntarget
DB06219DalbavancinD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DB06241ClenoliximabT-cell surface glycoprotein CD4target
DB06243EflornithineOrnithine decarboxylasetarget
DB06245LanoteplaseUrokinase plasminogen activator surface receptortarget
DB06245LanoteplaseFibrinogen alpha chaintarget
DB06245LanoteplaseKallikrein-1target
DB06245LanoteplaseLaminin subunit alpha-5target
DB06245LanoteplaseCoagulation factor Xtarget
DB06245LanoteplaseFibronectintarget
DB06245LanoteplasePlasminogen activator inhibitor 2target
DB06245LanoteplaseTetranectintarget
DB06245LanoteplaseKeratin, type II cytoskeletal 8target
DB06245LanoteplaseAnnexin A2target
DB06245LanoteplaseLaminin subunit beta-1target
DB06245LanoteplaseLaminin subunit gamma-1target
DB06245LanoteplaseLaminin subunit alpha-1target
DB06245LanoteplaseCalreticulintarget
DB06245LanoteplaseCalnexintarget
DB06245LanoteplaseProlow-density lipoprotein receptor-related protein 1target
DB06245LanoteplaseLaminin subunit alpha-3target
DB06262DroxidopaPhenylalanine-4-hydroxylasetarget
DB06262DroxidopaAlpha-1A adrenergic receptortarget
DB06262DroxidopaAlpha-1B adrenergic receptortarget
DB06262DroxidopaAlpha-1D adrenergic receptortarget
DB06262DroxidopaAlpha-2A adrenergic receptortarget
DB06262DroxidopaAlpha-2B adrenergic receptortarget
DB06262DroxidopaAlpha-2C adrenergic receptortarget
DB06262DroxidopaBeta-1 adrenergic receptortarget
DB06262DroxidopaBeta-2 adrenergic receptortarget
DB06262DroxidopaBeta-3 adrenergic receptortarget
DB06262DroxidopaAromatic-L-amino-acid decarboxylaseenzyme
DB06262DroxidopaMonocarboxylate transporter 10transporter
DB06262DroxidopaSodium-dependent noradrenaline transportertransporter
DB06273TocilizumabInterleukin-6 receptor subunit alphatarget
DB06273TocilizumabCytochrome P450 3A4enzyme
DB06285TeriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB06317ElotuzumabSLAM family member 7target
DB06318AVE9633Myeloid cell surface antigen CD33target
DB06318AVE9633Cytochrome P450 3A4enzyme
DB06322CarotuximabEndoglintarget
DB06324XmAb 2513Tumor necrosis factor receptor superfamily member 8target
DB06335SaxagliptinDipeptidyl peptidase 4target
DB06335SaxagliptinCytochrome P450 3A4enzyme
DB06335SaxagliptinCytochrome P450 3A5enzyme
DB06335SaxagliptinMultidrug resistance-associated protein 1transporter
DB06335SaxagliptinSolute carrier organic anion transporter family member 4C1transporter
DB06335SaxagliptinSolute carrier family 22 member 8transporter
DB06342Coltuximab ravtansineB-lymphocyte antigen CD19target
DB06342Coltuximab ravtansineCytochrome P450 3A4enzyme
DB06343TeprotumumabInsulin-like growth factor 1 receptortarget
DB06360LucatumumabTumor necrosis factor receptor superfamily member 5target
DB06366PertuzumabReceptor tyrosine-protein kinase erbB-2target
DB06371SiplizumabT-cell surface antigen CD2target
DB06372RilonaceptInterleukin-1 betatarget
DB06372RilonaceptInterleukin-1 alphatarget
DB06372RilonaceptInterleukin-1 receptor antagonist proteintarget
DB06404Human C1-esterase inhibitorComplement C1r subcomponenttarget
DB06404Human C1-esterase inhibitorComplement C1s subcomponenttarget
DB06404Human C1-esterase inhibitorPlasma kallikreintarget
DB06404Human C1-esterase inhibitorCoagulation factor XIItarget
DB06404Human C1-esterase inhibitorProthrombintarget
DB06404Human C1-esterase inhibitorCoagulation factor XItarget
DB06404Human C1-esterase inhibitorTissue-type plasminogen activatortarget
DB06423Endostatin72 kDa type IV collagenasetarget
DB06423EndostatinMatrix metalloproteinase-9target
DB06423EndostatinCollagenase 3target
DB06423EndostatinFocal adhesion kinase 1target
DB06423EndostatinE-selectintarget
DB06423EndostatinCytochrome P450 19A1enzyme
DB06474SibrotuzumabSeprasetarget
DB06495OnerceptTumor necrosis factortarget
DB06510MuraglitazarPeroxisome proliferator-activated receptor alphatarget
DB06510MuraglitazarPeroxisome proliferator-activated receptor gammatarget
DB06510MuraglitazarCytochrome P450 1A2enzyme
DB06510MuraglitazarUDP-glucuronosyltransferase 1-3enzyme
DB06510MuraglitazarUDP-glucuronosyltransferase 1-1enzyme
DB06510MuraglitazarCytochrome P450 2C8enzyme
DB06511AMGN-0007Tumor necrosis factor ligand superfamily member 11target
DB06534ThrombopoietinThrombopoietin receptortarget
DB06549LabradimilB2 bradykinin receptortarget
DB06550BivatuzumabCD44 antigentarget
DB06584TG4010Mucin-1target
DB06584TG4010Interleukin-2target
DB06599LexatumumabTumor necrosis factor receptor superfamily member 10Btarget
DB06602ReslizumabInterleukin-5target
DB06607CatumaxomabEpithelial cell adhesion moleculetarget
DB06607CatumaxomabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB06607CatumaxomabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB06607CatumaxomabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB06607CatumaxomabT-cell surface glycoprotein CD3 epsilon chaintarget
DB06607CatumaxomabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB06612MepolizumabInterleukin-5target
DB06643DenosumabTumor necrosis factor ligand superfamily member 11target
DB06650OfatumumabB-lymphocyte antigen CD20target
DB06654SafinamideAmine oxidase [flavin-containing] Btarget
DB06654SafinamideAmine oxidase [flavin-containing] Aenzyme
DB06654SafinamideATP-binding cassette sub-family G member 2transporter
DB06654SafinamideSolute carrier organic anion transporter family member 3A1transporter
DB06654SafinamideCytochrome P450 3A4enzyme
DB06654SafinamideCytochrome P450 1A1enzyme
DB06654SafinamideCytochrome P450 1A2enzyme
DB06654SafinamideCytochrome P450 2B6enzyme
DB06654SafinamideCytochrome P450 2C9enzyme
DB06654SafinamideCytochrome P450 2D6enzyme
DB06654SafinamideCytochrome P450 2C19enzyme
DB06654SafinamideCytochrome P450 2E1enzyme
DB06654SafinamideCytochrome P450 3A5enzyme
DB06655LiraglutideGlucagon-like peptide 1 receptortarget
DB06655LiraglutideDipeptidyl peptidase 4enzyme
DB06655LiraglutideNeprilysinenzyme
DB06655LiraglutideSerum albumincarrier
DB06663PasireotideSomatostatin receptor type 1target
DB06663PasireotideSomatostatin receptor type 2target
DB06663PasireotideSomatostatin receptor type 3target
DB06663PasireotideSomatostatin receptor type 5target
DB06663PasireotideCytochrome P450 3A4enzyme
DB06674GolimumabTumor necrosis factortarget
DB06681BelataceptT-lymphocyte activation antigen CD86target
DB06681BelataceptT-lymphocyte activation antigen CD80target
DB06692AprotininTrypsin-1target
DB06692AprotininChymotrypsinogen Btarget
DB06692AprotininPlasminogentarget
DB06692AprotininKallikrein-1target
DB06692AprotininCholinesteraseenzyme
DB06699DegarelixGonadotropin-releasing hormone receptortarget
DB06719BuserelinLutropin-choriogonadotropic hormone receptortarget
DB06719BuserelinGonadotropin-releasing hormone receptortarget
DB06719BuserelinCytochrome P450 19A1enzyme
DB06775Carglumic acidCarbamoyl-phosphate synthase [ammonia], mitochondrialtarget
DB06785GanirelixGonadotropin-releasing hormone receptortarget
DB06788HistrelinGonadotropin-releasing hormone receptortarget
DB06791LanreotideSomatostatin receptor type 2target
DB06791LanreotideSomatostatin receptor type 5target
DB06791LanreotideCytochrome P450 3A4enzyme
DB06823TioproninMyeloperoxidaseenzyme
DB06825TriptorelinGonadotropin-releasing hormone receptortarget
DB06827Viomycin16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyAtarget
DB07744Z-Val-Ala-Asp fluoromethyl ketoneCaspase-1target
DB08508N-BENZOYL-D-ALANINEPenicillin-binding protein 1btarget
DB08626ThiorphanNeprilysintarget
DB08847HydroxyprolineProton-coupled amino acid transporter 1transporter
DB08856DADLESolute carrier organic anion transporter family member 1B1transporter
DB08861DPDPESolute carrier organic anion transporter family member 1B3transporter
DB08862CholecystokininSolute carrier organic anion transporter family member 1B3transporter
DB08862CholecystokininCholecystokinin receptor type Atarget
DB08862CholecystokininRAF proto-oncogene serine/threonine-protein kinasetarget
DB08862CholecystokininMitogen-activated protein kinase 3target
DB08862CholecystokininPro-epidermal growth factortarget
DB08862CholecystokininProtein kinase C beta typetarget
DB08862CholecystokininGastrin/cholecystokinin type B receptortarget
DB08862CholecystokininSolute carrier organic anion transporter family member 1B1transporter
DB08862CholecystokininSolute carrier organic anion transporter family member 2B1transporter
DB08869TesamorelinGrowth hormone-releasing hormone receptortarget
DB08870Brentuximab vedotinTumor necrosis factor receptor superfamily member 8target
DB08870Brentuximab vedotinCytochrome P450 3A4enzyme
DB08870Brentuximab vedotinATP-binding cassette sub-family B member 5transporter
DB08872Gabapentin enacarbilVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB08872Gabapentin enacarbilVoltage-dependent calcium channel subunit alpha-2/delta-2target
DB08872Gabapentin enacarbilSodium-coupled monocarboxylate transporter 1transporter
DB08872Gabapentin enacarbilSodium-dependent multivitamin transportertransporter
DB08873BoceprevirCytochrome P450 3A4enzyme
DB08873BoceprevirCytochrome P450 3A5enzyme
DB08873BoceprevirP-glycoprotein 1transporter
DB08873BoceprevirNS3/4A proteintarget
DB08879BelimumabTumor necrosis factor ligand superfamily member 13Btarget
DB08885AfliberceptVascular endothelial growth factor Atarget
DB08885AfliberceptPlacenta growth factortarget
DB08885AfliberceptVascular endothelial growth factor Btarget
DB08888OcriplasminAlpha-2-macroglobulintarget
DB08888OcriplasminAlpha-2-antiplasmintarget
DB08888OcriplasminFibronectintarget
DB08889CarfilzomibP-glycoprotein 1transporter
DB08889CarfilzomibProteasome subunit beta type-5target
DB08889CarfilzomibProteasome subunit beta type-9target
DB08889CarfilzomibProteasome subunit beta type-10target
DB08889CarfilzomibProteasome subunit beta type-8target
DB08889CarfilzomibProteasome subunit beta type-1target
DB08889CarfilzomibProteasome subunit beta type-2target
DB08890LinaclotideHeat-stable enterotoxin receptortarget
DB08892Arbaclofen PlacarbilMonocarboxylate transporter 1transporter
DB08892Arbaclofen PlacarbilGamma-aminobutyric acid type B receptor subunit 1target
DB08892Arbaclofen PlacarbilGamma-aminobutyric acid type B receptor subunit 2target
DB08894PeginesatideErythropoietin receptortarget
DB08900TeduglutideGlucagon-like peptide 2 receptortarget
DB08902RaxibacumabProtective antigentarget
DB08904Certolizumab pegolTumor necrosis factortarget
DB08904Certolizumab pegolAlcohol dehydrogenase [NADP(+)]enzyme
DB08935ObinutuzumabB-lymphocyte antigen CD20target
DB09029SecukinumabInterleukin-17Atarget
DB09033VedolizumabIntegrin alpha-4target
DB09033VedolizumabIntegrin beta-7target
DB09035NivolumabProgrammed cell death protein 1target
DB09036SiltuximabInterleukin-6target
DB09036SiltuximabCytochrome P450 3A4enzyme
DB09037PembrolizumabProgrammed cell death protein 1target
DB09043AlbiglutideGlucagon-like peptide 1 receptortarget
DB09045DulaglutideGlucagon-like peptide 1 receptortarget
DB09046MetreleptinLeptin receptortarget
DB09052BlinatumomabB-lymphocyte antigen CD19target
DB09052BlinatumomabT-cell surface glycoprotein CD3 delta chaintarget
DB09059AtosibanOxytocin receptortarget
DB09059AtosibanVasopressin V1a receptortarget
DB09059AtosibanVasopressin V1b receptortarget
DB09059AtosibanVasopressin V2 receptortarget
DB09066Corifollitropin alfaFollicle-stimulating hormone receptortarget
DB09067Corticorelin ovine triflutateCorticotropin-releasing factor receptor 1target
DB09077DinutuximabGanglioside GD2target
DB09098SomatremGrowth hormone receptortarget
DB09098SomatremInsulin-like growth factor 1 receptortarget
DB09099SomatostatinSomatostatin receptor type 1target
DB09099SomatostatinSomatostatin receptor type 2target
DB09099SomatostatinSomatostatin receptor type 3target
DB09099SomatostatinSomatostatin receptor type 4target
DB09099SomatostatinSomatostatin receptor type 5target
DB09099SomatostatinP-glycoprotein 1transporter
DB09099SomatostatinCytochrome P450 3A4enzyme
DB09103AncestimMast/stem cell growth factor receptor Kittarget
DB09105Asfotase alfaSphingosine 1-phosphate receptor 1target
DB09105Asfotase alfaPyrophosphatetarget
DB09107Methoxy polyethylene glycol-epoetin betaErythropoietin receptortarget
DB09109Turoctocog alfaCoagulation factor IXtarget
DB09109Turoctocog alfaCoagulation factor Xtarget
DB09109Turoctocog alfaProthrombintarget
DB09122Peginterferon beta-1aCytochrome P450 1A2enzyme
DB09126Chorionic Gonadotropin (Human)Lutropin-choriogonadotropic hormone receptortarget
DB09137Technetium Tc-99m mebrofeninSolute carrier organic anion transporter family member 1B1transporter
DB09137Technetium Tc-99m mebrofeninSolute carrier organic anion transporter family member 1B3transporter
DB09141Protamine sulfateCoagulation factor Xtarget
DB09141Protamine sulfateAntithrombin-IIItarget
DB09142SincalideSolute carrier organic anion transporter family member 1B3transporter
DB09221PolaprezincTumor necrosis factortarget
DB09221PolaprezincInterleukin-6target
DB09221PolaprezincInterleukin-3target
DB09221PolaprezincSuperoxide dismutase [Cu-Zn]enzyme
DB09221PolaprezincHeme oxygenase 1enzyme
DB09221PolaprezincSuperoxide dismutase [Mn], mitochondrialenzyme
DB09221PolaprezincGlutathione S-transferase theta-1enzyme
DB09221PolaprezincGlutathione peroxidase 1enzyme
DB09221PolaprezincPeroxiredoxin-1enzyme
DB09221PolaprezincPeroxiredoxin-5, mitochondrialenzyme
DB09221PolaprezincVascular endothelial growth factor receptor 1target
DB09221PolaprezincBeta-nerve growth factortarget
DB09221PolaprezincPlatelet-derived growth factor receptor betatarget
DB09221PolaprezincHeat shock protein HSP 90-alphatarget
DB09221PolaprezincHeat shock protein HSP 90-betatarget
DB09230AzelnidipineCytochrome P450 3A4enzyme
DB09230AzelnidipineVoltage-dependent L-type calcium channel subunit beta-1target
DB09265LixisenatideGlucagon-like peptide 1 receptortarget
DB09272EluxadolineMu-type opioid receptortarget
DB09272EluxadolineDelta-type opioid receptortarget
DB09272EluxadolineKappa-type opioid receptortarget
DB09272EluxadolineSolute carrier organic anion transporter family member 1B1transporter
DB09272EluxadolineCanalicular multispecific organic anion transporter 1transporter
DB09272EluxadolineSolute carrier family 22 member 8transporter
DB09292SacubitrilNeprilysintarget
DB09292SacubitrilSolute carrier organic anion transporter family member 1B1transporter
DB09292SacubitrilSolute carrier organic anion transporter family member 1B3transporter
DB09302AlirocumabProprotein convertase subtilisin/kexin type 9target
DB09303EvolocumabProprotein convertase subtilisin/kexin type 9enzyme
DB09331DaratumumabADP-ribosyl cyclase 1target
DB09421ProtirelinThyrotropin Releasing Hormone Receptortarget
DB09477EnalaprilatAngiotensin-converting enzymetarget
DB09477EnalaprilatB1 bradykinin receptortarget
DB09559NecitumumabEpidermal growth factor receptortarget
DB09564Insulin DegludecInsulin receptortarget
DB09564Insulin DegludecInsulin-like growth factor 1 receptortarget
DB09564Insulin DegludecSerum albumincarrier
DB09564Insulin DegludecCytochrome P450 1A2enzyme
DB09570IxazomibCytochrome P450 3A4enzyme
DB09570IxazomibCytochrome P450 1A2enzyme
DB09570IxazomibCytochrome P450 2B6enzyme
DB09570IxazomibCytochrome P450 2C8enzyme
DB09570IxazomibCytochrome P450 2D6enzyme
DB09570IxazomibCytochrome P450 2C19enzyme
DB09570IxazomibCytochrome P450 2C9enzyme
DB11091Hydrogen peroxideGlutathione peroxidase 1enzyme
DB11091Hydrogen peroxideCatalaseenzyme
DB11091Hydrogen peroxideAlkaline phosphatase, placental-likeenzyme
DB11095DesirudinCarboxypeptidase A1enzyme
DB11256Levomefolic acidProton-coupled folate transportertransporter
DB11256Levomefolic acidFolate transporter 1transporter
DB11256Levomefolic acidMethionine synthaseenzyme
DB11300ThrombinProteinase-activated receptor 1target
DB11300ThrombinProteinase-activated receptor 4target
DB11300ThrombinCoagulation factor XItarget
DB11300ThrombinCoagulation factor XIII A chaintarget
DB11300ThrombinCoagulation factor XIII B chaintarget
DB11300ThrombinFibrinogen alpha chaintarget
DB11300ThrombinFibrinogen beta chaintarget
DB11300ThrombinFibrinogen gamma chaintarget
DB11300ThrombinCoagulation factor Vtarget
DB11300ThrombinCoagulation factor VIIItarget
DB11311ProthrombinFibrinogen alpha chaintarget
DB11311ProthrombinFibrinogen beta chaintarget
DB11311ProthrombinCoagulation factor XIII A chaintarget
DB11311ProthrombinCarboxypeptidase B2target
DB11311ProthrombinCoagulation factor Xenzyme
DB11332SinapultideLung epithelial cellstarget
DB11567Insulin peglisproCytochrome P450 1A2enzyme
DB11569IxekizumabInterleukin-17Atarget
DB11595AtezolizumabProgrammed cell death 1 ligand 1target
DB11598Antithrombin III humanAntithrombin-IIItarget
DB11611LifitegrastIntegrin alpha-Ltarget
DB11611LifitegrastCytochrome P450 2C9enzyme
DB11611LifitegrastSolute carrier organic anion transporter family member 1A2transporter
DB11611LifitegrastSolute carrier organic anion transporter family member 2B1transporter
DB11639Dibotermin alfaBone morphogenetic protein receptor type-1Atarget
DB11639Dibotermin alfaBone morphogenetic protein receptor type-2target
DB11653BremelanotideMelanocyte-stimulating hormone receptortarget
DB11653BremelanotideMelanocortin receptor 4target
DB11653BremelanotideMelanocortin receptor 3target
DB11653BremelanotideMelanocortin receptor 5target
DB11653BremelanotideAdrenocorticotropic hormone receptortarget
DB11714DurvalumabProgrammed cell death 1 ligand 1target
DB11714DurvalumabT-lymphocyte activation antigen CD80target
DB11767SarilumabAlanine aminotransferase 1enzyme
DB11767SarilumabAlanine aminotransferase 2enzyme
DB11767SarilumabAspartate aminotransferaseenzyme
DB11767SarilumabCytochrome P450 3A4enzyme
DB11767SarilumabInterleukin-6 receptor subunit alphatarget
DB11767SarilumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB11781TosedostatPuromycin-sensitive aminopeptidasetarget
DB11781TosedostatLeukotriene A-4 hydrolasetarget
DB11834GuselkumabInterleukin-23 subunit alphatarget
DB11842Angiotensin IIType-1 angiotensin II receptortarget
DB11854AstodrimerEnvelope glycoprotein gp160target
DB11866RomosozumabSclerostintarget
DB11869ValspodarSolute carrier organic anion transporter family member 1B1transporter
DB11869ValspodarSolute carrier organic anion transporter family member 1B3transporter
DB11915Valbenazinevesicular monoamine transporter 2 (VMAT2)target
DB11915ValbenazineCytochrome P450 2D6enzyme
DB11915ValbenazineCytochrome P450 3A4enzyme
DB11915ValbenazineCytochrome P450 3A5enzyme
DB11945AvelumabProgrammed cell death 1 ligand 1target
DB11988OcrelizumabB-lymphocyte antigen CD20target
DB12089Lorvotuzumab mertansineCytochrome P450 3A4enzyme
DB12095Telotristat ethylTryptophan 5-hydroxylase 2target
DB12095Telotristat ethylTryptophan 5-hydroxylase 1target
DB12118SotaterceptActivin receptor type-2Atarget
DB12119GevokizumabInterleukin-1 betatarget
DB12159DupilumabInterleukin-4 receptor subunit alphatarget
DB12240Polatuzumab vedotinCytochrome P450 3A4enzyme
DB12240Polatuzumab vedotinB-cell antigen receptor complex-associated protein beta chaintransporter
DB12240Polatuzumab vedotinB-cell antigen receptor complex-associated protein beta chaintarget
DB12250CixutumumabInsulin-like growth factor 1 receptortarget
DB12271ORE-1001Carboxypeptidase N catalytic chaintarget
DB12271ORE-1001Carboxypeptidase N subunit 2target
DB12489Mirvetuximab SoravtansineCytochrome P450 3A4enzyme
DB12498MogamulizumabC-X-C chemokine receptor type 4target
DB12589DacetuzumabTumor necrosis factor receptor superfamily member 5target
DB126293,5-diiodothyropropionic acidCytochrome P450 3A4enzyme
DB12698IbalizumabT-cell surface glycoprotein CD4target
DB12698IbalizumabC-C chemokine receptor type 5target
DB12698IbalizumabC-X-C chemokine receptor type 4target
DB12845AmatuximabMesothelintarget
DB12865EtelcalcetideExtracellular calcium-sensing receptortarget
DB13074MacimorelinGrowth hormone secretagogue receptor type 1target
DB13074MacimorelinCytochrome P450 3A4enzyme
DB13133Von Willebrand Factor HumanCoagulation factor VIIItarget
DB13133Von Willebrand Factor HumanCollagen alpha-1(I) chaintarget
DB13133Von Willebrand Factor HumanA disintegrin and metalloproteinase with thrombospondin motifs 13enzyme
DB13144LenograstimGranulocyte colony-stimulating factor receptortarget
DB13149Protein S humanCoagulation factor Vtarget
DB13149Protein S humanCoagulation factor Xtarget
DB13149Protein S humanVitamin K-dependent protein Ctarget
DB13150Coagulation factor VII humanTissue factortarget
DB13150Coagulation factor VII humanCoagulation factor Xtarget
DB13150Coagulation factor VII humanCoagulation factor IXtarget
DB13166ZofenoprilAngiotensin-converting enzymetarget
DB13191PhosphocreatineGuanidinoacetate N-methyltransferasetarget
DB13191PhosphocreatineSodium- and chloride-dependent creatine transporter 1target
DB13191PhosphocreatineCreatine kinase M-typetarget
DB13191PhosphocreatineCreatine kinase U-type, mitochondrialtarget
DB13191PhosphocreatineCreatine kinase S-type, mitochondrialtarget
DB13191PhosphocreatineCreatine kinase B-typetarget
DB13192Antihemophilic factor humanCoagulation factor IXtarget
DB13192Antihemophilic factor humanCoagulation factor Xtarget
DB13192Antihemophilic factor humanVitamin K-dependent protein Cenzyme
DB13200LipegfilgrastimGranulocyte colony-stimulating factor receptortarget
DB13257Ferrous sulfate anhydrousSerotransferrintransporter
DB13257Ferrous sulfate anhydrousFerritin light chaintransporter
DB13257Ferrous sulfate anhydrousFerritin heavy chaintransporter
DB13257Ferrous sulfate anhydrousDivalent metal ion transporter 1transporter
DB13257Ferrous sulfate anhydrousIron binding protein FbpAtransporter
DB13257Ferrous sulfate anhydrousNADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrialenzyme
DB13257Ferrous sulfate anhydrousSuccinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialenzyme
DB13257Ferrous sulfate anhydrousXanthine dehydrogenase/oxidaseenzyme
DB13257Ferrous sulfate anhydrousAconitate hydratase, mitochondrialenzyme
DB13257Ferrous sulfate anhydrousCytochrome P450 4A11enzyme
DB13257Ferrous sulfate anhydrousSulfite oxidase, mitochondrialenzyme
DB13257Ferrous sulfate anhydrousMyeloperoxidaseenzyme
DB13257Ferrous sulfate anhydrousCatalaseenzyme
DB13257Ferrous sulfate anhydrousNitric oxide synthase, inducibleenzyme
DB13257Ferrous sulfate anhydrousProstaglandin G/H synthase 1enzyme
DB13257Ferrous sulfate anhydrousProstaglandin G/H synthase 2enzyme
DB13257Ferrous sulfate anhydrousTryptophan 5-hydroxylase 1enzyme
DB13257Ferrous sulfate anhydrousProlyl 4-hydroxylase subunit alpha-1enzyme
DB13257Ferrous sulfate anhydrousPterin-4-alpha-carbinolamine dehydrataseenzyme
DB13257Ferrous sulfate anhydrousCeruloplasminenzyme
DB13257Ferrous sulfate anhydrousFree radicalstarget
DB13503TyrothricinAcetylcholinesterasetarget
DB13503TyrothricinBeta-galactosidasetarget
DB13503TyrothricinPhospholipid membranetarget
DB13615MifamurtideToll-like receptor 4target
DB13615MifamurtideNucleotide-binding oligomerization domain-containing protein 2target
DB13923EmicizumabCoagulation factor IXtarget
DB13923EmicizumabCoagulation factor Xtarget
DB13928SemaglutideSerum albumincarrier
DB13928SemaglutideDipeptidyl peptidase 4enzyme
DB13928SemaglutideNeprilysinenzyme
DB13928SemaglutideGlucagon-like peptide 1 receptortarget
DB13928SemaglutideLipoprotein lipaseenzyme
DB13928SemaglutideAlpha-amylase 1enzyme
DB13931NetarsudilRho-associated protein kinase 1target
DB13931NetarsudilRho-associated protein kinase 2target
DB13931NetarsudilSodium-dependent noradrenaline transportertarget
DB13933Nonacog beta pegolCoagulation factor VIItarget
DB13933Nonacog beta pegolCoagulation factor VIIItarget
DB13933Nonacog beta pegolCoagulation factor Xtarget
DB13979BesilesomabCarcinoembryonic antigentarget
DB13985Lutetium Lu 177 dotatateSomatostatin receptor type 2target
DB13985Lutetium Lu 177 dotatateSomatostatin receptor type 1target
DB13985Lutetium Lu 177 dotatateSomatostatin receptor type 3target
DB13985Lutetium Lu 177 dotatateSomatostatin receptor type 4target
DB13985Lutetium Lu 177 dotatateSomatostatin receptor type 5target
DB13999Moroctocog alfaCoagulation factor Xtarget
DB13999Moroctocog alfaPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB13999Moroctocog alfaCoagulation factor IXtarget
DB13999Moroctocog alfaAsialoglycoprotein receptor 2target
DB13999Moroctocog alfa78 kDa glucose-regulated proteintarget
DB13999Moroctocog alfaCalreticulintarget
DB13999Moroctocog alfaCalnexintarget
DB13999Moroctocog alfaProtein ERGIC-53target
DB13999Moroctocog alfaProlow-density lipoprotein receptor-related protein 1target
DB13999Moroctocog alfaMultiple coagulation factor deficiency protein 2target
DB13999Moroctocog alfavon Willebrand factortarget
DB13999Moroctocog alfaProthrombinenzyme
DB13999Moroctocog alfaVitamin K-dependent protein Cenzyme
DB14004TildrakizumabInterleukin-23target
DB14004TildrakizumabCytochrome P450 4A11enzyme
DB14039ErenumabCalcitonin gene-related peptide type 1 receptortarget
DB14041FremanezumabCalcitonin gene-related peptide 1target
DB14041FremanezumabCalcitonin gene-related peptide 2target
DB05624TeverelixGonadotropin-releasing hormone receptortarget
DB14057ValinomycinBile salt export pumptransporter
DB14058BasifunginInositol phosphorylceramide synthasetarget
DB14072Reversin 121P-glycoprotein 1target
DB09532Secretin humanSecretin receptortarget
DB14562Andexanet alfaTissue factor pathway inhibitortarget
DB14597LanadelumabPlasma kallikreintarget
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factortarget
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factorcarrier
DB14642LypressinVasopressin V1a receptortarget
DB14642LypressinVasopressin V2 receptortarget
DB14642LypressinVasopressin V1b receptortarget
DB14642LypressinCanalicular multispecific organic anion transporter 1transporter
DB12688Moxetumomab PasudotoxB-cell receptor CD22target
DB12688Moxetumomab PasudotoxElongation factor 2target
DB08766ZofenoprilatCytosol aminopeptidasetarget
DB06111AB192Myeloperoxidaseenzyme
DB14042GalcanezumabCalcitonin gene-related peptide 1target
DB14042GalcanezumabCalcitonin gene-related peptide 2target
DB07558acetylleucyl-leucyl-norleucinalProteasome subunit alpha type-7target
DB00129OrnithineOrnithine aminotransferase, mitochondrialtarget
DB00129OrnithineOrnithine carbamoyltransferase, mitochondrialtarget
DB00129OrnithineArginase-1target
DB00129OrnithineOrnithine decarboxylase antizyme 1target
DB00129OrnithineLow affinity cationic amino acid transporter 2target
DB00129OrnithineMitochondrial ornithine transporter 2target
DB00129OrnithineCationic amino acid transporter 4target
DB00129OrnithineHigh affinity cationic amino acid transporter 1target
DB00129OrnithineArginase-2, mitochondrialtarget
DB00129OrnithineMitochondrial ornithine transporter 1target
DB00129OrnithineCationic amino acid transporter 3target
DB00129OrnithineOrnithine decarboxylase antizyme 2target
DB00129OrnithineGlycine amidinotransferase, mitochondrialtarget
DB00129OrnithineOrnithine decarboxylase antizyme 3target
DB01752S-adenosyl-L-homocysteineCap-specific mRNA (nucleoside-2'-O-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCobalt-precorrin-4 C(11)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineProtein-L-isoaspartate(D-aspartate) O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGenome polyproteintarget
DB01752S-adenosyl-L-homocysteinePhenylethanolamine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase 2target
DB01752S-adenosyl-L-homocysteineModification methylase RsrItarget
DB01752S-adenosyl-L-homocysteineCatechol O-methyltransferase domain-containing protein 1target
DB01752S-adenosyl-L-homocysteineCarminomycin 4-O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGuanidinoacetate N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRelease factor glutamine methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRelease factor glutamine methyltransferasetarget
DB01752S-adenosyl-L-homocysteineProtein arginine N-methyltransferase 3target
DB01752S-adenosyl-L-homocysteineHistamine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRibosomal RNA small subunit methyltransferase Htarget
DB01752S-adenosyl-L-homocysteinerRNA adenine N-6-methyltransferasetarget
DB01752S-adenosyl-L-homocysteinetRNA (cytosine(38)-C(5))-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGlycine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteinetRNA (cytidine(34)-2'-O)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineModification methylase PvuIItarget
DB01752S-adenosyl-L-homocysteineDNA adenine methylasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase 3target
DB01752S-adenosyl-L-homocysteineProtein arginine N-methyltransferase 1target
DB01752S-adenosyl-L-homocysteineSiroheme synthasetarget
DB01752S-adenosyl-L-homocysteineModification methylase HhaItarget
DB01752S-adenosyl-L-homocysteineHistone-lysine N-methyltransferase SETD7target
DB01752S-adenosyl-L-homocysteinetRNA (guanine-N(1)-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase MmaA2target
DB01752S-adenosyl-L-homocysteineDiphthine synthasetarget
DB01752S-adenosyl-L-homocysteineRdmBtarget
DB01752S-adenosyl-L-homocysteinetRNA (guanine-N(1)-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineUroporphyrinogen-III C-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineUncharacterized proteintarget
DB01752S-adenosyl-L-homocysteineChemotaxis protein methyltransferasetarget
DB01752S-adenosyl-L-homocysteineModification methylase TaqItarget
DB01752S-adenosyl-L-homocysteineProtein-L-isoaspartate O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineHistamine N-methyltransferaseenzyme
DB02458S-(2,4-dinitrophenyl)glutathioneGlutathione S-transferase Mu 1target
DB02458S-(2,4-dinitrophenyl)glutathioneGlutathione S-transferase Mu 2target
DB02530gamma-Aminobutyric acidGlycine amidinotransferase, mitochondrialtarget
DB02530gamma-Aminobutyric acidProton-coupled amino acid transporter 1transporter
DB02530gamma-Aminobutyric acidGamma-aminobutyric acid type B receptor subunit 1target
DB02530gamma-Aminobutyric acidGamma-aminobutyric acid type B receptor subunit 2target
DB02691Glycocholic acidGastrotropintarget
DB02691Glycocholic acidSolute carrier organic anion transporter family member 1A2transporter
DB02691Glycocholic acidSolute carrier organic anion transporter family member 1B1transporter
DB02691Glycocholic acidSolute carrier organic anion transporter family member 1B3transporter
DB02751GlycocyamineGuanidinoacetate N-methyltransferasetarget
DB03310Glutathione disulfideGlutathione S-transferase Mu 2target
DB03310Glutathione disulfideGlutathione reductase, mitochondrialtarget
DB03604TiratricolThyroid hormone receptor betatarget
DB11693VoclosporinCalcineurin subunit B type 1target
DB11693VoclosporinCalcineurin subunit B type 2target
DB11914LebrikizumabInterleukin-13target
DB11914LebrikizumabIL13 proteintarget
DB12023BenralizumabInterleukin-5 receptor subunit alphatarget
DB12023BenralizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB12202ZalutumumabEpidermal growth factor receptortarget
DB12520PlozalizumabC-C chemokine receptor type 2target
DB12773SifalimumabInterferon alpha-2target
DB13170PlecanatideGuanylate cyclase soluble subunit alpha-2target
DB14724EmapalumabInterferon gammatarget
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 2target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 1target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 5target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 4target
DB14731TagraxofuspInterleukin-3 receptor subunit alphatarget
DB14731TagraxofuspADP-ribosylation factor-like protein 2target
DB00091CyclosporineCalcium signal-modulating cyclophilin ligandtarget
DB00091CyclosporinePeptidyl-prolyl cis-trans isomerase Atarget
DB00091CyclosporineCalcineurin subunit B type 2target
DB00091CyclosporineCytochrome P450 3A5enzyme
DB00091CyclosporineCytochrome P450 3A4enzyme
DB00091CyclosporineCytochrome P450 3A7enzyme
DB00091CyclosporineP-glycoprotein 1transporter
DB00091CyclosporineCanalicular multispecific organic anion transporter 2transporter
DB00091CyclosporineBile salt export pumptransporter
DB00091CyclosporineSolute carrier organic anion transporter family member 1A2transporter
DB00091CyclosporineIleal sodium/bile acid cotransportertransporter
DB00091CyclosporineSodium/bile acid cotransportertransporter
DB00091CyclosporineSolute carrier family 22 member 6transporter
DB00091CyclosporineMultidrug resistance-associated protein 7transporter
DB00091CyclosporineCanalicular multispecific organic anion transporter 1transporter
DB00091CyclosporineATP-binding cassette sub-family G member 2transporter
DB00091CyclosporineSolute carrier organic anion transporter family member 1B1transporter
DB00091CyclosporineCytochrome P450 2C19enzyme
DB00091CyclosporineCytochrome P450 2C9enzyme
DB00091CyclosporineCytochrome P450 2D6enzyme
DB00091CyclosporinePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
DB00091CyclosporineSolute carrier organic anion transporter family member 1B3transporter
DB14738Turoctocog alfa pegolVitamin K-dependent protein Cenzyme
DB14738Turoctocog alfa pegolCoagulation factor Xenzyme
DB14738Turoctocog alfa pegolCoagulation factor IXtarget
DB14738Turoctocog alfa pegolCoagulation factor Xtarget
DB14738Turoctocog alfa pegolProthrombintarget
DB14738Turoctocog alfa pegolvon Willebrand factorcarrier
DB00781Polymyxin BBacterial outer membranetarget
DB00781Polymyxin BSolute carrier family 15 member 2transporter
DB02446Glutamine hydroxamateGlutamine--fructose-6-phosphate aminotransferase [isomerizing]target
DB033145-fluorotryptophanTriosephosphate isomerasetarget
DB033145-fluorotryptophanGlutathione S-transferase Mu 1target
DB05304GirentuximabCarbonic anhydrase 9target
DB05304GirentuximabInterleukin-2target
DB14762RisankizumabInterleukin-23target
DB05386RegramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
DB05386RegramostimGM-CSF receptor alpha subunittarget
DB05386RegramostimCholinesteraseenzyme
DB05875Sar9, Met (O2)11-Substance PCytochrome P450 19A1enzyme
DB05875Sar9, Met (O2)11-Substance PCholinesteraseenzyme
DB05875Sar9, Met (O2)11-Substance PProstaglandin G/H synthase 2enzyme
DB14999Human interferon betaCytochrome P450 1A2enzyme
DB15131Interferon alfa-2cCytochrome P450 1A2enzyme
DB05916CT-011Programmed cell death protein 1target
DB05950Contulakin-GVoltage-dependent N-type calcium channel subunit alpha-1Btarget
DB08898GlucarpidaseMethotrexatetarget
DB11572Thrombin alfaCoagulation factor XItarget
DB11572Thrombin alfaCoagulation factor VIIItarget
DB11572Thrombin alfaCoagulation factor Vtarget
DB11572Thrombin alfaCoagulation factor XIII A chaintarget
DB11572Thrombin alfaCoagulation factor XIII B chaintarget
DB11572Thrombin alfaFibrinogen alpha chaintarget
DB11572Thrombin alfaFibrinogen beta chaintarget
DB11572Thrombin alfaFibrinogen gamma chaintarget
DB11580RavulizumabComplement C5target
DB11731Depatuxizumab mafodotinEpidermal growth factor receptortarget
DB11731Depatuxizumab mafodotinTubulin beta chaintarget
DB12077UrelumabTumor necrosis factor receptor superfamily member 9target
DB13140BezlotoxumabClostridium difficile Toxin Btarget
DB13151Anti-inhibitor coagulant complexCoagulation factor Xtarget
DB13151Anti-inhibitor coagulant complexProthrombintarget
DB13151Anti-inhibitor coagulant complexFibrinogen alpha chaintarget
DB13151Anti-inhibitor coagulant complexFibrinogen beta chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor XIII A chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor Vtarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIItarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIItarget
DB13151Anti-inhibitor coagulant complexProthrombinenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIIenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor IXenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor Venzyme
DB13173Cerliponase alfaCation-independent mannose-6-phosphate receptortarget
DB13881TisagenlecleucelB-lymphocyte antigen CD19target
DB13884Albutrepenonacog alfaCoagulation factor Xtarget
DB13884Albutrepenonacog alfaCoagulation factor VIIIenzyme
DB14012BurosumabFibroblast growth factor 23target
DB14040EptinezumabCalcitonin gene-related peptide 1target
DB14040EptinezumabCalcitonin gene-related peptide 2target
DB14051Malacidin ANAM/NAG peptide subunits of peptidoglycantarget
DB14052Malacidin BNAM/NAG peptide subunits of peptidoglycantarget
DB14568IvosidenibIsocitrate dehydrogenase [NADP] cytoplasmictarget
DB14568IvosidenibCytochrome P450 3A4enzyme
DB14568IvosidenibCytochrome P450 2B6enzyme
DB14568IvosidenibCytochrome P450 2C9enzyme
DB14568IvosidenibCytochrome P450 2C8enzyme
DB14568IvosidenibSolute carrier family 22 member 8transporter
DB14568IvosidenibP-glycoprotein 1transporter
DB14707CemiplimabProgrammed cell death protein 1target
DB14754SolriamfetolSolute carrier family 22 member 2transporter
DB14754SolriamfetolSolute carrier family 22 member 4transporter
DB14754SolriamfetolSolute carrier family 22 member 5transporter
DB14754SolriamfetolSodium-dependent dopamine transportertarget
DB14754SolriamfetolSodium-dependent noradrenaline transportertarget
DB14864BrolucizumabVascular endothelial growth factor Atarget
DB15466TallimustineDNAtarget
DB13925Dotatate gallium Ga-68Somatostatin receptor type 2target
DB02668JE-2147Gag-Pol polyproteintarget
DB01833CanavanineNitric oxide synthase, endothelialtarget
DB01934Arylomycin A2Signal peptidase Itarget